<SEC-DOCUMENT>0001437749-23-032371.txt : 20231116
<SEC-HEADER>0001437749-23-032371.hdr.sgml : 20231116
<ACCEPTANCE-DATETIME>20231116172509
ACCESSION NUMBER:		0001437749-23-032371
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231110
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231116
DATE AS OF CHANGE:		20231116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN SHARED HOSPITAL SERVICES
		CENTRAL INDEX KEY:			0000744825
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				942918118
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08789
		FILM NUMBER:		231415618

	BUSINESS ADDRESS:	
		STREET 1:		601 MONTGOMERY STREET
		STREET 2:		SUITE 1112
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		415-788-5300

	MAIL ADDRESS:	
		STREET 1:		601 MONTGOMERY STREET
		STREET 2:		SUITE 1112
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>asha20231116_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ams="http://www.ams.com/20231110"><head>
	<title>asha20231116_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 11/16/2023 10:04:40 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0000744825</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="ams-20231110.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000744825</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-11-10</xbrli:startDate>
<xbrli:endDate>2023-11-10</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION </b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549 </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b>&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT </b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of report (Date of earliest event reported): <ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 10, 2023</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>AMERICAN SHARED HOSPITAL SERVICES</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in Its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:33.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>California</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>1-08789</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>94-2918118</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">of Incorporation)</div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">File Number)</div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(IRS Employer</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Identification No.)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:67.1%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:bottom;width:33.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:67.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>601 Montgomery Street, Suite 1112</b></ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>San Francisco</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>California</b></ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:31.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>94111</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:67.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:31.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Zip Code)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode">415</ix:nonNumeric>) <ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber">788-5300</ix:nonNumeric>&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Not Applicable</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:97.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.5%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:97%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)&#xa0;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:97.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))&#xa0;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.4%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:97.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#xa0;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:34.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of Each Class</div>
			</td>
			<td style="vertical-align:bottom;width:2.9%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:26.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol</div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:34.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of Each Exchange on Which Registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:34.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">American Shared Hospital Services <ix:nonNumeric contextRef="d20238K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, No Par Value</div>
			</td>
			<td style="vertical-align:bottom;width:2.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:26.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:TradingSymbol">AMS</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:1.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:34.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric> AMERICAN</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 5pt;">Emerging growth company <ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On November 10, 2023, American Shared Hospital Services (the &#8220;Company&#8221;) entered into an Investment Purchase Agreement (the &#8220;IPA&#8221;) with GenesisCare USA, Inc. (the &#8220;Seller&#8221;) and GenesisCare USA Holdings, Inc. (&#8220;Topco&#8221;), pursuant to which Seller agreed to sell to the Company its entire equity interest in each of Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC, (collectively, the &#8220;Target Companies&#8221;) together with the assignment of certain payor contacts for a purchase price of $2,850,000.&#xa0; The equity interests to be acquired by the Company under the IPA equates to a 60% interest in each Target Company. The Target Companies operate three functional radiation therapy cancer centers in Rhode Island.&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In connection with the execution of the IPA the Company made a $285,000 earnest payment deposit with a third party escrow agent, of which up to 50% may be forfeited by the Company if the IPA is terminated under certain limited circumstances, but otherwise the deposit will be applied to the purchase price at closing or otherwise returned to the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The transaction is contingent upon a confirmation order of the United States Bankruptcy Court for the Southern District of Texas (the &#8220;Bankruptcy Court&#8221;) approving a chapter 11 plan of reorganization with respect to Seller, Topco and certain of their respective affiliates and the terms of any other orders of the Bankruptcy Court, as well as the satisfaction of other closing conditions, including the Seller and the Company entering into a consent agreement with the Rhode Island Department of Health and approval of all equity holders and managers of each Target Company. The Company anticipates that these conditions will be met in the next 60 days, and each party has the right to terminate the IPA if the closing conditions have not been met by March 10, 2024.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The IPA contains various customary representations, warranties and covenants of the Company, Seller and Topco with respect to a transaction of the nature contemplated by the IPA, including covenants by the Company to reasonably cooperate and assist Seller obtaining the Bankruptcy Court&#8217;s entry of a confirmation order and matters related to the requisite regulatory approvals for the transaction.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The foregoing summary of the IPA does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the IPA, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01. Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">(d) Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:14.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">Exhibit No.</span></div>
			</td>
			<td style="vertical-align:top;width:86.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">Description</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:14.3%;">&#xa0;</td>
			<td style="vertical-align:top;width:86.8%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:14.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exhibit 10.1</div>
			</td>
			<td style="vertical-align:top;width:84.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><a href="ex_598204.htm" style="-sec-extract:exhibit;">Investment Agreement by and among GenesisCare USA, Inc., GenesisCare USA Holdings, Inc., and American Shared Hospital Services dated as of November 10, 2023</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:14.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align:top;width:84.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:44.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:43.2%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:44.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:43.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">AMERICAN SHARED HOSPITAL SERVICES</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:44.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:43.2%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt;">(Registrant)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:44.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:bottom;width:5.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td colspan="3" style="vertical-align:bottom;width:46.1%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:44.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dated: November 16, 2023</div>
			</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:43.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">/s/ Raymond C. Stachowiak</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:44.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:43.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: Raymond C. Stachowiak</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:44.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:3.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:1.6%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:43.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title: Executive Chairman</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_598204.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_598204.htm</title>

	<!-- Generated by ThunderDome Portal - 11/16/2023 9:54:31 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INVESTMENT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DATED AS OF NOVEMBER 10, 2023,</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>by and among</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>GENESISCARE USA, INC.,</b><sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>GENESISCARE USA HOLDINGS, INC.,</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>and</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AMERICAN SHARED HOSPITAL SERVICES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p>&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>TABLE OF CONTENTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="2" style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><u><b>Page</b></u></td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; text-align: right;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE I PURCHASE AND SALE OF EQUITY INTERESTS AND ACQUIRED CONTRACTS</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>2</b></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Purchase and Sale of Equity Interests and Acquired Contracts</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consideration; Payment</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deposit</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.5</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Withholding</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE II&nbsp;REPRESENTATIONS AND WARRANTIES OF SELLER RELATING TO THE COMPANIES</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>4</b></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization and Qualification and Capitalization of Companies</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Issuance</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conflicts; Consents</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Brokers</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.5</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Actions</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.6</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compliance with Laws; Permits</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.7</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial Statements</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">6</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.8</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">7</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.9</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title to Property; Leases</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">7</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.10</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Matters</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">7</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.11</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Labor and Employment</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">8</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.12</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Benefit Plans</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">8</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.13</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Material Contracts</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">9</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.14</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Commercial Payors</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.15</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Managed Entity Agreements</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.16</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transactions with Related Parties</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.17</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.18</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Changes or Developments</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.19</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sufficiency of Assets</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE III&nbsp;REPRESENTATIONS AND WARRANTIES OF SELLER</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>11</b></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization of Seller</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authorization and Validity of Agreement</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title to Equity Interests</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conflicts; Consents</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.5</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Brokers</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.6</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Actions</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PURCHASER</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>13</b></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization and Qualification</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">13</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authorization of Agreement</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">13</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conflicts; Consents</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">13</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financing</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">14</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.5</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities Law Matters</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">14</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.6</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Brokers</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.7</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Actions</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">i</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="margin: 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><b><u>TABLE OF CONTENTS</u></b></p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><u><b>Page</b></u></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.8</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Arrangements</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.9</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Solvency</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.10</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WARN Act and Mass Layoffs</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.11</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Foreign Person</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.12</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Competitive Assets</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE V BANKRUPTCY COURT MATTERS</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>16</b></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bankruptcy Actions</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Approval</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE VI COVENANTS AND AGREEMENTS</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>17</b></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Access to Information</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Regulatory Approvals</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">19</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Reasonable Efforts; Cooperation</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Further Assurances</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.5</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Acknowledgment by Purchaser; Independent Investigation; No Outside Reliance</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">21</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.6</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Directors&#8217;&nbsp;and Officers&#8217;&nbsp;Indemnification</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">22</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.7</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transitional Use of Marks; Background Licenses</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">23</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.8</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">24</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.9</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation Support</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">24</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.10</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Post-Closing Payments</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">25</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.11</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intercompany Accounts</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">25</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE VII CONDITIONS TO CLOSING</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>26</b></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions Precedent to the Obligations of Purchaser and Seller</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">26</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions Precedent to the Obligations of Purchaser</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">26</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conditions Precedent to the Obligations of Seller</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">28</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Waiver of Conditions</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">28</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE VIII TERMINATION</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>28</b></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Termination of Agreement</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">28</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effect of Termination</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">30</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE IX MISCELLANEOUS</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>30</b></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-Survival of Representations and Warranties and Certain Covenants; Certain Waivers</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">30</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expenses</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">31</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notices</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">31</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Binding Effect; Assignment</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.5</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amendment and Waiver</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.6</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Third Party Beneficiaries</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.7</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-Recourse; Release</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.8</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Severability</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.9</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Construction</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.10</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Schedules</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.11</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Complete Agreement</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">35</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">ii</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><b><u>TABLE OF CONTENTS</u></b></p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b><u>Page</u></b></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.12</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Specific Performance</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.13</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jurisdiction and Exclusive Venue</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.14</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governing Law; Waiver of Jury Trial</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.15</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Right of Set-Off</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.16</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Counterparts and PDF</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.17</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Publicity</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.18</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bulk Sales Laws</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.19</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fiduciary Obligations</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.20</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.21</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Waiver of Conflicts Regarding Representation; Nonassertion of Attorney-Client Privilege</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.22</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Topco</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">41</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ARTICLE X ADDITIONAL DEFINITIONS AND INTERPRETIVE MATTERS</b></p>
			</td>
			<td style="vertical-align: top; width: 5%; text-align: right;"><b>41</b></td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Definitions</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">41</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Index of Defined Terms</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">48</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.3</p>
			</td>
			<td style="vertical-align: top; width: 90%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rules of Interpretation</p>
			</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">49</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;"><b>INDEX OF EXHIBITS</b></td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 90%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">Exhibit A &#8211; Form of Assignment of Equity Interests</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="2" rowspan="1" style="vertical-align: top; width: 5%;">Exhibit B &#8211; Form of Bill of Sale and Assignment and Assumption Agreement</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">iii</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INVESTMENT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Investment Agreement (this &#8220;<u>Agreement</u>&#8221;), dated as of November 10, 2023, is made by and among (a) American Shared Hospital Services, a California corporation (&#8220;<u>Purchaser</u>&#8221;), (b) GenesisCare USA, Inc., a Florida corporation (as in existence on the date hereof, as a debtor-in-possession and a reorganized debtor, as applicable, &#8220;<u>Seller</u>&#8221;), and (c)&nbsp;GenesisCare USA Holdings, Inc., a Delaware corporation (as in existence on the date hereof, as a debtor-in-possession and a reorganized debtor, as applicable, &#8220;<u>Topco</u>&#8221;). Purchaser, Seller, and Topco are referred to herein individually as a &#8220;<u>Party</u>&#8221; and collectively as the &#8220;<u>Parties</u>.&#8221; Capitalized terms used herein shall have the meanings set forth herein or in <u>Article X</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, on June 1, 2023 (the &#8220;<u>Petition Date</u>&#8221;), Seller and Topco, together with certain of their respective Affiliates, commenced voluntary cases under chapter 11 of title 11 of the United States Code, 11&nbsp;U.S.C.&nbsp;&#167;&#167;&nbsp;101&#8211;1532 (the &#8220;<u>Bankruptcy</u><u>&nbsp;</u><u>Code</u>&#8221;), in the United States Bankruptcy Court for the Southern District of Texas (the&nbsp;&#8220;<u>Bankruptcy Court</u>&#8221;), which cases are jointly administered for procedural purposes under Case No. 23-90614 (DRJ) (Bankr. S.D. Tex.) (collectively, the &#8220;<u>Bankruptcy Cases</u>&#8221;) to implement a financial and organizational restructuring in accordance with the terms and conditions set forth therein (the &#8220;<u>Restructuring</u>&#8221;) for the existing debt, equity and other obligations of such Affiliates through confirmation of a chapter&nbsp;11 plan of reorganization, the <i>Joint Chapter 11 Plan of Reorganization of Genesis Care Finance Pty Ltd. and Its Debtor Affiliates </i>[Docket No. 705] (as may be amended, supplemented or otherwise modified from time to time, the &#8220;<u>Plan</u>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, as of immediately prior to the Closing, Seller owns sixty percent (60.00%) of the equity interests of Southern New England Regional Cancer Center, LLC, a Rhode Island limited liability company (&#8220;<u>SNERCC</u>&#8221;), and sixty percent (60.00%) of the Roger Williams Radiation Therapy, LLC, a Rhode Island limited liability company, (&#8220;<u>RWRT</u>&#8221;, and together with SNERRC, each a &#8220;<u>Company</u>&#8221; and collectively, the &#8220;<u>Companies</u>&#8221; and such equity interests, the &#8220;<u>Equity Interests</u>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, Purchaser desires to acquire (i) one hundred percent (100.00%) of the Equity Interests and (ii) the Commercial Payor Contracts listed on <u>Schedule A</u> to that certain Bill of Sale and Assignment and Assumption Agreement (the &#8220;<u>Acquired Contracts</u>&#8221;) attached hereto as <u>Exhibit B</u>, in each case owned by the Seller on the terms and conditions and pursuant to the transactions set forth herein (the &#8220;<u>Acquisition</u>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">WHEREAS, subject to the entry of an order by the Bankruptcy Court confirming the Plan (the &#8220;<u>Confirmation Order</u>&#8221;, the satisfaction (or to the extent permitted by Law, written waiver by the Parties) on or prior to the Closing Date, of each of the conditions to Closing in <u>Article VII</u> of this Agreement, at the Closing, Purchaser will purchase the Equity Interests and the Acquired Contracts from Seller, and Seller will sell, convey, assign, and transfer to Purchaser the Equity Interests and the Acquired Contracts, in accordance with the Plan and the applicable provisions of the Bankruptcy Code, the Federal Rules of Bankruptcy Procedure, and the local rules for the Bankruptcy Court, all on the terms and subject to the conditions set forth in this Agreement, the Plan, and the Confirmation Order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW, THEREFORE, in consideration of the foregoing premises and the mutual representations, warranties, covenants, and agreements set forth herein, and intending to be legally bound hereby, the Parties hereby agree as follows.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE I</b><br>
<b>PURCHASE AND SALE OF EQUITY INTERESTS AND ACQUIRED CONTRACTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchase and Sale of Equity Interests and Acquired Contracts</u>.</p>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;On the terms and subject to the conditions set forth in this Agreement, at the Closing, Purchaser hereby agrees to consummate the Acquisition and shall purchase, and Seller, in exchange for payment in cash of the Purchase Price, hereby agrees to and shall sell, convey, assign and transfer to Purchaser, the Equity Interests and the Acquired Contracts (including the Assumed Liabilities) free and clear of any and all Encumbrances (other than restrictions on transfer arising under applicable securities Laws or as otherwise set forth in any Company&#8217;s Organizational Documents).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;On the terms and subject to the conditions set forth herein and in the Confirmation Order, effective as of the Closing, in addition to the cash payment of the Purchase Price in accordance with <u>Section 1.2</u>, Purchaser shall irrevocably assume and hereby agrees to pay, satisfy, discharge and perform all of the Liabilities of Seller (or with respect to Taxes, if applicable, Seller&#8217;s applicable Affiliate), its Subsidiaries and Affiliates to the extent related to or arising out of the Acquired Contracts accruing or arising at or after the Closing (collectively, the &#8220;<u>Assumed Liabilities</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Consideration; Payment</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The aggregate consideration to be paid by Purchaser for the purchase of the Equity Interests and the Acquired Contracts pursuant to <u>Section 1.1</u> shall be a cash payment of $2,850,000.00 (the &#8220;<u>Purchase Price</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing (as defined herein), Purchaser shall deliver, or cause to be delivered, to Seller (or such other Person that Seller may designate in writing to receive such payment) the Purchase Price <u>less</u> the Deposit (as defined in <u>Section 1.4</u>, and such payment, the &#8220;<u>Closing Date Payment</u>&#8221;). The Closing Date Payment and any payment required to be made pursuant to any other provision hereof shall be made in cash by wire transfer of immediately available funds to such bank account as shall be designated in writing by the Seller (or Seller&#8217;s designee) at least two&nbsp;(2) Business Days prior to the date on which the Closing Date Payment is to be made.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing</u>. The closing of the Acquisition of the purchase and sale of the Equity Interests and the Acquired Contracts, the delivery of the Closing Date Payment, the assumption of the Assumed Liabilities and the consummation of the other transactions contemplated by this Agreement and the Plan (the &#8220;<u>Closing</u>&#8221;) will take place by telephone conference and electronic exchange of documents at 10:00 am Eastern Time on the second (2nd) Business Day following full satisfaction or due waiver (by the Party entitled to the benefit of such condition) of the closing conditions set forth in <u>Article VII</u> (other than conditions that by their terms or nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at the Closing), or at such other place and time as the Parties may agree in writing. The date on which the Closing actually occurs is referred to herein as the &#8220;<u>Closing Date</u>.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Deposit</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser has, on or prior to the date hereof, made an earnest money deposit with Acquiom Clearinghouse LLC (the &#8220;<u>Escrow Agent</u>&#8221;) in the amount equal to $285,000.00 (the &#8220;<u>Deposit</u>&#8221;), by wire transfer of immediately available funds for deposit into a separate, segregated, non-interest bearing escrow account maintained by the Escrow Agent in accordance with the Bidding Procedures Order. The Deposit shall not be subject to any lien, attachment, trustee process, or any other judicial process of any creditor of any Party and shall be applied against payment of the Purchase Price on the Closing Date.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">&nbsp;&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated by Topco pursuant to <u>Section</u><u>&nbsp;</u><u>8.1(d)</u> or&nbsp;<u>8.1(f)</u> (or by Purchaser pursuant to <u>Section</u><u>&nbsp;</u><u>8.1(b)</u> or <u>8.1(c)</u>, in each case in circumstances where Topco would be entitled to terminate this Agreement pursuant to <u>Section</u><u>&nbsp;</u><u>8.1(d)</u> or&nbsp;<u>8.1(f)</u>), then Seller or its designee(s) shall retain 100% of the Deposit (together with all investment interest thereon, if any).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;If this Agreement is terminated by any Party in accordance with <u>Section</u><u>&nbsp;</u><u>8.1</u>, other than as contemplated by <u>Section</u><u>&nbsp;</u><u>1.4(b)</u>, then 100% of the Deposit (together with all investment interest thereon, if any) shall be returned to Purchaser within five (5) Business Days after such termination.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Parties agree Seller&#8217;s right to the Deposit, as set forth in <u>Section</u><u>&nbsp;</u><u>1.4(b)</u>, is not a penalty, but rather is liquidated damages in a reasonable amount that will compensate Seller for its efforts and resources expended and the opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the transactions contemplated hereby or thereby, which amount would otherwise be impossible to calculate with precision. The Parties further agree that Seller&#8217;s receipt of the Deposit shall not restrict, impair or otherwise limit any other remedies available to Seller under this Agreement (including those remedies set forth in <u>Section 9.12</u>) or at law or in equity.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;If the Closing occurs, the Deposit (together with all investment interest thereon, if any) shall be transferred to Seller or its designee(s) on the Closing Date in satisfaction of the balance of the Purchase Price, required to be delivered pursuant to <u>Section 1.2(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Withholding</u>. Purchaser shall not be entitled to deduct and withhold from any amounts payable pursuant to this Agreement; <u>provided</u> that Purchaser shall be entitled to deduct and withhold any Taxes required to be held under Section 1445 of the Code if Seller fails to deliver at or prior to Closing either an IRS Form W-9 executed by Seller or Seller&#8217;s regarded owner for U.S. federal income Tax purposes or a certificate stating that the interests in each Company are not &#8220;United States real property interests&#8221; (within the meaning of Section 897 of the Code), in form and substance as required by Treasury Regulations Sections 1.1445-2(c) and 1.897-2(h), together with the notice to the IRS required by Treasury Regulations Section 1.897-2(h)(2).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE II</b><br>
<b>REPRESENTATIONS AND WARRANTIES OF SELLER RELATING TO THE COMPANIES<sup style="vertical-align:top;line-height:120%;">1</sup></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except as (a)&nbsp;disclosed in any forms, statements or other documents filed with the Bankruptcy Court or (b) set forth in the schedules delivered by Seller concurrently herewith (each, a &#8220;<u>Schedule</u>&#8221; and collectively, the &#8220;<u>Schedules</u>&#8221;) and subject to <u>Section</u><u>&nbsp;</u><u>9.10</u>, Seller represents and warrants to Purchaser as of the date hereof or, if such representation and warranty is expressly made as of a different date, as of such different date, as follows.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Qualification and Capitalization of Companies</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Companies do not have any Subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Company is a limited liability company duly organized, validly existing, and in good standing under the laws of its jurisdiction of organization and has all requisite limited liability company power and authority necessary to enter into this Agreement and perform its obligations hereunder. Each Company is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable law) under the laws of each jurisdiction in which the nature of the business conducted by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp; Other than as set forth in the Organizational Documents of any Company, there are no outstanding options, warrants, securities or rights that are or may become exercisable or exchangeable for, convertible into, or that otherwise give any Person any right to acquire, shares of capital stock or other equity securities of any Company or to receive payments based in whole or in part upon the value of the capital stock or other equity securities of any Company. Other than the Organizational Documents of the Companies, as of the Closing, (i) there will be no Contracts relating to the issuance, grant, sale or transfer of any equity securities, options, warrants, convertible securities or other securities of any Company and (ii) there will be no Contracts of any Company to repurchase, redeem or otherwise acquire any of the Equity Interests or the Acquired Contracts.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Issuance</u>. Subject to entry by the Bankruptcy Court of the Confirmation Order and the terms and effectiveness of the Plan, the transfer of the Equity Interests to Purchaser hereunder in connection with the Acquisition and pursuant to the Plan shall have been duly and validly authorized and, when the Equity Interests are delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and non-assessable, and free and clear of all Encumbrances, other than restrictions on transfer arising under applicable securities Laws or as otherwise set forth any Company&#8217;s Organizational Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Conflicts; Consents</u>. Assuming that (a)&nbsp;the Confirmation Order and all other requisite Bankruptcy Court approvals are obtained, and (b)&nbsp;the notices, authorizations, approvals, Orders, permits and Consents set forth on <u>Schedule</u><u>&nbsp;</u><u>2.3</u> are made, given or obtained (as applicable), neither the execution and delivery by Seller of this Agreement nor the consummation by Seller of the transactions contemplated hereby, nor performance or compliance by Seller with any of the terms or provisions hereof, will (i) conflict with or violate any provision of the Organizational Documents of any Company, (ii)&nbsp;except as set forth on <u>Schedule</u><u>&nbsp;</u><u>2.3</u>, violate or constitute a breach of or default (with or without notice or lapse of time, or both) under or give rise to a right of termination, modification, or cancelation of any obligation or to the loss of any benefit, any of the terms or provisions of any Material Contract or accelerate obligations of any Company under any Material Contract, (iii) violate any Law or Order applicable to any Company or (iv)&nbsp;result in the creation of any Encumbrance (other than a Permitted Encumbrance) on any properties or assets owned by any Company, <u>except</u>, in the case of <u>clause (ii)</u>, <u>(iii)</u> or <u>(iv)</u>, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><sup style="vertical-align:top;line-height:120%;">1</sup> &nbsp;&nbsp;&nbsp;&nbsp; Representations and warranties remain subject to ongoing review of Seller and its advisors in all respects.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Brokers</u>. Except for PJT Partners L.P (&#8220;<u>PJT</u>&#8221;), no broker, investment banker, financial advisor or other Person is entitled to any broker&#8217;s, finder&#8217;s, financial advisor&#8217;s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of Seller or any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Actions</u>. Except as set forth on <u>Schedule 2.5</u> and other than any workers compensation claims, there are no, and during the two (2) years preceding the date hereof there have been no, Actions pending or, to the Knowledge of Seller, threatened in writing (a)&nbsp;to which any Company is or was a party or to which any property, rights or interests of any of them is or was subject, <u>except</u> for (i)&nbsp;such Action that, if adversely determined, would not reasonably be expected to result in (x)&nbsp;liabilities or obligations of any nature of any Company following the Closing in excess of $500,000 (in the case of medical malpractice Actions) and in excess of $250,000 (in the case of all other Actions), or (y)&nbsp;equitable remedies that would reasonably be expected to be material and adverse to the Business of any Company, taken as a whole, following the Closing, and (ii)&nbsp;following the Petition Date, claims of creditors or other parties in the Bankruptcy Cases or (b) that challenge, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, any of the transactions contemplated by this Agreement to be entered into by Seller or any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance with Laws; Permits</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 2.6(a)</u> or as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, each Company is and, to the Knowledge of Seller, the Managed Entities, are and during the two (2) years preceding the date hereof have been, in compliance in all respects with the requirements of all Healthcare Laws and Laws applicable to it or to its properties, and no written notices have been received by, and no claims have been made in writing against such Company or, to the Knowledge of Seller, any of the Managed Entities, alleging a violation of any such Laws (including Healthcare Laws).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of Seller, except as set forth on <u>Schedule 2.6(b),</u> each Company possesses and, to the Knowledge of Seller, the Managed Entities, possess all Permits (including Healthcare Permits) that are required to conduct their respective businesses as currently conducted, except for such Permits, the failure to have so obtained, made or delivered would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Within the two (2) years preceding the date hereof, no Company or, to the Knowledge of Seller, any Managed Entity, has received written notice of any revocation or modification of any Permit and all such Permits are in full force and effect, except where such revocation or modification, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, each physician, nurse practitioner, nurse, physician&#8217;s assistant, or other allied health professional currently employed or engaged by or on behalf of any Company in the Business and, to the Knowledge of Seller, the Managed Entities, to provide healthcare services in the Business is duly licensed, certified or credentialed, as applicable, pursuant to applicable Healthcare Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;No Company or, to the Knowledge of Seller, any of their respective officers, directors, or managing employees, is or has been within the two (2) years preceding the date hereof: (i) excluded, suspended or debarred from participation in any Governmental Health Program, (ii) subject to a civil monetary penalty assessed under Section 1128A of the Social Security Act, sanctioned, indicted or convicted of a crime, or pled nolo contendere or to sufficient facts, in connection with any material allegation of violation of any applicable Healthcare Law, or (iii) listed on the General Services Administration published list of parties excluded from federal procurement programs and non-procurement programs.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each Company and, to the Knowledge of Seller, the Managed Entities are in compliance with HIPAA, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. No Company or, to the Knowledge of Seller, the Managed Entities has within the two (2) years preceding the date hereof received any written notice or claim of, and there are no investigations or proceedings pending with respect to any alleged &#8220;breach&#8221; by the or, to the Knowledge of Seller, the Managed Entities, as defined under HIPAA, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Financial Statements</u>. Attached to <u>Schedule 2.7</u> are complete and correct copies of: (a) the unaudited statements of revenues and expenses of each Company for the 12-month period ended June 30, 2023, (b) the unaudited statements of revenues and expenses of each Company for the month of July 2023, and (c) the unaudited trial balances of each Company as of September 30, 2023, (the &#8220;<u>Trial Balances</u>&#8221;) (the items set forth in clauses (a) through (c), collectively, the &#8220;<u>Financial Statements</u>&#8221;). The Financial Statements have been prepared based upon the information contained in the Companies&#8217; books and records and present fairly in all material respects the revenues, expenses, assets, and liabilities set forth thereon as of the times and for the periods referred to therein, except for (y) changes resulting from fiscal year-end adjustments, (z) certain revenues, expenses, assets, and liabilities related to corporate and shared services (including the Overhead and Shared Services) shared between the Retained Business of the Seller Parties and the Business of the Companies, including after giving effect to the covenants and agreements of the Parties contained in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u>. Except, in each case, as would not reasonably be expected to have a Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The conduct of the Business as currently conducted by each Company does not infringe upon, misappropriate or otherwise violate the Intellectual Property rights of any Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Within the last two (2) years preceding the date hereof, to the Knowledge of Seller, there has been no unauthorized use, access, failures, breakdowns, interruption, corruption or continued substandard performance of the Company Systems that has caused any material disruption of or interruption in or to the Business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;With respect to the Business, to the Knowledge of Seller, each Company has complied, and is currently in compliance with, all Data Security Requirements. No Company has (i) to the Knowledge of Seller, experienced any incident in which confidential or sensitive information, payment card data, or personally identifiable information was stolen or improperly accessed or (ii) received any written notices, claims or complaints from any Person with respect thereto, in each case with respect to the Business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Title to Property; Leases</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Owned Real Property</u>. The Companies do not own real property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Leased Real Property</u><sup style="vertical-align:top;line-height:120%;">.</sup> <u>Schedule 2.9(b)</u> sets forth the address of each Leased Real Property, including, without limitation, the real property leased by SNERCC and located at 115 Cass Avenue, Woonsocket, RI 02895. Seller has made available to Purchaser or Purchaser&#8217;s Advisors true and complete copies of the Lease for the Leased Real Property. Except as set forth on <u>Schedule 2.9(b)</u> (and except as a result of the commencement of the Bankruptcy Cases), with respect to each of the Leases for the Leased Real Property: (i) such Lease is legal, valid, binding, enforceable and in full force and effect except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar Laws of general applicability relating to or affecting creditor&#8217;s rights generally and by the application of general principles of equity; (ii) no Company (except as a result of the Bankruptcy Cases), nor, to the Knowledge of Seller, any other party to the Lease, is in breach or default under such Lease, and no circumstance exists which, with the delivery of notice, the passage of time or both, would constitute such a breach or default, or permit the termination, modification or acceleration of rent under such Lease, except, in each case, for such breaches or defaults as would not reasonably be expected to be material to any Company; and (iii) no Company has within the two (2) years preceding the date hereof (1) subleased, licensed or otherwise has, as of the date hereof, granted any Person the right to use or occupy the Leased Real Property or any portion thereof or (2) collaterally assigned or granted any other security interest in such Lease or interest therein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental Matters</u>. Except as set forth on <u>Schedule 2.10</u> or as would not, individually or in the aggregate, be reasonably expected to result in a Material Adverse Effect, (a) each Company is, and for the last two (2) years preceding the date hereof has been, in compliance with all applicable Environmental Laws, (b) each Company possesses all Permits required pursuant to applicable Environmental Laws for the conduct of the Business as currently conducted, (c)&nbsp; no Company is subject to any outstanding decree, injunction or order issued by any Governmental Body under applicable Environmental Laws, (d) there are no Actions pending against any Company regarding any actual or alleged violation of or liability under Environmental Laws, and (e)&nbsp; no Company has released any Hazardous Material at the Leased Real Property in quantities or concentrations that currently require investigation, remediation or monitoring by any Company under Environmental Laws. The representations and warranties set forth in this <u>Section 2.10</u> are the sole and exclusive representations and warranties with respect to environmental, health or safety matters, including without limitation any arising under Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Labor and Employment</u>. Except as set forth on <u>Schedule 2.11</u>:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each Company and any Affiliate of the Companies employing or providing employees that work in the Business is, to the Knowledge of Seller, in compliance with all applicable Laws respecting labor, employment and employment practices, including those related to wages and hours, collective bargaining, immigration, employment harassment and employment discrimination and employee layoffs, except where the failure to be in compliance would not reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;No Company or any Affiliate of any such Company employing or providing employees that work in the Business is, to the Knowledge of Seller, a party to any collective bargaining agreement, and no employees of Company or any Affiliate of any Company employing or providing employees that work in the Business are represented by any labor union with respect to their employment with any Company or any of its Affiliates. To the Knowledge of Seller, no union organizing or decertification activities are underway or threatened with respect to any employees of any Company. There is not presently pending any material labor strike, slow-down, or work stoppage against any Company. No collective bargaining agreement is currently being negotiated by any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee Benefit Plans</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 2.12(a)</u> sets forth a complete and correct list of each material employee benefit plan in which current or former employees of the Business or employees of any Seller Party that work in the Business actively participate, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<u>ERISA</u>&#8221;), each other equity or equity-based, deferred compensation, bonus or incentive compensation, pension, retiree medical, disability or life insurance, or supplemental plan, program, contract, agreement or arrangement, each employment, severance, separation, change-of-control and each other benefit or compensation plan, program, contract, agreement or arrangement, in each case (i) that is maintained, sponsored, administered or contributed or required to by any Company for employees or former employees of any Company or by any Affiliate of any Company for employees that work in the Business, or (ii) with respect to which any Company or any of its Affiliate has any current or contingent liability or obligation (each, a &#8220;<u>Company Benefit Plan</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;No Company has, to the knowledge of Seller, neither the Companies nor any Affiliate of the companies have any current or contingent liability or obligation under or relating to any &#8220;pension plan&#8221; (as defined in Section 3(2) of ERISA) that is or was subject to Section 412 of the Code or Section 302 of ERISA. No Company contributes to, has any obligation to contribute to, or has any current or contingent liability under or with respect to any &#8220;multiemployer plan&#8221; (as defined in Section 3(37) of ERISA).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 2.12(c)</u> or as would not, individually or in the aggregate, be reasonably expected to result in a Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Each Company Benefit Plan has been maintained, funded and administered in compliance with its terms and the requirements of any applicable Law, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the &#8220;<u>Code</u>&#8221;). No prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Company Benefit Plan excluding transactions effected pursuant to a statutory or administrative exemption, and no breach of fiduciary duty (as determined under ERISA) has occurred with respect to any Company Benefit Plan. There is no pending or threatened Action relating to any Company Benefit Plan nor is there any basis for any such Action.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution and delivery of this Agreement nor the consummation of any of the other transactions contemplated by this Agreement, either alone or together with another event, will (A) result in any payment (including severance, unemployment compensation, forgiveness of indebtedness or otherwise) becoming due under any Company Benefit Plan, whether or not such payment is contingent, (B) increase any benefits or compensation otherwise payable under any Company Benefit Plan or (C) result in the acceleration of the time of payment, vesting or funding of any benefits or compensation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Each Company Benefit Plan intended to qualify under Section 401(a) of the Code has received a favorable determination letter from the Internal Revenue Service with respect to each such Company Benefit Plan as to its qualified status under the Code, and no fact or event has occurred that could adversely affect the qualified status of any such Company Benefit Plan. With respect to each Company Benefit Plan, all contributions, distributions, reimbursements and premium payments that are due have been made and all contributions, distributions, reimbursements and premium payments for any period ending on or before any Closing that are not yet due have been made or accrued. No Company has any obligation to provide any post-employment or post-termination welfare or welfare type benefits to any Person, except as required under Section 4980B of the Code. Each Company has complied with and is in compliance with the requirements of Section 4980B of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Material Contracts</u>. True and complete copies of all Material Contracts have been made available to Purchaser or Purchaser&#8217;s Advisors. Each Material Contract is in full force and effect and is valid, binding and enforceable against the applicable Company and, to the Knowledge of Seller, each other party thereto, in each case in accordance with its terms, except as such enforceability (a) may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar Laws of general application affecting or relating to the enforcement of creditors&#8217; rights generally and (b) is subject to general principles of equity whether considered in a proceeding at law or in equity (collectively, the &#8220;<u>Enforceability Exceptions</u>&#8221;). Subject to requisite Bankruptcy Court approvals and assumption by the applicable Company of the applicable Contract in accordance with applicable Law, and except (a) as a result of the commencement of the Bankruptcy Cases, (b) with respect to any Contract that has previously expired in accordance with its terms, been terminated, restated, or replaced, or (c) as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, no Company, nor, to the Knowledge of Seller, any other party to any Material Contract is in breach of or default under any Material Contract or, during the six (6)-month period prior to the date of this Agreement, has given written notice of breach or default thereunder to any other party thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.14&nbsp;&nbsp;&nbsp;&nbsp;<u>Commercial Payors</u>. <u>Schedule 2.14</u> sets forth a list of the five (5) largest Commercial Payors of each Company measured by gross billings for the fiscal year ended June 30, 2023. No such Commercial Payor has terminated or materially and adversely altered its business relationship or provided written notice of its intention to terminate or materially and adversely alter its business relationship, with any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.15&nbsp;&nbsp;&nbsp;&nbsp;<u>Managed Entity Agreements</u>. <u>Schedule 2.15</u> contains a complete and accurate list of the material Managed Entity Agreements. Except as disclosed in <u>Schedule 2.15 </u>or as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, since the date of the Financial Statements, no Managed Entity has cancelled or terminated (except for cancellation or termination of any Managed Entity Agreements pursuant to their respective terms) its business relationship with any Company, as applicable, or has notified any Company, in writing of any intent to do so.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.16&nbsp;&nbsp;&nbsp;&nbsp;<u>Transactions with Related Parties</u>. Except for any Contract entered into by the Seller Parties in connection with the Bankruptcy Cases, in connection with compensation or other incidence of employment (including participation in employee benefit plans) or as set forth in <u>Schedule 2.16</u>, there are no Contracts between or among any Company, on the one hand, and any Affiliate of Seller or any executive officer, director or employee of Seller or any Company, or, to the Knowledge of Seller, any relative or spouse of any such officer, director or employee, on the other hand.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.17&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u>. Except as set forth on <u>Schedule 2.17</u> or as would not, individually or in the aggregate, be reasonably expected to result in a Material Adverse Effect:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;All Tax Returns with respect to the Companies required to be filed prior to the Closing Date by the Companies have been prepared and timely filed with the appropriate Taxing Authorities (after giving effect to any valid extensions of time in which to make such filings).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;All Taxes payable by the Companies with respect to the Companies prior to the Closing Date have been timely paid or adequately reserved against in accordance with GAAP, except to the extent the nonpayment thereof is permitted or required by the Bankruptcy Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No agreement, waiver or other document or arrangement extending or having the effect of extending the period for assessment or collection of a material amount of Taxes with respect to the Companies (including any applicable statute of limitation) has been executed or filed with the IRS or any other Taxing Authority by any Company (other than pursuant to extensions of time to file Tax Returns obtained in the Ordinary Course), in each case, which is currently in force and could have effect after the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;There are no Encumbrances for Taxes on any of the assets of any Company used in the Business other than Permitted Encumbrances.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;There are no audits or investigations by any Taxing Authority with respect to a material amount of Taxes or any Tax Return of any Company with respect to the Business currently in progress, nor has any Company received notice in writing from any Taxing Authority that it intends to initiate any such an audit or investigation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, the representations and warranties in this <u>Section 2.17</u> and in <u>Section 2.12</u> (to the extent specifically related to Taxes) shall constitute the sole representations and warranties with respect to Taxes. No representation or warranty is made with respect to the validity of any Tax position or the availability of any Tax attribute for any Tax period (or any portion thereof) following the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.18&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Certain Changes or Developments</u>. Except as set forth on <u>Schedule</u><u>&nbsp;</u><u>2.18 </u>or in connection with the transactions contemplated by this Agreement or the Bankruptcy Cases, since the date of the Financial Statements, (a) each Company has conducted the Business in the Ordinary Course, and (b) no event, change or circumstance has occurred that has had, or would be reasonably expected to have, either individually or in the aggregate, a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.19&nbsp;&nbsp;&nbsp;&nbsp;<u>Sufficiency of Assets</u>. Except for (a) assets and properties used or disposed of in the Ordinary Course, (b) assets, services, rights and benefits to be made available to Purchaser or any Company pursuant to this Agreement, the Plan or any other ancillary agreement contemplated herein or therein, (c) the Overhead and Shared Services provided to the Business by Seller or any Affiliate of any Seller Party, and (d) as set forth on <u>Schedule 2.19 </u>or as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, subject to Bankruptcy Court approval, entry of the Bidding Procedures Order and Confirmation Order, and assuming receipt of all other Consents as may be required in connection with the consummation of the transactions contemplated by this Agreement, immediately after giving effect to the Restructuring, the assets and rights owned by or licensed each Company will constitute all of the material assets necessary for Purchaser to operate the Business as of immediately following the Closing in all material respects as conducted by such Companies as of immediately prior to the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE III</b><br>
<b>REPRESENTATIONS AND WARRANTIES OF SELLER</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except as (a)&nbsp;disclosed in any forms, statements or other documents filed with the Bankruptcy Court or (b) set forth in the Schedules delivered by Seller concurrently herewith and subject to <u>Section</u><u>&nbsp;</u><u>9.10</u>, Seller represents and warrants to Purchaser as of the date hereof as follows.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization of Seller</u>. Seller is a corporation duly organized and validly existing under the laws of Florida and has all requisite corporate power and authority necessary to enter into this Agreement and perform its obligations hereunder.<sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization and Validity of Agreement</u>. The execution, delivery and performance by Seller of this Agreement and the consummation by Seller of the transactions contemplated hereby or thereby, subject to requisite Bankruptcy Court approvals, have been duly authorized by all requisite corporate action, and no other corporate proceedings on its part are necessary to authorize the execution, delivery and performance by Seller of this Agreement, and the consummation by it of the transactions contemplated hereby or thereby.&nbsp;Subject to requisite Bankruptcy Court approvals, this Agreement has been duly executed and delivered by Seller and, assuming due authorization, execution and delivery hereof by the other Parties, constitutes a legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, except that such enforceability may be limited by the Enforceability Exceptions.<sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Title to Equity Interests</u>. Seller owns the Equity Interests and, at the Closing, Seller shall deliver to Purchaser good and valid title to the Equity Interests, free and clear of all Encumbrances other than restrictions on transfer arising under applicable securities Laws or as otherwise set forth in the Organizational Documents of any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Conflicts; Consents</u>. Assuming that (a)&nbsp;the Confirmation Order and all other requisite Bankruptcy Court approvals are obtained, and (b)&nbsp;the notices, authorizations, approvals, Orders, permits and Consents set forth on <u>Schedule 3.4</u> are made, given or obtained (as applicable), neither the execution and delivery by Seller of this Agreement nor the consummation by Seller of the transactions contemplated hereby, nor performance or compliance by Seller with any of the terms or provisions hereof, will (i) conflict with or violate any provision of the Organizational Documents of Seller, (ii) except as set forth on <u>Schedule 2.3</u> or <u>Schedule 3.4</u>, violate or constitute a breach of or default (with or without notice or lapse of time, or both) under or give rise to a right of termination, modification, or cancelation of any obligation or to the loss of any benefit, any of the terms or provisions of any Contract or accelerate obligations of Seller under any Contract to which Seller is bound, (iii) violate any Law or Order applicable to Seller or (iv) result in the creation of any Encumbrance (other than a Permitted Encumbrance) on any properties or assets owned by Seller, <u>except</u>, in the case of <u>clause (ii)</u>, <u>(iii)</u> or <u>(iv)</u>, as would not, individually or in the aggregate, reasonably be expected to materially and adversely affect Seller&#8217;s performance of its material obligations under this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Brokers</u>. Except for PJT, no broker, investment banker, financial advisor or other Person is entitled to any broker&#8217;s, finder&#8217;s, financial advisor&#8217;s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of Seller or Topco.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Actions</u>. Except as set forth on <u>Schedule 3.6</u>, there are no, and during the two (2) years preceding the date hereof there have been no, Actions pending or, to the Knowledge of Seller, threatened in writing to which Seller is or was a party, which would challenge, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, any of the transactions contemplated by this Agreement, <u>except</u> for claims of creditors or other parties in the Bankruptcy Cases following the Petition Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE IV</b><br>
<b>REPRESENTATIONS AND WARRANTIES OF PURCHASER</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Purchaser represents and warrants to Seller as of the date hereof or, if such representation and warranty is expressly made as of a different date, as of such different date, as follows.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Qualification</u>. Purchaser is an entity<sup style="vertical-align:top;line-height:120%;"> </sup>duly created, formed or organized (as applicable), validly existing and in good standing under the laws of the jurisdiction of its creation, formation or organization (as applicable) and has all requisite corporate power and authority necessary to conduct its business as it is now being conducted, except (other than with respect to Purchaser&#8217;s due formation and valid existence) as would not, individually or in the aggregate, reasonably be expected to have an adverse effect on Purchaser&#8217;s ability to consummate the transactions contemplated by this Agreement.&nbsp;Purchaser is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable Law) under the Laws of each jurisdiction in which the nature of the business conducted by it or the character or location of the properties owned or used by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have an adverse effect on Purchaser&#8217;s ability to consummate the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization of Agreement</u>. Purchaser has all necessary power and authority to execute and deliver this Agreement and to perform its obligations hereunder and to consummate the transactions contemplated hereby or thereby.&nbsp;The execution, delivery and performance by Purchaser of this Agreement and the consummation by Purchaser of the transactions contemplated hereby or thereby, subject to requisite Bankruptcy Court approvals, have been duly authorized by all requisite corporate or similar organizational action and no other corporate or similar organizational proceedings on its part are necessary to authorize the execution, delivery and performance by Purchaser of this Agreement and the consummation by it of the transactions contemplated hereby or thereby.&nbsp;Subject to requisite Bankruptcy Court approvals, this Agreement has been duly executed and delivered by Purchaser and, assuming due authorization, execution and delivery hereof by the other Parties, constitutes the legal, valid and binding obligations of Purchaser, enforceable against Purchaser in accordance with its terms, except that such enforceability may be limited by the Enforceability Exceptions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Conflicts; Consents</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Assuming that&nbsp;(i) the Confirmation Order and all other requisite Bankruptcy Court approvals are obtained, and (ii) the notices, authorizations, approvals, Orders, permits and Consents set forth on <u>Schedule 4.3(a)</u> are made, given or obtained (as applicable), neither the execution and delivery by Purchaser of this Agreement, nor the consummation by Purchaser of the transactions contemplated hereby or thereby, nor performance or compliance by Purchaser with any of the terms or provisions hereof, will (A)&nbsp;conflict with or violate any provision of Purchaser&#8217;s Organizational Documents, (B)&nbsp;violate any Law or Order applicable to Purchaser, (C)&nbsp;violate or constitute a breach of or default (with or without notice or lapse of time, or both) under or give rise to a right of termination, modification, or cancelation of any obligation or to the loss of any benefit, any of the terms or provisions of any loan or credit agreement or other material Contract to which Purchaser is a party or accelerate Purchaser&#8217;s obligations under any such Contract, or (D)&nbsp;result in the creation of any Encumbrance (other than a Permitted Encumbrance) on any properties or assets of Purchaser or any of its Subsidiaries, except, in the case of clauses (B) through (C), as would not, individually or in the aggregate, reasonably be expected to prevent or materially impair, alter or delay the ability of Purchaser to consummate the transactions contemplated hereby or thereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser is not required to file, seek or obtain any notice, authorization, approval, Order, permit or Consent of or with any Governmental Body in connection with the execution, delivery and performance by Purchaser of this Agreement or the consummation by Purchaser of the transactions contemplated hereby or thereby, except (i) where failure to obtain such Consent, approval, authorization or action, or to make such filing or notification, would not, individually or in the aggregate, reasonably be expected to prevent or materially impair, alter or delay the ability of Purchaser to consummate the transactions contemplated hereby or thereby or (ii) except as set forth on <u>Schedule</u><u>&nbsp;</u><u>4.3(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Financing</u>. Purchaser has, and will have at the Closing, the financial capability and all sufficient cash on hand necessary to pay the Purchase Price in full and to consummate all of the other transactions contemplated to be consummated by it pursuant to this Agreement, including the payment in full of all fees, expenses of, and other amounts required to be paid by Purchaser in connection with the transactions contemplated by this Agreement, and does not know of any circumstance or condition that could reasonably be expected to prevent or substantially delay the availability of such funds or otherwise impair such capability at the Closing and such other dates that such obligations and transactions are required to be satisfied pursuant to the terms hereof. Purchaser affirms that it is not a condition to Closing or to any of its obligations under this Agreement that Purchaser obtains financing for the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Securities Law Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser understands that the Equity Interests have not been registered under the Securities Act and that the Equity Interests are, to the extent not acquired pursuant to section 1145 of the Bankruptcy Code, being offered and sold pursuant to an exemption from registration contained in the Securities Act, based in part upon Purchaser&#8217;s representations contained in this Agreement and cannot be sold unless subsequently registered under the Securities Act or an exemption from registration is available.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser is acquiring the Equity Interests for its own account (or for the accounts for which it is acting as investment advisors or manager) for investment and not with a present view toward distribution, within the meaning of the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser is an &#8220;accredited investor&#8221; as that term is defined in Regulation D promulgated under the Securities Act and has such knowledge and experience in financial and business matters that Purchaser is capable of evaluating the merits and risks of its investment. Purchaser understands and is able to bear any economic risks with such investment. Purchaser acknowledges that it has been afforded the opportunity to ask questions and receive answers concerning the Companies and to obtain additional information that it has requested.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Brokers</u>. There is no investment banker, broker, finder, or other intermediary which has been retained by or is authorized to act on behalf of Purchaser that might be entitled to any fee or commission in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Actions</u>. There are no Actions pending or, to Purchaser&#8217;s knowledge, threatened against or affecting Purchaser that will or would be reasonably likely to adversely affect Purchaser&#8217;s performance of its obligations under this Agreement or the consummation of the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Arrangements</u>. There are no Contracts, undertakings, commitments or obligations, whether written or oral, between or among any member of the Purchaser Group, on the one hand, and any member of the management of Seller or any Company or any of their respective board of directors (or applicable governing body of any Affiliate of Seller or any Company), any holder of equity or debt securities of Seller or any Company, or any lender or creditor of Seller or any Company or any Affiliate of Seller or any Company, on the other hand, (a) relating in any way to the acquisition of the Equity Interests or the Acquired Contracts or the transactions contemplated by this Agreement or (b) that would be reasonably likely to prevent, restrict, impede or affect adversely the ability of Seller or any Company or any of their respective Affiliates to entertain, negotiate or participate in any such transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Solvency</u>. Purchaser is, and immediately after giving effect to the transactions contemplated by this Agreement each of Purchaser and the Companies shall be, solvent and at all times shall: (a) be able to pay its debts as they become due; (b) own property that has a fair saleable value greater than the amounts required to pay its debt (including a reasonable estimate of the amount of all contingent Liabilities) and (c) have adequate capital to carry on its business. No transfer of property is being made and no obligation is being incurred in connection with the transactions contemplated hereby with the intent to hinder, delay or defraud either present or future creditors of Purchaser or any Company. In connection with the transactions contemplated hereby, Purchaser has not incurred, nor plans to incur, debts beyond its ability to pay as they become absolute and matured.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.10&nbsp;&nbsp;&nbsp;&nbsp;<u>WARN Act and Mass Layoffs</u>. Purchaser does not currently plan or contemplate any plant closings, reduction in force or terminations of employees of any Company that would trigger obligations under the Worker Adjustment and Retraining Notification Act of 1988 or any similar Laws (&#8220;<u>WARN Act</u>&#8221;) or similar laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.11&nbsp;&nbsp;&nbsp;&nbsp;<u>No Foreign Person</u>. Purchaser is not a &#8220;foreign person&#8221; as defined in 31 C.F.R. &#167; 800.224 and the transactions contemplated under this Agreement will not constitute a &#8220;covered transaction,&#8221; as defined at 31 C.F.R. &#167; 800.213.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.12&nbsp;&nbsp;&nbsp;&nbsp;<u>No Competitive Assets</u>. Neither Purchaser nor any of its &#8220;associates&#8221; or &#8220;affiliates&#8221; (each as defined in 16 CFR 801.1(d)) hold five percent (5%) or more of the economic interest, voting securities or non-corporate interests (as &#8220;hold,&#8221; &#8220;voting securities&#8221; and &#8220;non-corporate interest&#8221; are defined under 16 CFR 801) of any entity that competes with any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE V</b><br>
<b>BANKRUPTCY COURT MATTERS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.1<sup style="vertical-align:top;line-height:120%;">&nbsp;&nbsp;&nbsp;&nbsp; </sup><u>Bankruptcy Actions</u>.<sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Seller shall seek approval of the Confirmation Order. Seller may modify the Confirmation Order pursuant to discussions with the United States Trustee assigned to the Bankruptcy Case, the Bankruptcy Court, any creditor or committee representing a group of creditors in the Bankruptcy Case, or any other party in interest, with such modifications being acceptable to Purchaser in its commercially reasonable discretion.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The bidding procedures to be employed with respect to this Agreement shall be those reflected in the Bidding Procedures Order. Purchaser agrees and acknowledges that Seller, including through its Advisors, is and may continue soliciting inquiries, proposals or offers from third parties in connection with any Alternative Transaction pursuant to the terms of the Bidding Procedures Order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;From the date hereof until the earlier of (i) the termination of this Agreement in accordance with <u>Article VIII</u> and (ii) the Closing Date, the Seller Parties shall use their respective commercially reasonable efforts to obtain entry by the Bankruptcy Court of the Confirmation Order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall promptly take all actions as are reasonably requested by Seller to assist in obtaining the Bankruptcy Court&#8217;s entry of the Confirmation Order and any other Order reasonably necessary in connection with the transactions contemplated by this Agreement as promptly as practicable, including furnishing affidavits, financial information, or other documents or information for filing with the Bankruptcy Court and making such employees and Advisors of Purchaser and its Affiliates available to testify before the Bankruptcy Court.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Seller and Purchaser shall (i) appear formally or informally in the Bankruptcy Court if reasonably requested by the other Party or required by the Bankruptcy Court in connection with the transactions contemplated by this Agreement and (ii) keep the other reasonably apprised of the status of material matters related to the Agreement, including, upon reasonable request promptly furnishing the other with copies of notices or other communications received by Seller from the Bankruptcy Court with respect to the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;If an Auction is conducted, and Purchaser is not the prevailing party at the conclusion of such Auction (such prevailing party, the &#8220;<u>Winning Bidder</u>&#8221;) but is the next highest bidder at the Auction, Purchaser shall be required to serve as a back-up bidder (the&nbsp;&#8220;<u>Back-Up</u><u>&nbsp;</u><u>Bidder</u>&#8221;) and keep Purchaser&#8217;s bid to consummate the transactions contemplated by this Agreement on the terms and conditions set forth in this Agreement (as the same may be revised in the Auction) open and irrevocable until the earlier of (i) the closing of the transaction with the Winning Bidder notwithstanding any outside date set forth in such Back-Up Bidder&#8217;s proposed purchase agreement or the chapter 11 plan and (ii) the date that is four (4)<sup style="vertical-align:top;line-height:120%;"> </sup> months following the conclusion of the Auction (the earlier of (i) and (ii), the &#8220;<u>Auction Outside Date</u>&#8221;). If the Winning Bidder fails to consummate the applicable Alternative Transaction or the purchase agreement with the Winning Bidder is otherwise validly terminated in accordance with its terms, the Back-Up Bidder will be deemed to have the new prevailing bid, and Seller, Topco, and the Companies may consummate the transactions contemplated by this Agreement on the terms and conditions set forth in this Agreement (as&nbsp;the&nbsp;same may have been improved upon in the Auction).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Each Party acknowledges that this Agreement and the sale of Companies are subject to higher and better bids and Bankruptcy Court approval. Purchaser acknowledges that Seller must take reasonable steps to demonstrate that it has sought to obtain the highest or otherwise best price for the Equity Interests and the Acquired Contracts, including giving notice thereof to the creditors of Seller, Companies and other interested parties, providing information about Seller and Companies to prospective bidders, entertaining higher and better offers from such prospective bidders, and, in the event that additional qualified prospective bidders desire to bid for the Equity Interests and the Acquired Contracts, conducting an Auction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this <u>Section 5.1</u> shall prevent Seller or Topco from modifying the bidding procedures pursuant to the Bidding Procedures Order as necessary or appropriate to maximize value for Seller&#8217;s estate in accordance with Seller&#8217;s fiduciary obligations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Approval</u>. Seller&#8217;s and each Company&#8217;s respective obligations under this Agreement and in connection with the transactions contemplated hereby are subject to entry of and, to the extent entered, the terms of any Orders of the Bankruptcy Court (including entry of the Confirmation Order). Nothing in this Agreement shall require Seller or any Company or any of their respective Affiliates to give testimony to or submit a motion to the Bankruptcy Court that is untruthful or to violate any duty of candor or other fiduciary duty to the Bankruptcy Court or its stakeholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE VI</b><br>
<b>COVENANTS AND AGREEMENTS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Access to Information</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;From the date hereof until the Closing (or the earlier termination of this Agreement pursuant to <u>Article VIII</u>), Topco will provide Purchaser and its authorized Advisors with reasonable access and upon reasonable advance notice and during regular business hours (so long as consistent with applicable Law and in accordance with the reasonable procedures established by it) to the Companies&#8217; books and records (excluding any personnel files) to the extent related to the Business, in order for Purchaser and its authorized Advisors to access such information regarding the Companies as is reasonably necessary in order to consummate the transactions contemplated by this Agreement; <u>provided</u> that (i)&nbsp;such access does not unreasonably interfere with the normal operations of Seller or any Company, (ii)&nbsp;such access will occur in such a manner as Topco reasonably determines to be appropriate to protect the confidentiality of the transactions contemplated by this Agreement and such books and records, (iii)&nbsp;all requests for access will be directed to PJT or such other Person(s) as Topco may designate in writing from time to time, (iv) such access shall not include any environmental sampling, monitoring or testing or other invasive, intrusive, surface or subsurface investigations, assessments or analysis of soil, groundwater, air, building materials or other environmental media of the sort generally referred to as a Phase II environmental investigation, and (v)&nbsp;nothing herein will require Topco or any Company to provide access to, or to disclose any information to, Purchaser or any other Person if such access or disclosure would (A) reasonably cause competitive harm to Seller or any Company, (B)&nbsp; reasonably require any Company to disclose any financial or proprietary information of or regarding any of its Affiliates or otherwise disclose information regarding any of its Affiliates that any Company deems to be commercially sensitive, (C) reasonably waive any legal privilege, (D) reasonably be in violation of applicable Laws or the provisions of any Contract to which any Company or any of its Affiliates is bound or would reasonably violate any fiduciary duty, or (E) require the disclosure of or access to information of the Retained Business (including copies of any consolidated, combined, unitary or other affiliated group Tax Return of Seller).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The information provided pursuant to this <u>Section</u><u>&nbsp;</u><u>6.1</u> will be used solely for the purpose of consummating the transactions contemplated by this Agreement and will be governed by all the terms and conditions of the Confidentiality Agreement, which Confidentiality Agreement shall survive the execution of this Agreement through the first to occur of the Closing and two (2) years following the date hereof notwithstanding anything to the contrary therein. Purchaser will, and will cause its Advisors to, abide by the terms of the Confidentiality Agreement with respect to such access and any information furnished to Purchaser or any of its Advisors. Seller, the Companies and their respective Affiliates make no representation or warranty as to the accuracy of any information, if any, provided pursuant to this <u>Section</u><u>&nbsp;</u><u>6.1</u>, and none of Purchaser or its Advisors may rely on the accuracy of any such information, in each case, other than the Express Representations defined in <u>Section 6.5(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser will not, and will not permit any Advisor or any other member of the Purchaser Group to, contact any officer, manager, director, employee, customer, supplier, lessee, lessor, lender, licensee, licensor, distributor, noteholder or other material business relation of Seller or any Company or any of their respective Affiliates prior to the Closing with respect to Seller, any Company, or any of their respective businesses (including the Business) or the transactions contemplated by this Agreement, in each case, without the prior written Consent of Topco for each such contact.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;From and after the Closing, Purchaser will, and will cause each Company, the other members of the Purchaser Group, and their respective Advisors to, provide Seller and its authorized Advisors with such information in its possession or under its control (including accounting, Tax and any other information) and reasonable access (for the purpose of examining and copying), during normal business hours, to the personnel, books and records of the Companies with respect to periods or occurrences prior to or on the Closing Date in connection with any matter, whether or not relating to or arising out of this Agreement or the transactions contemplated hereby. Unless otherwise consented to in writing by Topco or any Seller Party, for a period of seven (7) years following the Closing Date, Purchaser shall, and shall cause each such Company to, properly retain and maintain all books and records (in any medium) of such Company, or any portions thereof, relating to periods on or prior to the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Regulatory Approvals</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp; Seller will, and will cause each Company (to the extent it is able) to, (i)&nbsp;make or cause to be made all filings, submissions and notices required to be made by Seller or any Company under any applicable Laws for the consummation of the transactions contemplated by this Agreement, including any material consent required to be issued by the appropriate Governmental Bodies, (ii)&nbsp;cooperate with Purchaser in exchanging such information and providing such assistance as Purchaser may reasonably request in connection with any filings or notices required to be made by any member of the Purchaser Group pursuant to <u>Section</u><u>&nbsp;</u><u>6.2(b)</u>, and (iii) (A)&nbsp;supply promptly any additional information and documentary material that may be requested in connection with the filings made pursuant to this <u>Section</u><u>&nbsp;</u><u>6.2(a)</u> or <u>Section</u><u>&nbsp;</u><u>6.2(b)</u> and (B)&nbsp;use reasonable best efforts to take all actions necessary to obtain all required Governmental Authorizations or Consents in connection with such filings.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser will, and will cause its Affiliates and Advisors to, (i)&nbsp;make or cause to be made all filings and submissions required to be made by any member of the Purchaser Group under any applicable Laws for the consummation of the transactions contemplated by this Agreement, including, any material consent required to be issued by the appropriate Governmental Bodies, (ii)&nbsp;cooperate with Seller and the Companies in exchanging such information and providing such assistance as Seller or the Companies may reasonably request in connection with any filings made by Seller or any Company pursuant to <u>Section 6.2(a)</u>, and (iii)&nbsp;(A)&nbsp;supply promptly any additional information and documentary material that may be requested in connection with the filings made pursuant to this <u>Section 6.2(b)</u> or <u>Section 6.2(a)</u> and (B)&nbsp;use reasonable best efforts to take all actions necessary to obtain all required Governmental Authorizations or Consents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Reasonable Efforts; Cooperation</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the other terms of this Agreement, each Party shall, and shall cause its respective Subsidiaries (and in the case of Seller, each Company (to the extent it is able)) and its and their respective Advisors to, use its and their respective reasonable best efforts to perform its obligations hereunder and to take, or cause to be taken, and do, or cause to be done, all things necessary, proper or advisable to cause the transactions contemplated herein to be effected as soon as practicable, but in any event on or prior to the Outside Date defined in <u>Section 8.1(c)</u>, in accordance with the terms hereof and to cooperate with each other Party, its Affiliates and its and their respective Advisors in connection with any step required to be taken as a part of its obligations hereunder. Notwithstanding the foregoing or anything else herein to the contrary, the &#8220;reasonable best efforts&#8221; of Seller or Companies, as applicable, will not require Seller, any Company or any of their respective Affiliates or Advisors to expend any money to remedy any breach of any representation or warranty, to commence any Action, to waive or surrender any right, to modify any Contract or to waive or forego any right, remedy or condition hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The obligations of Seller and the Companies pursuant to this Agreement, including this <u>Section</u><u>&nbsp;</u><u>6.3</u>, shall be subject to any Orders entered, or approvals or authorizations granted or required, by or under the Bankruptcy Court or the Bankruptcy Code (including in connection with the Bankruptcy Cases), Seller&#8217;s debtor-in-possession financing, Seller&#8217;s obligations as a debtor&nbsp;in possession to comply with any Order of the Bankruptcy Court (including the Bidding Procedures Order, and the Confirmation Order), and Seller&#8217;s or Companies&#8217; duty to seek and obtain the highest or otherwise best price for the Equity Interests and the Acquired Contracts as required by the Bankruptcy Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Assurances</u>. From time to time, as and when requested by any Party and at such requesting Party&#8217;s expense, any other Party will execute and deliver, or cause to be executed and delivered, all such documents and instruments and will take, or cause to be taken, all such further or other actions as such requesting Party may reasonably deem necessary or desirable to evidence and effectuate the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Acknowledgment by Purchaser; Independent Investigation; No Outside Reliance</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser acknowledges and agrees, on its own behalf and on behalf of the other members of the Purchaser Group, that it has been afforded full access to the books and records, facilities and personnel of the Companies and has conducted, to its full satisfaction, an independent investigation and verification of the Business (including its financial condition, results of operations, assets, Liabilities, properties, Contracts, environmental, health or safety conditions and compliance, employee matters, regulatory compliance, business risks and prospects) of the Companies, and, in making its determination to proceed with the transactions contemplated by this Agreement, Purchaser and the other members of the Purchaser Group have relied, are relying, and will rely solely on the representations and warranties of Seller and Companies expressly contained in <u>Article II</u> and <u>Article III</u> (as qualified by the Schedules and in accordance with the express terms and conditions (including limitations and exclusions) of this Agreement) (the &#8220;<u>Express Representations</u>&#8221;) and the results of the Purchaser Group&#8217;s own independent investigation and verification and have not relied on, are not relying on, and will not rely on, any information, statements, disclosures, documents, projections, forecasts or other material made available to Purchaser or any of its Affiliates or Advisors in that certain datasite administered by Intralinks (the &#8220;<u>Dataroom</u>&#8221;) and any other electronic or &#8220;virtual&#8221; dataroom, any presentations or other materials prepared by or on behalf of Seller or any other Seller Party, including those prepared by PJT (the &#8220;<u>Information Presentation</u>&#8221;), or any projections, forward-looking statements and other forecasts (whether in written, electronic, or oral form, and including in the Information Presentation, Dataroom, management meetings, etc.) (collectively, &#8220;<u>Projections</u>&#8221;) or any other information, statements, disclosures or materials, in each case, whether written or oral, made or provided by or on behalf of Seller or any other Seller Party, or any failure of any of the foregoing to disclose or contain any information, except for the Express Representations (it being understood that Purchaser and the other members of the Purchaser Group have relied only on the Express Representations). Purchaser acknowledges and agrees, on its own behalf and on behalf of the other members of the Purchaser Group, that (i) the Express Representations are the sole and exclusive representations, warranties and statements of any kind made to Purchaser or any other member of the Purchaser Group and on which Purchaser or any other member of the Purchaser Group may rely in connection with the transactions contemplated by this Agreement and (ii) all other representations, warranties and statements of any kind or nature expressed or implied, whether in written, electronic or oral form, including (A) the completeness or accuracy of, or any omission to state or to disclose, any information (other than solely to the extent expressly set forth in the Express Representations), including in the Dataroom, Information Presentation, Projections, meetings, calls or correspondence with management of Seller, any other Seller Parties or any other Person on behalf of Seller or any other Seller Parties or any of their respective Affiliates or Advisors and (B)&nbsp;any other statement relating to the historical, current or future business, financial condition, results of operations, assets, Liabilities, properties, Contracts, environmental, health or safety conditions and compliance, employee matters, regulatory compliance, business risks and prospects of the Companies, the Business, or the quality, quantity or condition of Companies&#8217; assets, are, in each case, specifically disclaimed by Seller, on their behalf and on behalf of each other Seller Parties. Purchaser, on its own behalf and on behalf of the other members of the Purchaser Group: (1) disclaims reliance on the items in clause (ii) in the immediately preceding sentence; (2) acknowledges and agrees that it does not have any knowledge that the representations and warranties of Seller or the Companies in this Agreement are not true and correct in all respects, and does not have any knowledge of any errors in, or material omissions from, the Schedules, (3) acknowledges and agrees that it has relied on, is relying on and will rely on only the items in clause (i) in the immediately preceding sentence, and (4) that neither Seller nor any other Person (including the other Seller Parties) will have any obligation to updated any information (including any information in the Dataroom, the Information Presentation, or the Projections) provided to Purchaser or any other member of the Purchaser Group or its or their respective Advisors. Without limiting the generality of the foregoing, Purchaser acknowledges and agrees, on its own behalf and on behalf of the other members of the Purchaser Group, that no Company or any other Person (including the Seller Parties) has made, is making or is authorized to make, and Purchaser, on its own behalf and on behalf of the other members of the Purchaser Group, hereby waives, all rights and claims it or they may have against any Seller Party with respect to the accuracy of, any omission or concealment of, or any misstatement with respect to, (x) any potentially material information regarding any Company or any of its assets, Liabilities or operations and (y)&nbsp;any warranty or representation (whether in written, electronic or oral form), express or implied, as to the quality, merchantability, fitness for a particular purpose, or condition of any Company&#8217;s business (including the Business), operations, assets, Liabilities, Contracts, environmental, health or safety conditions and compliance, employee matters, regulatory compliance, business risks and prospects or any portion thereof, except, in each case, solely to the extent expressly set forth in the Express Representations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Without limiting the generality of the foregoing, in connection with the investigation by the Purchaser Group of the Companies, Purchaser and the other members of the Purchaser Group, and the Advisors of each of the foregoing, have received or may receive, from or on behalf of Seller or other Seller Parties, certain Projections. Purchaser acknowledges and agrees, on its own behalf and on behalf of the other members of the Purchaser Group, that (i)&nbsp;such Projections are being provided solely for the convenience of Purchaser to facilitate its own independent investigation of Companies, (ii) there are uncertainties inherent in attempting to make such Projections, (iii) Purchaser is familiar with such uncertainties, and (iv)&nbsp;Purchaser is taking full responsibility for making its own evaluation of the adequacy and accuracy of all Projections (including the reasonableness of the assumptions underlying such Projections).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser acknowledges and agrees, on its own behalf and on behalf of the other members of the Purchaser Group, that it will not assert, institute, or maintain, and will cause each member of the Purchaser Group not to assert, institute or maintain, any Action that makes any claim contrary to the agreements and covenants set forth in this <u>Section</u><u>&nbsp;</u><u>6.5</u>, including any such Action with respect to the distribution to Purchaser or any other member of the Purchaser Group, or Purchaser&#8217;s or any other member of the Purchaser Group&#8217;s use, of the information, statements, disclosures or materials in the Information Presentation, the Dataroom or Projections or any other information, statements, disclosures, or materials, in each case whether written or oral, provided by them or any other Seller Party or any failure of any of the foregoing to disclose any information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser acknowledges and agrees, on its own behalf and on behalf of the other members of the Purchaser Group, that the covenants and agreements contained in this <u>Section</u><u>&nbsp;</u><u>6.5</u> (i)&nbsp;require performance after the Closing to the maximum extent permitted by applicable Law and (ii)&nbsp;are an integral part of the transactions contemplated by this Agreement and that, without these agreements set forth in this <u>Section</u><u>&nbsp;</u><u>6.5</u>, Seller would not enter into this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Directors&#8217;</u><u> and Officers&#8217; Indemnification</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;For a period of six (6) years following the Closing, Purchaser shall (i) cause the Companies not to amend, repeal or otherwise modify their respective Organizational Documents as in effect as of immediately prior to the Closing, in any manner that would adversely affect the rights thereunder relating to the exculpation or indemnification of individuals who are or were directors, officers or similar functionaries of any Company (each, a &#8220;<u>D&amp;O Indemnified Party</u>&#8221;) and (ii) cause each such Company to honor the indemnification, advancement of expenses and exculpation provisions and pay any amounts associated therewith pursuant to such Company&#8217;s Organizational Documents as in effect immediately prior to the Closing; <u>provided</u> that all rights to exculpation, indemnification or advancement of expenses in respect of any Action pending or asserted prior to Closing or within the six (6) year period after the Closing shall continue until the final disposition of such Action or final resolution of such claim.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If Purchaser or any Company, as applicable, or any of their respective successors or assigns proposes to (i) consolidate with or merge into any other Person and Purchaser or such Company, as applicable, shall not be the continuing or surviving entity in such consolidation or merger or (ii) transfer all or substantially all of its properties and assets to any Person, then, and in each case, such Party shall use reasonable best efforts to ensure that proper provision be made prior to or concurrently with the consummation of such transaction so that the successors and assigns of Purchaser or such Company, as the case may be, shall, from and after the consummation of such transaction, honor the indemnification and other obligations set forth in this <u>Section 6.6(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The obligations of Purchaser under this <u>Section 6.6</u> (i) shall survive the consummation of the transactions contemplated by this Agreement and the Closing, (ii) are intended to be for the benefit of, and shall be enforceable by, each D&amp;O Indemnified Party and his or her successors, heirs and representatives as if such Persons were a party to this Agreement, (iii) are in addition to, and not in substitution for, any other rights to indemnification or contribution that any such Person may have by Contract or otherwise, (iv) will not be terminated or modified in such a manner as to adversely affect any D&amp;O Indemnified Party without the prior written Consent of such affected Person and (v) shall be binding on Purchaser&#8217;s and each applicable Company&#8217;s acquirors, successors and assigns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Transitional Use of Marks; Background Licenses</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Companies may, solely for a period from the Closing Date until the date that is six (6) months thereafter (the &#8220;<u>Phase-Out Period</u>&#8221; &#8206;), continue to use the GenesisCare Marks listed on <u>Schedule 6.7(a)</u>, solely to the extent and in substantially the same manner as used by the Companies immediately prior to the Closing. After the Closing, Purchaser shall cause the Companies and any other member of the Purchaser Group who uses the GenesisCare Marks after the Closing (as applicable) to, maintain quality standards at least as high as those in effect as of the Closing with respect to any products or services provided or delivered in connection with any GenesisCare Marks during the Phase-Out Period. All goodwill arising from or associated with the Purchaser Group&#8217;s use of any GenesisCare Mark shall inure to the benefit of the Seller or its Affiliates, as applicable, that own the applicable GenesisCare Mark.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of Seller and Purchaser, for itself, its Affiliates (including in the case of Seller, the Companies) and other members of the Purchaser Group, acknowledges and agrees that, except as expressly permitted under <u>Section 6.7(a)</u>, no member of the Purchaser Group (including, after the Closing, the Companies) shall have, or are obtaining, any right, title or interest in, to or under any GenesisCare Marks. Purchaser (i) shall not, and following the Closing shall cause the other members of the Purchaser Group (including, after the Closing, the Companies) not to, hold themselves out as having any affiliation with Seller, its Subsidiaries, or the Retained Business; (ii)&nbsp;shall use commercially reasonable efforts to, to the extent practicable, avoid consumer confusion as between the Purchaser Group (including, after the Closing, the Companies) and the Business, on the one hand, and the Retained Entities and the Retained Business, on the other hand; and (iii) shall use commercially reasonable efforts to minimize (where reasonably practicable) during the Phase-Out Period, and shall eliminate by the expiration of the Phase-Out Period, any use of the GenesisCare Marks by any members of the Purchaser Group (including, after the Closing, the Companies), including (A) from all websites, social and mobile media or other digital content in their possession or control, and (B) from all products, signage, vehicles, properties, technical information, stationery and promotional or other marketing materials and other assets. Notwithstanding anything to the contrary in this Agreement, the Purchaser Group (including, after the Closing, the Companies) has the right to use the GenesisCare Marks in a non-trademark manner after the Closing solely (w) as required by applicable Law, (x) on internal business and legal documents, materials, and items, (y) to factually and accurately describe the history of the Companies or the business of the Seller Parties that previously constituted the Business, on the one hand, and Seller and the other Seller Parties, on the other hand, and (z) as otherwise permitted by Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser, for itself and on behalf of the other members of the Purchaser Group, acknowledges and agrees that, from and after the Closing, it shall indemnify Seller and the other Seller Parties and each of their respective officers, directors, employees, agents and representatives against and hold harmless from any losses suffered or incurred by any such indemnified party to the extent arising from any use by Purchaser or any other member of the Purchaser Group (including, after the Closing, the Companies) of the GenesisCare Marks or any breach of this <u>Section 6.7</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance</u>. Purchaser acknowledges and agrees that, from and after the Closing, the Companies and the operations, assets and Liabilities of the Business in respect thereof, shall cease to be insured by Seller&#8217;s or the applicable Company or its or their respective Affiliates&#8217; insurance policies or by any of their respective self-insured programs, and neither Purchaser nor its Affiliates (including the Business and the Companies) shall have any access, right, title or interest to or in any such insurance policies (including to all claims and rights to make claims and all rights to proceeds) to cover the Business, Companies, or the operations or assets or Liabilities in respect thereof. Seller or its Affiliates may amend any insurance policies in the manner it deems appropriate to give effect to this <u>Section 6.8</u>. From and after the Closing, Purchaser shall be responsible for securing all insurance it considers appropriate for the Business, Companies, and the operations and assets and Liabilities in respect thereof. Purchaser further covenants and agrees not to seek to assert or to exercise any rights or claims of, or in respect of, the Business, the Companies, and the operations and assets and Liabilities in respect thereof, under or in respect of any past or current insurance policy under which any Company or any of its Affiliates is a named insured.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation Support</u>. In the event that, and for so long as, any Seller Party or, any of the other Retained Entities, is prosecuting, contesting or defending any Action, investigation, charge, claim or demand by or against a third party or otherwise addressing, negotiating, disputing, investigating, complying with, mitigating, discharging or otherwise performing or managing any obligation, liability or loss in connection with (a) the transactions contemplated under this Agreement, or (b) any fact, situation, circumstance, status, condition, activity, practice, plan, occurrence, event, incident, action, failure to act, or transaction relating to, in connection with or arising from the Business or the Companies, Purchaser shall, and shall cause the other members of the Purchaser Group (and its and their respective Advisors) to, reasonably cooperate with the Seller Party and the other Retained Entities (as applicable) and its or their counsel, in such prosecution, contest or defense, including making available its personnel, participating in meetings and providing such testimony and access to its books and records and taking such other actions as shall be reasonably necessary in connection with such prosecution, contest or defense. Notwithstanding anything in this Agreement to the contrary, Seller and the other Seller Parties shall retain full control of prosecuting, contesting, defending, compromising, settling or taking any other action related to or in connection with any Action, investigation, charge, claim or demand by or against a third party related to any Retained Entity or the Retained Business, whether arising before or after the Closing, and neither Purchaser nor its Affiliates shall have any rights in connection therewith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Post-Closing Payments</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;During the twenty-four (24) month period after the Closing (or in the case of any Seller Party, after the closing of the Bankruptcy Cases or winding-up of any such Seller Party, if earlier), in the event that any Seller Party or any member of the Purchaser Group receives payments or funds or such party discovers funds due or belonging to the other party pursuant to the terms of this Agreement, the Plan, or any of the other documents or certificates to be delivered in connection herewith or therewith, then the party receiving or discovering such payments or funds shall promptly forward or transfer or cause to be promptly forwarded or transferred such payments or funds to the proper party (with appropriate endorsements, as applicable), for no additional consideration, and will account to such other party for all such receipts. Each Party acknowledges and agrees, on its own behalf and on behalf of the other members of the Seller Party or Purchaser Group, as applicable, and its and their respective assigns, that, except as otherwise explicitly provided in this Agreement, there is no right of offset regarding such payments and neither the Seller Parties nor any member of the Purchaser Group may withhold funds received from third parties for the account of the other party in the event there is a dispute regarding any other issue under this Agreement, the Plan, or any of the other documents or certificates to be delivered in connection herewith or therewith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;During the twenty-four (24) month period after the Closing, if any member of the Purchaser Group receives any mail or packages addressed to any Seller Party and which do not relate to the Business, such member of the Purchaser Group shall promptly deliver (or cause to be delivered) such mail or packages to the appropriate Seller Party at the address listed in <u>Section 9.3</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;During the twenty-four (24) month period after the Closing, if any of the Seller Parties receives any mail or packages solely relating to the Business, such Seller Party shall promptly deliver (or cause to be delivered) such mail or packages to the appropriate member of the Purchaser Group.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Prior to any such transfer or delivery of such payments or funds referred in <u>Section 6.10(a)</u>, <u>6.10(b)</u> or <u>6.10(c)</u>, the applicable payments or funds shall be held in trust for the benefit or burden (as applicable), insofar as reasonably possible, of the Person entitled thereto or to be charged therewith (as applicable) until the consummation of the transfer or delivery thereof in accordance with this <u>Section 6.10</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Intercompany Accounts</u>. At the Closing, each Company shall have sufficient Cash on hand to pay off all net intercompany balances and accounts accrued, due, or payable as of the Closing, including the net amounts of the intercompany balances and accounts set forth on <u>Schedule 6.11</u> that are still due and payable at Closing, between or among the Retained Entities and/or any of their Affiliates (including Massachusetts Oncology Services, P.C. &#8220;<u>MoS</u>&#8221; ) (collectively, the &#8220;<u>Entities</u>&#8221; ), on the one hand, and any Company, on the other hand (the &#8220;<u>Intercompany Balances</u>&#8221; ). To the extent any Intercompany Balances are paid before the Closing, any and all such amounts due and payable to MoS shall be paid first. Notwithstanding the foregoing, if either of the Companies does not have sufficient Cash on hand at the Closing to pay off all Intercompany Balances of such Company due and payable at the Closing (other than any Intercompany Balances due and payable to MoS), the obligations and liabilities relating to such remaining Intercompany Balances shall be forgiven, released, and eliminated by the Entities (other than MoS) to which such Intercompany Balances are owed by execution of a legally binding written instrument evidencing that there will no longer be any outstanding Intercompany Balances of such Company as of the Closing As used in this <u>Section 6.11</u>, &#8220;Cash&#8221; means, as of the 12:01 am Eastern Time on the Closing Date, (i) the actual cash balances and cash equivalents of a particular Company, including amounts in transit and all third party-checks deposited or held in any account of the Company that have not yet cleared, and (ii) net of any outstanding checks and drafts.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="25" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE VII</b><br>
<b>CONDITIONS TO CLOSING</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions Precedent to the Obligations of Purchaser and Seller</u>. The respective obligations of each Party to consummate the transactions contemplated by this Agreement are subject to the satisfaction (or to the extent permitted by Law, written waiver by Topco and Purchaser) on or prior to the Closing Date, of each of the following conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;no court of competent jurisdiction shall have entered any Order (including any temporary restraining Order or preliminary or permanent injunction) restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement that is still in effect;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;the Bankruptcy Court shall have entered the Confirmation Order in a form reasonably acceptable to Purchaser and the Plan shall have become effective in accordance with its terms;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;the receipt of written Consent by the appropriate Governmental Body to the indirect transfer of the radioactive materials license held by RWRT as of the date hereof; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Entry by Seller and Purchaser into a Consent Agreement with the Rhode Island Department of Health regarding the Change in Effective Control application process for the Organized Ambulatory Care Facility Licenses, issued by the Rhode Island Department of Health, to (1) SNERCC (ACF01647, ACF01647-01) and (2) RWRT (ACF01646).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions Precedent to the Obligations of Purchaser</u>. The obligations of Purchaser to consummate the transactions contemplated by this Agreement are subject to the satisfaction (or to the extent permitted by Law, written waiver by Purchaser), on or prior to the Closing Date, of each of the following conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;(i) the representations and warranties made by Seller set forth in <u>Article II</u> and <u>Article III</u>, (in each case, other than the Fundamental Representations) shall be true and correct in all respects as of the Closing as though made on and as of the Closing, <u>except</u> (A) that representations and warranties that are made as of a specified date need be true and correct in all respects only as of such date and (B) to the extent the failure of such representations and warranties to be true and correct as of such dates has not had a Material Adverse Effect and (ii)&nbsp;the representations and warranties set forth in <u>Section 2.1</u> (Organization and Qualification and Capitalization of Company), <u>Section 2.4</u> (Brokers), <u>Section 3.1</u> (Organization of Seller), <u>Section 3.2</u> (Authorization and Validity of Agreement), and <u>Section 3.5</u> (Brokers) (collectively, the &#8220;<u>Fundamental Representations</u>&#8221;) shall be true and correct in all material respects as of the Closing as though made on and as of the Closing, <u>except</u> that such Fundamental Representations that are made as of a specified date need be true and correct in all material respects only as of such date;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="26" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Seller shall not have breached in a manner that is material with respect to the transactions contemplated by this Agreement, taken as a whole, the covenants required to be performed or complied with by Seller under this Agreement at or prior to Closing;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp; Purchaser shall have received on and as of the Closing a certificate of an authorized officer of Seller confirming that (i) the conditions set forth in <u>Sections 7.2(a)</u> and <u>7.2(b)</u> applicable to Seller have been satisfied; and (ii) the conditions to (A) the Closing Date set forth in the Plan and (B) the Restructuring set forth in the Plan, in each case, shall have been satisfied (or waived with the Consent of Purchaser) in accordance with the Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall have received on and as of the Closing an Assignment of Equity Interests for each Company substantively in the form attached hereto as <u>Exhibit A</u>, executed and delivered by Seller and New England Radiation Therapy Management Services, Inc.;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall have received on and as of the Closing a Bill of Sale and Assignment and Assumption Agreement substantively in the form attached hereto as <u>Exhibit B</u>, executed and delivered by Seller and Purchaser; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Seller shall have delivered or caused to be delivered to Purchaser the following items:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the consent of all members of the Board of Managers of RWRT, to the continuation of RWRT as a limited liability company notwithstanding the bankruptcy of the applicable Seller as a member of RWRT, effective as of a date prior to the end of the 90-day period following June 1, 2023;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the consent of all members of the Board of Managers of SNERCC, effective as of prior to June 1, 2023, to the continuation of SNERCC as a limited liability company notwithstanding the bankruptcy of the applicable seller as a member of SNERCC, effective as of a date prior to the end of the 90-day period following June 1, 2023;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the consent of all members of the Board of Managers of RWRT to the transfer of the applicable seller&#8217;s membership interest in RWRT to Purchaser in accordance with Section 13.1 of the operating agreement of RWRT;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the consent of all members of the Board of Managers of SNERCC to the transfer of the applicable seller&#8217;s membership interest in SNERCC to Purchaser in accordance with Section 13.1 of the operating agreement of SNERCC;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="27" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">27</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;the waiver by the non-seller members of RWRT of the right of first refusal set forth in Section 14 of the operating agreement of RWRT; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;the waiver by the non-seller members of SNERCC of the right of first refusal set forth in Section 14 of the operating agreement of SNERCC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions Precedent to the Obligations of Seller</u>. The obligations of Seller to consummate the transactions contemplated by this Agreement are subject to the satisfaction (or to the extent permitted by Law, written waiver by Topco), on or prior to the Closing Date, of each of the following conditions:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties made by Purchaser in <u>Article IV</u> shall be true and correct in all respects as of the Closing as though made on and as of the Closing (except that representations and warranties that are made as of a specified date need be true and correct in all respects only as of such date), <u>except</u> for any failure of such representations and warranties to so true and correct that has not had, individually or in the aggregate, a material adverse effect on the ability of Purchaser to consummate the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall not have breached in a manner that is material with respect to the transactions contemplated hereby, taken as a whole, the covenants required to be performed or complied with by it under this Agreement at or prior to the Closing;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp; Seller shall have received on and as of the Closing a certificate of an authorized officer of Purchaser confirming that the conditions set forth in <u>Sections</u><u>&nbsp;</u><u>7.3(a)</u> and <u>7.3(b)</u> have been satisfied.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Waiver of Conditions</u>. Upon the occurrence of the Closing, any condition set forth in this <u>Article VII</u> that was not satisfied as of the Closing will be deemed to have been waived for all purposes by the Party having the benefit of such condition as of and after the Closing. None of Purchaser or Seller may rely on the failure of any condition set forth in this <u>Article VII</u>, as applicable, to be satisfied if such failure was caused by such Party&#8217;s failure to perform any of its obligations under this Agreement, including its obligation to use its reasonable best efforts to consummate the transactions contemplated hereby as required under this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE VIII</b><br>
<b>TERMINATION</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Termination of Agreement</u>. This Agreement may be terminated at any time prior to the Closing only in accordance with this <u>Section</u><u>&nbsp;</u><u>8.1</u>, and in no other manner:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;by the mutual written Consent of Topco and Purchaser;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;by written notice of either Purchaser, on the one hand, or Topco, on the other hand, to the other, upon the issuance of an Order by a court of competent jurisdiction restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement or declaring unlawful the transactions contemplated by this Agreement, and such Order having become final, binding and non-appealable; <u>provided</u> that no Party may terminate this Agreement under this <u>Section</u><u>&nbsp;</u><u>8.1(b)</u> if the issuance of such Order was caused by such Party&#8217;s failure to perform any of its obligations under this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="28" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">28</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;by written notice of either Purchaser, on the one hand, or Topco, on the other hand, to the other, if the Closing shall not have occurred on or before the later of (i) March 10, 2024 and, where applicable, (ii) the Auction Outside Date (the later of (i) and (ii), the &#8220;<u>Outside Date</u>&#8221;); <u>provided</u> that a Party shall not be permitted to terminate this Agreement pursuant to this <u>Section</u><u>&nbsp;</u><u>8.1(c)</u> if the failure of the Closing to have occurred by the Outside Date was caused by such Party&#8217;s failure to perform any of its obligations under this Agreement; <u>provided</u> <u>further</u> that Topco may extend the Outside Date up to an additional thirty (30) days to the extent necessary to satisfy the conditions set forth in <u>Section 7.1</u> so long as the other conditions in <u>Article VII</u> have been satisfied (other than conditions that by their nature are to be satisfied at the Closing, but which conditions are capable of being satisfied);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;by written notice from Topco to Purchaser, upon a breach of any covenant or agreement on the part of Purchaser, or if any representation or warranty of Purchaser will have become untrue, in each case, such that the conditions set forth in <u>Section</u><u>&nbsp;</u><u>7.3(a)</u> or&nbsp;<u>7.3(b)</u> would not be satisfied, including a breach of Purchaser&#8217;s obligation to consummate the Closing; <u>provided</u> that (i) if such breach is curable by Purchaser (other than a breach or failure by Purchaser to close when required pursuant to <u>Section 1.3</u>), then Topco may not terminate this Agreement under this <u>Section</u><u>&nbsp;</u><u>8.1(d)</u> for so long as Purchaser continues to exercise reasonable best efforts to cure such breach unless such breach has not been cured by the date which is the earlier of (A)&nbsp;two&nbsp;(2) Business Days prior to the Outside Date and (B)&nbsp;15 days after Topco first notifies Purchaser of such breach, and (ii) Topco&#8217;s right to terminate this Agreement pursuant to this <u>Section</u><u>&nbsp;</u><u>8.1(d)</u> will not be available to Topco at any time that Seller is in material breach of any covenant, representation or warranty hereunder;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;by written notice from Purchaser to Topco, upon a breach of any covenant or agreement on the part of Seller, or if any representation or warranty of Seller will have become untrue, in each case, such that the conditions set forth in <u>Section</u><u>&nbsp;</u><u>7.2(a)</u> or&nbsp;<u>7.2(b)</u> would not be satisfied; <u>provided</u> that (i) if such breach is curable by Seller (other than a breach or failure by Seller to close when required pursuant to <u>Section 1.3</u>), then Purchaser may not terminate this Agreement under this <u>Section</u><u>&nbsp;</u><u>8.1(e)</u> for so long as Seller continues to exercise reasonable best efforts to cure such breach unless such breach has not been cured by the date which is the earlier of (A)&nbsp;two&nbsp;(2) Business Days prior to the Outside Date and (B)&nbsp;15 days after Purchaser first notifies Topco of such breach and (ii)&nbsp;the right to terminate this Agreement pursuant to this <u>Section</u><u>&nbsp;</u><u>8.1(e)</u> will not be available to Purchaser at any time that Purchaser is in material breach of any covenant, representation or warranty hereunder;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;by written notice from Topco to Purchaser, if all of the conditions set forth in <u>Sections</u><u>&nbsp;</u><u>7.1</u> and&nbsp;<u>7.2</u> have been satisfied (other than conditions that by their nature are to be satisfied at the Closing, but which conditions are capable of being satisfied) or waived and Purchaser fails to complete the Closing at the time required by <u>Section 1.3</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;by written notice from Topco to Purchaser, if Seller or the board of directors (or equivalent governing body) of Seller determines that proceeding with the transactions contemplated by this Agreement or failing to terminate this Agreement would be inconsistent with its or such Person&#8217;s or body&#8217;s fiduciary duties;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="29" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;by written notice of either Purchaser or Topco, if (i)&nbsp;Seller enters into one or more Alternative Transactions with one or more Persons other than Purchaser or the Winning Bidder or the Back-Up Bidder at the Auction or (ii)&nbsp;the Bankruptcy Court approves an Alternative Transaction other than with the Winning Bidder or the Back-Up Bidder; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;by written notice either from Purchaser, on the one hand, or Topco, on the other hand, if Purchaser is not the Winning Bidder or the Back-Up Bidder at the Auction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Effect of Termination</u>. In the event of termination of this Agreement in accordance with <u>Section</u><u>&nbsp;</u><u>8.1</u>, this Agreement shall forthwith become null and void and no Party or any of its partners, officers, directors, managers or equityholders will have any Liability under this Agreement; <u>provided</u> that <u>Sections 1.4</u>, <u>6.1(b)</u>, and <u>8.2</u> and <u>Article IX</u> shall survive any such termination; <u>provided</u> <u>further</u> that no termination will relieve Purchaser from any Liability for damages, losses, costs or expenses (which the Parties acknowledge and agree shall not be limited to reimbursement of expenses or out-of-pocket costs, and would include the benefits of the transactions contemplated by this Agreement lost by Topco, Seller and Companies (taking into consideration all relevant matters, including other combination opportunities and the time value of money), which shall be deemed in such event to be damages of Topco, Seller and such Company) resulting from any Willful Breach of this Agreement by Purchaser prior to the date of such termination (which will be deemed to include any failure by Purchaser to consummate the Closing if and when it is obligated to do so hereunder). Subject to <u>Section 9.12</u>, nothing in this <u>Section 8.2</u> will be deemed to impair the right of any Party to be entitled to specific performance or other equitable remedies to enforce specifically the terms and provisions of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE IX</b><br>
<b>MISCELLANEOUS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Survival of Representations and Warranties and Certain Covenants; Certain Waivers</u>. Each of the representations and warranties and the covenants and agreements (to the extent such covenant or agreement contemplates or requires performance by such Party prior to the Closing) of the Parties set forth in this Agreement or in any other document contemplated hereby, or in any certificate delivered hereunder or thereunder, will terminate effective immediately as of the Closing such that no claim for breach of any such representation, warranty, covenant or agreement, detrimental reliance or other right or remedy (whether in contract, in tort or at law or in equity) may be brought with respect thereto after the Closing. Each covenant and agreement that explicitly contemplates performance after the Closing, will, in each case and to such extent, expressly survive the Closing in accordance with its terms, and if no term is specified, then for five (5) years following the Closing Date, and nothing in this <u>Section</u><u>&nbsp;</u><u>9.1</u> will be deemed to limit any rights or remedies of any Person for breach of any such surviving covenant or agreement. Purchaser and Seller each acknowledge and agree, on their own behalf and, with respect to Seller, on behalf of the Companies, and with respect to Purchaser, on behalf of the other members of the Purchaser Group, that the agreements contained in (among others) <u>Section</u><u>&nbsp;</u><u>6.5</u> and this <u>Section</u><u>&nbsp;</u><u>9.1</u> require performance after the Closing to the maximum extent permitted by applicable Law and will survive the Closing for five (5) years. Purchaser, on behalf of itself and the other members of the Purchaser Group, hereby waives all rights and remedies with respect to any environmental, health or safety matters, including those arising under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, or any other Environmental Laws, relating to this Agreement or the transactions contemplated hereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="30" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">30</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses</u>. Whether or not the Closing takes place, except as otherwise provided herein (including <u>Section 6.6</u> and <u>Section 8.2</u>), all fees, costs and expenses (including fees, costs and expenses of Advisors) incurred in connection with the negotiation of this Agreement, and the other agreements contemplated hereby and thereby, the performance of this Agreement and the other agreements contemplated hereby and thereby and the consummation of the transactions contemplated hereby and thereby will be paid by the Party incurring such fees, costs and expenses; it being acknowledged and agreed that all Transfer Taxes will be allocated pursuant to <u>Section 9.20(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices</u>. Except as otherwise expressly provided herein, all notices, demands and other communications to be given or delivered under or by reason of the provisions of this Agreement will be in writing and will be deemed to have been given (a)&nbsp;when personally delivered, (b)&nbsp;when transmitted by electronic mail (<u>provided</u> that the sender receives confirmation of such delivery), if before 5:00 pm Eastern Standard Time on a Business Day and otherwise, on the next Business Day, (c)&nbsp;the day following the day on which the same has been delivered prepaid to a reputable national overnight air courier service or (d)&nbsp;the third Business Day following the day on which the same is sent by certified or registered mail, postage prepaid, in each case, to the respective Party at the number, electronic mail address or street address, as applicable, set forth below, or at such other number, electronic mail address or street address as such Party may specify by written notice to the other Party.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;"><u>Notices to Purchaser</u>:<br>
<br>
American Shared Hospital Services</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">601 Montgomery St. Suite 1112</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">San Francisco, CA 94111<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Craig K. Tagawa, President<br>
&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; Ray Stachowiak, Executive Chairman<br>
E-mail:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp; ctagawa@ashs.com; rstachowiak@ashs.com<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">with copies to (which shall not constitute notice):<br>
<br>
Adler Pollock &amp; Sheehan P.C.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">One Citizens Plaza, 8<sup style="vertical-align:top;line-height:120%;">th</sup> Floor</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">Providence, RI 02903<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patricia K. Rocha, Esq.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 9pt; text-align: justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joseph Avanzato, Esq.<br>
E-mail:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; procha@apslaw.com</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 9pt; text-align: justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; javanzato@apslaw.com<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="31" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">31</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;"><u>Notices to Seller, Topco, and Companies (if before Closing)</u>:<br>
<br>
GenesisCare USA Holdings, Inc.<br>
1419 SE 8<sup style="vertical-align:top;line-height:120%;">th</sup> Terrace, Suite 200<br>
Cape Coral, FL 33990<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shaden Marzouk<br>
&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; Jack Seal<br>
E-mail:&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; Shaden.marzouk@usa.genesiscare.com<br>
&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; Jack.seal@usa.genesiscare.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Legalnotices@usa.genesiscare.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">with copies to (which shall not constitute notice):<br>
<br>
Kirkland &amp; Ellis LLP<br>
200 Clarendon Street, 47th Floor<br>
Boston, MA 02116<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shayla K. Harlev<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steven N. Serajeddini, P.C.<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steve Toth<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Daniel W. Vaczy<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Larissa Cespedes-Yaffar<br>
&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neil K. Vohra<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jaimie Fedell<br>
E-mail:&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; Shayla.harlev@kirkland.com<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; Steven.serajeddini@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steve.toth@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dan.vaczy@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Larissa.cespedesyaffar@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neil.vohra@kirkland.com</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 9pt; text-align: justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jaimie.Fedell@kirkland.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;"><u>Notices to Seller or Topco (if after Closing):</u><br>
<br>
GenesisCare USA Holdings, Inc.<br>
c/o Genesis Care Finance Pty Ltd.<br>
Building 7, Level 1<br>
41/43 Bourke Road<br>
Alexandria NSW 2015, Australia<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;David Young<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; Nicola Brookes<br>
E-mail: &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; David.young@genesiscare.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nicola.brookes@genesiscare.co.uk<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCCompanySecretary@genesiscare.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="32" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-align: justify;">with copies to (which shall not constitute notice):<br>
<br>
Kirkland &amp; Ellis LLP<br>
200 Clarendon Street, 47th Floor<br>
Boston, MA 02116<br>
Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shayla K. Harlev<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steven N. Serajeddini, P.C.<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steve Toth<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Daniel W. Vaczy<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Larissa Cespedes-Yaffar<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neil K. Vohra<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jaimie Fedell<br>
E-mail:&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp; Shayla.harlev@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steven.serajeddini@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Steve.toth@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dan.vaczy@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Larissa.cespedesyaffar@kirkland.com<br>
&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neil.vohra@kirkland.com</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 9pt; text-align: justify;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; Jaimie.Fedell@kirkland.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.4&nbsp;&nbsp;&nbsp;&nbsp;<u>Binding Effect; Assignment</u>. This Agreement shall be binding upon Purchaser and, subject to the terms of the Bidding Procedures Order (with respect to the matters covered thereby) and the entry and terms of the Confirmation Order, Seller, and shall inure to the benefit of and be so binding on the Parties and their respective successors and permitted assigns, including any trustee or estate representative appointed in the Bankruptcy Cases or any successor Chapter 11 cases; <u>provided</u> that such assignee assumes all of the assignors obligations hereunder and neither this Agreement nor any of the rights or obligations hereunder may be assigned or delegated without the prior written Consent of each of Purchaser and Topco, and any attempted assignment or delegation without such prior written Consent shall be null and void and not relieve Purchaser of any of its obligations under this Agreement and the transactions contemplated hereby and Purchaser shall remain liable for such assignee&#8217;s breach or failure to perform any of its or Purchaser&#8217;s obligations under this Agreement and the transactions contemplated hereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.5&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment and Waiver</u>. Any provision of this Agreement or the Schedules or exhibits hereto may be (a)&nbsp;amended only in a writing signed by Purchaser and Topco or (b)&nbsp;waived only in a writing executed by the Party against which enforcement of such waiver is sought. No waiver of any provision hereunder or any breach or default thereof will extend to or affect in any way any other provision or prior or subsequent breach or default.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.6&nbsp;&nbsp;&nbsp;&nbsp;<u>Third Party Beneficiaries</u>. Except as otherwise expressly provided herein, nothing expressed or referred to in this Agreement will be construed to give any Person, other than (a) for purposes of <u>Section 6.6</u> (Directors&#8217; and Officers&#8217; Indemnification), the D&amp;O Indemnified Parties, and (b) the Parties hereto and their permitted successor and assigns, to any legal or equitable right, remedy, or claim under or with respect to this Agreement or any provision of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="33" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.7&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Recourse; Release</u>. This Agreement may only be enforced against, and any Action based upon, arising out of or related to this Agreement may only be brought against, the Persons that are expressly named as parties to this Agreement. Except to the extent named as a party to this Agreement, and then only to the extent of the specific obligations of such parties set forth in this Agreement, (a) no past, present or future equityholder, member, partner, manager, director, officer, employee, Affiliate, agent or Advisor of any Party will have any Liability (whether in contract, tort, equity or otherwise) for any of the representations, warranties, covenants, agreements or other obligations or Liabilities of any of the Parties to this Agreement or for any Agreement Dispute (as defined herein), and (b) in no event shall any Party have any shared or vicarious liability, or otherwise be the subject of legal or equitable claims, for the actions, omissions or fraud (including through equitable claims (such as unjust enrichment) not requiring proof of wrongdoing committed by the subject of such claims) of any other Person. Without in any way limiting the foregoing, each Party, both for itself and its past, present or future equityholders, members, partners, managers, directors, officers, employees, Affiliates, agents or Advisors and their respective successors and assigns, (i) waives and releases all such Liabilities against any such Persons who are not expressly Parties, including any and all causes of Action arising from or otherwise relating to such Person&#8217;s receipt of consideration or other benefits from this Agreement and the transactions contemplated hereby and thereby, and (ii) acknowledges and agrees that no past, present or future equityholders, members, partners, managers, directors, officers, employees, Affiliates, agents or Advisors of an expressly named Party to this Agreement or their respective successors and assigns shall have any shared or vicarious liability or otherwise be the subject of legal or equitable claims (such as unjust enrichment) not requiring proof of wrongdoing committed by the subject of such claims for the actions, omissions, or fraud of any other Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law in any jurisdiction, such provision will be ineffective only to the extent of such prohibition or invalidity in such jurisdiction, without invalidating the remainder of such provision or the remaining provisions of this Agreement or in any other jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.9&nbsp;&nbsp;&nbsp;&nbsp;<u>Construction</u>. The language used in this Agreement will be deemed to be the language chosen by the Parties to express their mutual intent, and no rule of strict construction will be applied against any Person. The headings of the sections and paragraphs of this Agreement have been inserted for convenience of reference only and will in no way restrict or otherwise modify any of the terms or provisions hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedules</u>. The Schedules have been arranged for purposes of convenience in separately numbered schedules corresponding to the sections of this Agreement; <u>provided</u> that each section of the Schedules will be deemed to incorporate by reference all information disclosed in any other section of the Schedules, references in the Schedules to any documents, schedules or exhibits attached thereto will be deemed to incorporate the contents of such attachment into the Schedules, and any disclosure in the Schedules will be deemed a disclosure against any representation or warranty set forth in this Agreement. No information set forth in the Schedules will be deemed to broaden in any way the scope of the Parties&#8217; representations and warranties. The headings of the sections and paragraphs contained in the Schedules have been inserted for convenience of reference only and will in no way restrict or otherwise modify or influence the interpretation of any of the terms or provisions of this Agreement or the information contained in the Schedules. The information contained in this Agreement, in the Schedules and exhibits and other attachments hereto and thereto is disclosed solely for purposes of this Agreement, and no information contained herein or therein will be deemed to be an admission of liability by any Party or any of their respective Advisors to any third party of any matter whatsoever, including any violation of Law, breach of Contract or otherwise. Capitalized terms used in the Schedules and not otherwise defined therein have the meanings given to them in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="34" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Complete Agreement</u>. This Agreement, the exhibits attached hereto, together with the Confidentiality Agreement and any other agreements expressly referred to herein or therein, contains the entire agreement of the Parties respecting the sale and purchase of the Equity Interests and the Acquired Contracts and the transactions contemplated by this Agreement and supersedes all prior agreements among the Parties respecting the sale and purchase of the Equity Interests and the Acquired Contracts and the transactions contemplated by this Agreement. In the event of any conflict between this Agreement, on the one hand, and the Plan or any other documents delivered in connection hereby or thereby, on the other hand, the terms of this Agreement shall control. In the event an ambiguity or question of intent or interpretation arises with respect to this Agreement, the terms and provisions of the execution version of this Agreement will control and prior drafts of this Agreement and the documents referenced herein will not be considered or analyzed for any purpose (including in support of parol evidence proffered by any Person in connection with this Agreement), will be deemed not to provide any evidence as to the meaning of the provisions hereof or the intent of the Parties with respect hereto and will be deemed joint work product of the Parties.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Performance</u>. The Parties agree that irreparable damage, for which monetary relief, even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached, including if any of the Parties fails to take any action required of it hereunder to consummate the transactions contemplated by this Agreement. It is accordingly agreed that (a)&nbsp;the Parties will be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in <u>Section</u><u>&nbsp;</u><u>9.13</u> without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement, and (b)&nbsp;the right of specific performance and other equitable relief is an integral part of the transactions contemplated by this Agreement and without that right, none of Seller or Purchaser would have entered into this Agreement. The Parties acknowledge and agree that any Party pursuing an injunction or injunctions or other Order to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this <u>Section</u><u>&nbsp;</u><u>9.12</u> will not be required to provide any bond or other security in connection with any such Order. The remedies available to any Party pursuant to this <u>Section</u><u>&nbsp;</u><u>9.12</u> will be in addition to any other remedy to which they were entitled at law or in equity, and the election to pursue an injunction or specific performance will not restrict, impair or otherwise limit such Party from seeking to collect or collecting damages. Notwithstanding anything in this Agreement to the contrary, if any Party pursues any injunction(s) or other Order to enforce specifically the terms of this Agreement, the Outside Date shall automatically be extended by (a) the amount of time during which such injunction(s) or Order is ending, plus twenty (20) Business Days or (b) such longer time period established by the Court presiding over such injunction(s) or Order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="35" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Jurisdiction and Exclusive Venue</u>. Each of the Parties irrevocably agrees that any Action of any kind whatsoever, including a counterclaim, cross-claim, or defense, regardless of the legal theory under which any Liability or obligation may be sought to be imposed, whether sounding in contract or in tort or under statute, or whether at law or in equity, or otherwise under any legal or equitable theory, that may be based upon, arising out of, or related to this Agreement or the negotiation, execution, or performance of this Agreement or the transactions contemplated hereby and any questions concerning the construction, interpretation, validity and enforceability of this Agreement (each, an &#8220;<u>Agreement Dispute</u>&#8221;) brought by any other Party or its successors or assigns will be brought and determined only in (a)&nbsp;the Bankruptcy Court and any federal court to which an appeal from the Bankruptcy Court may be validly taken or (b) if the Bankruptcy Court is unwilling or unable to hear such Action, in the Court of Chancery of the State of Delaware (or if such court lacks jurisdiction, any other state or federal court sitting in the State of Delaware) (the &#8220;<u>Chosen Courts</u>&#8221;), and each of the Parties hereby irrevocably submits to the exclusive jurisdiction of the Chosen Courts for itself and with respect to its property, generally and unconditionally, with regard to any Agreement Dispute. Each of the Parties agrees not to commence any Agreement Dispute except in the Chosen Courts, other than Actions in any court of competent jurisdiction to enforce any Order, decree or award rendered by any Chosen Courts, and no Party will file a motion to dismiss any Agreement Dispute filed in a Chosen Court on any jurisdictional or venue-related grounds, including the doctrine of <i>forum non-conveniens</i>. The Parties irrevocably agree that venue would be proper in any of the Chosen Court, and hereby irrevocably waive any objection that any such court is an improper or inconvenient forum for the resolution of any Agreement Dispute. Each of the Parties further irrevocably and unconditionally consents to service of process in the manner provided for notices in <u>Section 9.3</u>. Nothing in this Agreement will affect the right of any Party to serve process in any other manner permitted by Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.14&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law; Waiver of Jury Trial</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except to the extent the mandatory provisions of the Bankruptcy Code apply, this Agreement and any Agreement Dispute will be governed by and construed in accordance with the internal Laws of the State of Delaware applicable to agreements executed and performed entirely within such State without regards to conflicts of law principles of the State of Delaware or any other jurisdiction that would cause the Laws of any jurisdiction other than the State of Delaware to apply.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY AGREEMENT DISPUTE IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND THEREFORE HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY AGREEMENT DISPUTE. EACH OF THE PARTIES AGREES AND CONSENTS THAT ANY SUCH AGREEMENT DISPUTE WILL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE IRREVOCABLE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY (I)&nbsp;CERTIFIES THAT NO ADVISOR OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY AGREEMENT DISPUTE, SEEK TO ENFORCE THE FOREGOING WAIVER AND (II)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="36" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.15&nbsp;&nbsp;&nbsp;&nbsp;<u>No Right of Set-Off</u>. Purchaser, on its own behalf and on behalf of the other members of Purchaser Group and its and their respective successors and permitted assigns, hereby waives any rights of set-off, netting, offset, recoupment or similar rights that Purchaser, any other member of the Purchaser Group or any of its or their respective successors and permitted assigns has or may have with respect to the payment of the Purchase Price or any other payments to be made by Purchaser pursuant to this Agreement or any other document or instrument delivered by Purchaser in connection herewith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.16&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts and PDF</u>. This Agreement and any other agreements referred to herein or therein, and any amendments hereto or thereto, may be executed in multiple counterparts, any one of which need not contain the signature of more than one Party hereto or thereto, but all such counterparts taken together will constitute one and the same instrument. Any counterpart, to the extent signed and delivered by means of a .PDF or other electronic transmission, will be treated in all manner and respects as an original Contract and will be considered to have the same binding legal effects as if it were the original signed version thereof delivered in person. Minor variations in the form of the signature page to this Agreement or any agreement or instrument contemplated hereby, including footers from earlier versions of this Agreement or any such other document, will be disregarded in determining the effectiveness of such signature. At the request of any Party or pursuant to any such Contract, each other party hereto or thereto will re-execute original forms thereof and deliver them to all other parties. No Party hereto or to any such Contract will raise the use of a .PDF or other electronic transmission to deliver a signature or the fact that any signature or Contract was transmitted or communicated through the use of PDF or other electronic transmission as a defense to the formation of a Contract and each such party forever waives any such defense.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.17&nbsp;&nbsp;&nbsp;&nbsp;<u>Publicity</u>. None of Seller or Purchaser shall, and none of them shall permit their respective controlled Affiliates (including the Companies) to, issue any press release or public announcement concerning this Agreement or the transactions contemplated hereby or thereby without obtaining the prior written approval of the other Party, which approval will not be unreasonably conditioned, withheld or delayed, unless, in the reasonable judgment of Purchaser or Topco, as applicable, disclosure is otherwise required of such Party by applicable Law, such disclosure is consistent with (and discloses no substantive terms of the Agreement other than those disclosed in prior permitted releases) or by the Bankruptcy Court with respect to filings to be made with the Bankruptcy Court in connection with this Agreement or by the applicable rules of any stock exchange on which Purchaser, Seller or the Companies (or their respective Affiliates) lists securities; <u>provided</u> that the Party intending to make such release shall use its reasonable efforts consistent with such applicable Law, Bankruptcy Court requirement, or rule to consult with the other Party with respect to the text thereof. Without limiting the foregoing, no Party, without the prior written approval of each of Topco and Purchaser, shall disclose the Purchase Price, the approximate amount of the Purchase Price, any other financial information from which the approximate amount of the Purchase Price may be determined, or disclose any of the other essential terms of this Agreement, except (a) as required by Law or required for financial reporting purposes and except, (b), in the case of Seller, to its Affiliates or its or their respective Advisors or its or their respective financing sources as necessary in connection with the ordinary conduct of its or their respective businesses, or (c) to the extent such statements are consistent with, and disclose no substantive terms of this Agreement other than those disclosed in any previous press releases, public disclosures or public statements made jointly by the Parties (or individually, if approved by each of Topco and Purchaser).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="37" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.18<sup style="vertical-align:top;line-height:120%;">&nbsp;&nbsp;&nbsp;&nbsp; </sup><u>Bulk Sales Laws</u>. The Parties intend that pursuant to section&nbsp;1141(d)(1) and section 365(a) of the Bankruptcy Code, the transfer of the Equity Interests and the Acquired Contracts under the Plan shall be free and clear of any Encumbrances in the Equity Interests and the Acquired Contracts including any liens or claims arising out of the bulk transfer laws except Permitted Encumbrances and restrictions on transfer arising under applicable securities Laws or as otherwise set forth in the Organizational Documents of any Company, and the Parties shall take such steps as may be necessary or appropriate to so provide in the Confirmation Order. In furtherance of the foregoing, each Party hereby waives compliance by the Parties with the &#8220;bulk sales,&#8221; &#8220;bulk transfers&#8221; or similar Laws and all other similar Laws in all applicable jurisdictions in respect of the transactions contemplated by this Agreement.<sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.19&nbsp;&nbsp;&nbsp;&nbsp;<u>Fiduciary Obligations</u>. Nothing in this Agreement or any document related to the transactions contemplated hereby or thereby will require Seller any of its Affiliates or their respective directors, officers or members, in each case, in their capacity as such, to take any action, or to refrain from taking any action, to the extent inconsistent with their fiduciary obligations or applicable Law. Seller retains the right to pursue any transaction or restructuring strategy of the Companies that, in Seller&#8217;s business judgment, will maximize the value of the estate of the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.20&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer Taxes</u>. Any sales, use, purchase, transfer, franchise, deed, fixed asset, stamp, documentary stamp, use or other similar Taxes and recording charges payable by reason of the Acquisition and the transfer of assets related to the Business or to any Company pursuant to the transactions contemplated hereby (excluding, income taxes of Seller) (the &#8220;<u>Transfer Taxes</u>&#8221;) shall be borne and timely paid by Purchaser, and Purchaser shall timely file all Tax Returns related to any Transfer Taxes. Purchaser shall indemnify Seller against any losses suffered by Seller as a result of Purchaser failing to comply with its obligations under this <u>Section 9.20</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Preparation of Tax Returns and Payment of Taxes; Cooperation</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(i)&nbsp; &nbsp;&nbsp; Seller shall prepare and file all Tax Returns with respect to the Companies and the Acquired Contracts for any Tax period ending on or before the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Each of Purchaser and Seller shall, and Seller (to the extent it is able) shall cause the Companies to, fully cooperate, as and to the extent reasonably requested by the other Party, in connection with the filing of any Tax Returns, any Action with respect to Taxes, and any other Tax matters, in each case relating to the Business, the Acquired Contracts or any Company (including in connection with any obligations of Seller under Treasury Regulations Section 1.751-1(a)(3)); <u>provided</u> that in providing any information, assistance and access in accordance therewith, each Party shall be entitled to redact information that is not Exclusive to the Business (including the Acquired Contracts). Such cooperation shall include the provision of records and information which are reasonably relevant to any such Tax matter and making relevant employees reasonably available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. In addition, Purchaser shall provide to Seller and its Advisors such reasonable access to or copies of the books and records of the Companies, upon reasonable notice and during normal business hours, as Seller may reasonably request in connection with any Tax matters or other reasonable business purpose.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="38" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall prepare and timely file all Tax Returns with respect to the Companies and the Acquired Contracts that are not addressed by <u>Section 9.20(b)(i)</u>. With respect to any Straddle Period, Purchaser shall prepare such Tax Returns consistent with past practice and shall provide Topco with a draft of such Tax Returns for its review and comment, as follows: (i)&nbsp;with respect to income Taxes, at least 30 days prior to the applicable filing deadline, and (ii) with respect to any other Taxes, at least 15 days prior to the applicable filing deadline, in each case, taking into account any ordinary course extensions. Purchaser shall incorporate any changes reasonably requested by Topco with respect to such Tax Returns. Purchaser shall be responsible for paying any Taxes of any Company reflected on any Tax Return that Purchaser is obligated to prepare and file under this <u>Section 9.20(b)</u>. In the preparation of any such Tax Return with respect to income Taxes properly allocable to a Straddle Period, Purchaser (on behalf of the applicable Company) shall use the &#8220;interim closing method&#8221; (and the &#8220;calendar day convention&#8221;) pursuant to Section 706 of the Code (and any similar provision of state, local or non-U.S. Law) to account for any varying interests in the applicable Company for a Straddle Period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 72pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;Without Seller&#8217;s prior written consent, Purchaser shall not file any Tax Return, file an amendment to any previously-filed Tax Return, or otherwise take any Tax position or action that could increase any Tax that is payable or otherwise borne by the Companies with respect to a Tax period ending on or before the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp; Notwithstanding anything herein to the contrary, the Companies shall not, and the Purchaser shall use reasonable best efforts to cause the Companies to not, make an election under Section 6226 of the Code with respect to any tax period (or portion thereof) ending on or before the Closing Date during which Seller was a member.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser shall use reasonable best efforts to deliver or cause the Companies to deliver no later than ninety (90) days following the Closing Date, such Company&#8217;s proposed amount of gain or loss attributable to &#8220;section 751 property&#8221; attributable to the sale of the Equity Interests and the Acquired Contracts, together with information reasonably necessary or requested by Seller to confirm or validate such proposed amounts. If Seller delivers a written objection within thirty (30) days after receipt of such proposal, then Purchaser shall, and shall use reasonable best efforts to cause the each Company to, and Seller shall negotiate in good faith to resolve any such objection, and, if such objection cannot be resolved within thirty (30) days of Purchaser&#8217;s receipt of Seller&#8217;s objection, then a nationally recognized accounting firm mutually acceptable to Purchaser and the Companies and Seller shall resolve such dispute (in its capacity as an expert and not an arbiter) and the resolution of such dispute shall be final and binding on the Parties. The Parties and their respective Affiliates shall file all Tax Returns in accordance with such amount of &#8220;section 751 property&#8221; (as finally determined under this <u>Section 9.20(d)</u>) and not take any Tax related action inconsistent with such amount, in each case, unless otherwise required by a &#8220;determination&#8221; within the meaning of Section 1313(a) of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="39" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.21&nbsp;&nbsp;&nbsp;&nbsp;<u>Waiver of Conflicts Regarding Representation; Nonassertion of Attorney-Client Privilege</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser waives and will not assert, and agrees to cause the other members of the Purchaser Group (including, following the Closing, the Companies), to waive and not assert, any conflict of interest arising out of or relating to the representation, after the Closing (the &#8220;<u>Post-Closing Representation</u>&#8221;), of any Seller Party (any such Person, a &#8220;<u>Designated Person</u>&#8221;) in any matter involving this Agreement, the Bankruptcy Cases or any other agreements or transactions contemplated hereby or thereby, by any legal counsel currently representing any Designated Person in connection with this Agreement, the Bankruptcy Cases or any other agreements or transactions contemplated hereby or thereby, including Kirkland &amp; Ellis, LLP (any such representation, the &#8220;<u>Current Representation</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser waives and will not assert, and agrees to cause the other members of the Purchaser Group (including, following the Closing, the Companies), to waive and not assert, any attorney-client or other applicable legal privilege or protection with respect to any communication between or among any legal counsel and any Designated Person occurring during the Current Representation (the &#8220;<u>Privileged Communications</u>&#8221;) or in connection with any Post-Closing Representation, including in connection with a dispute with Purchaser or any other member of the Purchaser Group (including, following the Closing, any Company), it being the intention of the Parties that all such rights to such attorney-client and other applicable legal privilege or protection and to control such attorney-client and other applicable legal privilege or protection shall be retained by the applicable Seller Party and that the Seller Parties (including the Companies), and not Purchaser or any other member of the Purchaser Group or the Companies, shall have the sole right to decide whether or not to waive any attorney-client or other applicable legal privilege or protection. Accordingly, from and after the Closing, none of Purchaser or any other member of the Purchaser Group (including, following the Closing, the Companies), shall have any access to any such communications or to the files of the Current Representation, all of which shall be and remain the property of Seller and the other Seller Parties, as applicable, and not of Purchaser or any of the other members of the Purchaser Group (including the Companies), and none of Purchaser or any other members of the Purchaser Group or any Person acting or purporting to act on their behalf shall seek to obtain the same by any process on the grounds that the privilege and protection attaching to such communications and files belongs to Purchaser or any other member of the Purchaser Group (including, following the Closing, the Companies), or does not belong to any Seller Party (including the Companies). Notwithstanding the foregoing, in the event that a dispute arises between Purchaser or any other member of the Purchaser Group (including, following the Closing, the Companies), on the one hand, and a third party other than a Seller Party, on the other hand, Purchaser or the other member(s) of the Purchaser Group (including, following the Closing, the Companies), may seek to prevent the disclosure of the Privileged Communications to such third party and request that such Seller Party not permit such disclosure, and Seller shall cause such Seller Party to consider such request in good faith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="40" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.22&nbsp;&nbsp;&nbsp;&nbsp;<u>Topco</u>. Each Party agrees that Topco has the power and authority, and Topco has the unilateral right to delegate all such power and authority to one or more designees under common control or to an affiliated entity, to unilaterally act on behalf of Seller for the purposes specified under this Agreement or the transactions contemplated hereby. Such power will include the power to make all decisions, actions, Consents and determinations on behalf of Seller, including to make any waiver of any Closing condition or agree to any amendment to this Agreement. Purchaser shall be entitled to rely on any action or omission taken by Topco or it&#8217;s designee(s) on behalf of Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE X</b><br>
<b>ADDITIONAL DEFINITIONS AND INTERPRETIVE MATTERS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">10.1&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Definitions</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp; &#8220;<u>Action</u>&#8221; means any action, complaint, summons, decree, suit, litigation, arbitration, third-party mediation, audit, or proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), regardless of the legal theory under which such Liability or obligation may be sought to be imposed, whether sounding in contract or tort, or whether at law or in equity, or otherwise under any legal or equitable theory, commenced, brought, conducted or heard by or before any Governmental Body.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp; &#8220;<u>Advisors</u>&#8221; means, with respect to any Person, any directors, officers, employees, investment bankers, financial advisors, accountants, agents, attorneys, consultants, or other representatives of such Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp; &#8220;<u>Affiliate</u>&#8221; means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person, and the term &#8220;control&#8221; (including the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through ownership of voting securities, by Contract or otherwise. The term &#8220;Affiliate&#8221; does not include the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp; &#8220;<u>Alternative Transaction</u>&#8221; means any transaction (or series of transactions), whether direct or indirect, whereby any Person or group of Persons (other than Seller and its Affiliates or Purchaser and its Affiliates) acquires (i) beneficial ownership of a majority of the equity interests of the Companies or (ii) a material portion of the assets and liabilities of the Companies, whether by merger, sale of assets or equity, recapitalization, plan of reorganization or otherwise; <u>provided</u> that (y) a plan or liquidation of any Company will not constitute an Alternative Transaction and (z) any plan of reorganization or liquidation of any Retained Entity or Seller&#8217;s Affiliates (other than the Companies) shall not constitute an Alternative Transaction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp; &#8220;<u>Auction</u>&#8221; shall have the meaning ascribed to such term in the Bidding Procedures Order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="41" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">41</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp; &#8220;<u>Bidding Procedures Order</u>&#8221; means the Bankruptcy Court&#8217;s Order (i) Approving the Bidding Procedures, (ii) Approving Bid Protections, (iii) Establishing Related Dates and Deadlines, (iv) Approving the Form and Manner of Notice Thereof, (v) Approving Contract Assumption and Assignment Procedures, and (vi) Granting Related Relief [Docket No. 227].<sup style="vertical-align:top;line-height:120%;"> </sup></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp; &#8220;<u>Business</u>&#8221; means the business of the Companies, in each instance, solely within the United States, pursuant to which the Companies own medical and radiation treatment centers (or similar centers) that provide outpatient radiation oncology services; <u>provided</u> that all businesses owned, operated or managed by Seller and the other Seller Parties in respect of the Retained Business shall not be included in the &#8220;Business&#8221;.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp; &#8220;<u>Business Day</u>&#8221; means any day other than a Saturday, Sunday or other day on which banks in New York City, New York are authorized or required by Law to be closed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp; &#8220;<u>Commercial Payor</u>&#8221; means any private insurer, managed care plan, health benefit plan, health maintenance organization, preferred provider organization, employer-sponsored health plan or any other Person or entity that maintains a similar payor program.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp; &#8220;<u>Company Systems</u>&#8221; means any and all computer systems, servers, hardware systems, software, websites, databases, circuits, networks, workstations, and other information technology systems owned by any Company, Seller or any other Seller Party, in each case, to the extent Exclusive to the Business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp; &#8220;<u>Confidentiality Agreement</u>&#8221; means that certain letter agreement, dated as of August 9, 2023, by and between Genesis Care Pty Ltd. and Purchaser.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp; &#8220;<u>Consent</u>&#8221; means any approval, consent, ratification, permission, waiver or authorization, or an Order of the Bankruptcy Court that deems or renders unnecessary the same.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp; &#8220;<u>Contract</u>&#8221; means any contract, indenture, note, bond, lease, sublease, mortgage, agreement, guarantee, or other agreement that is legally binding upon a Person or its property, in each case, other than a purchase order, service order, letter of intent, or sales order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp; &#8220;<u>COVID-19</u>&#8221; means SARS-CoV-2 or COVID-19, and any evolutions thereof or related or associated epidemics, pandemic or disease outbreaks.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp; &#8220;<u>Data Security Requirements</u>&#8221; means all of the following, to the extent relating to the collection, storage, security, use, transfer, or disposition of data, in each case to the extent applicable to any Company: (i) all applicable Laws, (ii) policies, procedures and practices of any Company, and (iii) applicable provisions of Contracts to which any such Company is a party.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="42" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp; &#8220;<u>Encumbrance</u>&#8221; means any lien (as defined in section&nbsp;101(37) of the Bankruptcy Code), encumbrance, claim (as defined in section&nbsp;101(5) of the Bankruptcy Code), charge, mortgage, deed of trust, option, pledge, security interest or similar interests, title defects, hypothecations, easements, rights of way, encroachments, Orders, conditional sale or other title retention agreements and other similar impositions, imperfections or defects of title or restrictions on transfer or use.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(q)&nbsp;&nbsp;&nbsp; &#8220;<u>Environmental Laws</u>&#8221; means all Laws concerning pollution, Hazardous Materials, or protection of the environment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(r)&nbsp;&nbsp;&nbsp; &#8220;<u>Exclusive to the Business</u>&#8221; means used exclusively or held for use exclusively in or arising exclusively out of the operation or conduct of the Business as conducted by the Companies and their respective Affiliates as of immediately prior to the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(s)&nbsp;&nbsp;&nbsp; &#8220;<u>GAAP</u>&#8221; means generally accepted accounting principles in the United States, as in effect on the date hereof or, as applicable, the date of the Financial Statements (except for Leases for Leased Real Property, which shall mean the International Financial Reporting Standards issued by the International Accounting Standards Board).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(t)&nbsp;&nbsp;&nbsp; &#8220;<u>GenesisCare Marks</u>&#8221; means any and all trademarks, service marks, logos and other indicia of origin of Seller or any of its Affiliates at any time prior to the Closing, including &#8220;GenesisCare,&#8221; and in each case, including any translations, transliterations, variations or derivatives thereof, either alone or in combination with other words, trademarks or elements, and including any trademarks confusingly similar thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(u)&nbsp;&nbsp;&nbsp; &#8220;<u>Governmental Authorization</u>&#8221; means any permit, license, certificate, Consent, clearance, designation, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp; &#8220;<u>Governmental Body</u>&#8221; means any government, quasi-governmental entity, or other governmental or regulatory body, agency or political subdivision thereof of any nature, whether foreign, federal, state or local, or any agency, branch, department, official, entity, instrumentality or authority thereof, or any court or arbitrator (public or private) of applicable jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(w)&nbsp;&nbsp;&nbsp; &#8220;<u>Governmental Health Program</u>&#8221; means any federal health program as defined in 42 U.S.C. &#167; 1320a-7b(f), including Medicare, Medicaid, TRICARE, CHAMPVA, and state healthcare programs (as defined therein).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp; &#8220;<u>Hazardous Material</u>&#8221; means any toxic, hazardous, or radioactive material, substance, or waste regulated under Environmental Laws due to its dangerous or deleterious properties or characteristics.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(y)&nbsp;&nbsp;&nbsp; &#8220;<u>Healthcare Laws</u>&#8221; means those Laws that are applicable to the healthcare operations of the Business, including: (i) Title XVIII of the Social Security Act, 42 U.S.C. &#167;&#167; 1395-1395lll (the Medicare statute), Title XIX of the Social Security Act, 42 U.S.C. &#167;&#167; 1396-1396w-5 (the Medicaid statute); (ii) all Laws related to fraud and abuse, false claims and kickbacks, including the Federal Anti-Kickback Law (42 U.S.C. &#167; 1320a-7b), the Federal False Claims Act (31 U.S.C. &#167;&#167; 3729, et seq.), the Federal Civil Monetary Penalties Law (42 U.S.C. &#167; 1320a-7a), the Federal Program Fraud Civil Remedies Act (31 U.S.C. &#167; 3801 et seq.) and the Federal Health Care Fraud Law (18 U.S.C. &#167; 1347); (iii) the Exclusion Laws (42 U.S.C. &#167; 1320a-7); (iv) HIPAA (defined below); and (v) the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; in each case, as amended, and all regulations promulgated pursuant thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="43" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">43</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(z)&nbsp;&nbsp;&nbsp; &#8220;<u>Healthcare Permits</u>&#8221; means all material licenses, permits, authorizations, and approvals that are required for the healthcare operations of the Business as currently conducted or in connection with each Company&#8217;s ability to own, lease, operate or manage any of its property or business, in each case that are issued or enforced by a Governmental Body with jurisdiction over any Healthcare Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(aa)&nbsp;&nbsp;&nbsp; &#8220;<u>HIPAA</u>&#8221; shall mean the following, as the same may be amended, modified or supplemented from time to time, any successor statute thereto, and together with any and all rules or regulations promulgated from time to time thereunder: (i) the Health Insurance Portability and Accountability Act of 1996; and (ii) the Health Information Technology for Economic and Clinical Health Act (Title XIII of the American Recovery and Reinvestment Act of 2009).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(bb)&nbsp;&nbsp;&nbsp; &#8220;<u>Intellectual Property</u>&#8221; means any and all intellectual property and other proprietary rights in any jurisdiction throughout the world, whether registered or unregistered including any and all inventions, patents, trademarks, service marks or trade names, works of authorship, copyrights, mask works, domain names, software, trade secrets and know-how, applications and registrations for and goodwill associated with any of the foregoing and rights to sue or recover and retain damages and costs and attorneys&#8217; fees for past, present and future infringement, misappropriation or other violation of any of the forgoing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(cc)&nbsp;&nbsp;&nbsp; &#8220;<u>IRS</u>&#8221; means the Internal Revenue Service and any Governmental Body succeeding to the functions thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(dd)&nbsp;&nbsp;&nbsp; &#8220;<u>Knowledge of Seller</u>&#8221; or words of similar like import means the actual knowledge of each of Shaden Marzouk, Chad Gober, Jack Seal, Jenny Robinson, and Mike McLeroy, in each case without personal liability on the part of any of them.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ee)&nbsp;&nbsp;&nbsp; &#8220;<u>Law</u>&#8221; means any law, rule, regulation, judgment, order, of any Governmental Body in effect on or prior to the date of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ff)&nbsp;&nbsp;&nbsp; &#8220;<u>Lease</u>&#8221; means all leases, subleases, licenses, concessions and other agreements pursuant to which any Company holds any Leased Real Property, including the right to all security deposits and other amounts and instruments deposited by or on behalf of any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(gg)&nbsp;&nbsp;&nbsp; &#8220;<u>Leased Real Property</u>&#8221; means, collectively, each leasehold interest to each real property leased by any Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="44" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(hh)&nbsp;&nbsp;&nbsp; &#8220;<u>Liability</u>&#8221; means as to any Person, any debt, adverse claim, liability, duty, responsibility, obligation, commitment, assessment, cost, expense, loss, expenditure, charge, fee, penalty, fine, contribution, or premium of any kind or nature whatsoever, whether known or unknown, asserted or unasserted, absolute or contingent, direct or indirect, accrued or unaccrued, liquidated or unliquidated, or due or to become due, and regardless of when sustained, incurred or asserted or when the relevant events occurred or circumstances existed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp; &#8220;<u>Managed Entities</u>&#8221; means any Person that is party to a management agreement with any Company whereby such Company manages such Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(jj)&nbsp;&nbsp;&nbsp; &#8220;<u>Managed Entity Agreement</u>&#8221; means a management services agreement or administrative services agreement between any Company and any Managed Entity.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(kk)&nbsp;&nbsp;&nbsp; &#8220;<u>Material Adverse Effect</u>&#8221; means any matter, event, change, development, occurrence, circumstance or effect (each, an &#8220;<u>Effect</u>&#8221;) that has a material adverse effect on the Business of the Companies, taken as whole; <u>provided</u> that none of the following (or consequences thereof), either alone or in combination, shall constitute, or be taken into account in determining whether or not there has been, a Material Adverse Effect: (i)&nbsp;any Effect in, arising from or relating to general business or economic conditions affecting the industry in which any Company or any of their respective Affiliates operate or their respective business (including the Business) is conducted, including Effects arising from or relating to competition or matters in the Ordinary Course and other Effects within such industry, new entrants into such industry, new products from other participants in such industry, changes in product pricing due to such competition, changes in market share or financial results due to such competition, and other related changes resulting from such competition; (ii)&nbsp;Effects in, arising from or relating to national or international political or social conditions, including tariffs, riots, protests, the engagement by the United States or other countries in hostilities or the escalation thereof, whether or not pursuant to the declaration of a national emergency or war, or the occurrence or the escalation of any military, cyber or terrorist (whether or not state-sponsored) attack upon the United States or any other country, or any of its territories, possessions, or diplomatic or consular offices or upon any military installation, asset, equipment or personnel of the United States or of any other country; (iii) Effects in, arising from or relating to any fire, flood, hurricane, earthquake, tornado, windstorm, other calamity or act of God, global or national health concern, epidemic, pandemic (whether or not declared as such by any Governmental Body), viral outbreak (including COVID-19 or the worsening thereof) or any quarantine or trade restrictions related thereto or any other <i>force majeure</i>; (iv)&nbsp;Effects in, arising from or relating to the decline or rise in price of any currency or any equipment or supplies necessary to or used in the provision of services by any Company (including any resulting inability to meet customer demands or fulfill purchase orders and any resulting breaches of Contracts); (v) Effects in, arising from, or relating to financial, banking, or securities markets (including (A) any disruption of any of the foregoing markets, (B) any change in currency exchange rates, (C) any decline or rise in the price of any security, commodity, Contract, or index, and (D) any increased cost, or decreased availability, of capital or pricing or terms related to any financing for the transactions contemplated by this Agreement); (vi) Effects in, arising from or relating to changes in, GAAP or the interpretation thereof; (vii)&nbsp;Effects in, arising from or relating to changes in, Laws or other binding directives or determinations issued or made by or agreements with or Consents of any Governmental Body (including, any such items related to <u>Section</u><u>&nbsp;</u><u>6.2</u>) and any increase (or decrease) in the terms or enforcement of (or negotiations or disputes with respect to) any of the foregoing; (viii)&nbsp;Effects in, arising from or relating to (A)&nbsp;the taking of any action permitted or contemplated by this Agreement (including the Acquisition) or at the request of Purchaser or its Affiliates, (B)&nbsp;the failure to take any action if such action is prohibited by this Agreement, or (C)&nbsp;the negotiation, announcement, or pendency of this Agreement or the transactions contemplated hereby, the identity, nature, or ownership of Purchaser or Purchaser&#8217;s plans with respect to the Companies, including the impact thereof on the relationships, contractual or otherwise, of the business of any Company (including the Business) with employees, customers, lessors, suppliers, vendors, or other commercial partners or litigation arising from or relating to this Agreement or the transactions contemplated hereby; (ix)&nbsp;Effects in, arising from, or relating to any existing event, occurrence or circumstance that is publicly known or disclosed or with respect to which Purchaser has knowledge as of the date hereof, including any matter set forth in the Schedules; (x)&nbsp;Effects in, arising from or relating to any action required to be taken under any existing Contract to which any Company (or any of their respective assets or properties) is bound; (xi) Effects that arise from any seasonal fluctuations in the business of any Company (including the Business); (xii)&nbsp;any failure, in and of itself, to achieve any budgets, projections, forecasts, estimates, plans, predictions, performance metrics or operating statistics or the inputs into such items (whether or not shared with Purchaser or its Affiliates or Advisors) and any other failure to win or maintain customers or business (including the Business); (xiii)&nbsp;the Effect of any action taken by Purchaser or its Affiliates with respect to the transactions contemplated by this Agreement, (including the Acquisition) or the financing thereof or the Plan or any breach by Purchaser of this Agreement (including the Acquisition) or the Plan; (xiv)&nbsp;the matters set forth on the Schedules and any changes or developments in, or Effects or results arising from or relating to, matters set forth on the Schedules; or (xv) (A) the commencement or pendency of the Bankruptcy Cases; (B)&nbsp;any objections in the Bankruptcy Court to (1) this Agreement or any of the transactions contemplated hereby or thereby, (2)&nbsp;the Confirmation Order, the Plan, liquidation or Restructuring of the Companies, or their Affiliates or (3) the assumption or rejection of any Contract or (C) any Order of the Bankruptcy Court or any actions or omissions of any Company or its Affiliates in compliance therewith; <u>provided</u> that any adverse Effects resulting or arising from the matters described in clauses (i) through (vii) may be taken into account in determining whether there has been a Material Adverse Effect to the extent, and only to the extent, that they have a materially disproportionate adverse effect on the Companies in the aggregate relative to similarly situated participants in the industries and geographic areas in which the Companies operate (in which case only such incremental materially disproportionate adverse effect may be taken into account in determining whether there has been a Material Adverse Effect).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="45" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">45</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ll)&nbsp;&nbsp;&nbsp; &#8220;<u>Material Contracts</u>&#8221; means each Contract, or group of Contracts with the same party or related parties, Exclusive to the Business of any Company (excluding any Leases, Contracts with Commercial Payors, employees and physicians and purchase orders) currently in effect which by its, or their, terms is a Contract set forth on <u>Schedule 10.1(ll)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(mm)&nbsp;&nbsp;&nbsp; &#8220;<u>Order</u>&#8221; means any order, injunction, order, judgment, decree, ruling, writ, assessment or arbitration award of a Governmental Body, including any order entered by the Bankruptcy Court in the Bankruptcy Cases (including the Confirmation Order).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(nn)&nbsp;&nbsp;&nbsp; &#8220;<u>Ordinary Course</u>&#8221; means the ordinary and usual course of operations of the Business of the Companies taken as a whole and taking into account the contemplation, commencement and pendency of the Bankruptcy Cases and past practice in light of the current pandemic, epidemic or disease outbreak (including COVID-19); <u>provided</u> that any action taken, or omitted to be taken, that relates to, or arises out of, any pandemic, epidemic or disease outbreak (including COVID-19) shall be deemed to be in the ordinary course of business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(oo)&nbsp;&nbsp;&nbsp; &#8220;<u>Organizational Documents</u>&#8221; means, with respect to any Person other than a natural person, the documents by which such Person was organized (such as a certificate of incorporation, certificate of formation, certificate of limited partnership or articles of organization, and including any certificates of designation for preferred stock or other forms of preferred equity) or which relate to the internal governance of such Person (such as bylaws, a partnership agreement or an operating, limited liability or members agreement).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(pp)&nbsp;&nbsp;&nbsp; &#8220;<u>Overhead and Shared Services</u>&#8221; includes the following ancillary or corporate shared services that are provided to the Business by Seller or the other Seller Parties (including any physician group affiliated with Seller): travel and entertainment services; medical equipment maintenance and support services; procurement and supply arrangements; treasury services; strategy and business development, business planning and forecasting, financial reporting and billing services; accounting services; tax services; internal audit services; investor relations services; human resources and employee relations management services; employee benefits services; physician services; customs and excise services; medical and clinical advisory services; information technology and platform services; and service improvement and operational excellence services.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(qq)&nbsp;&nbsp;&nbsp; &#8220;<u>Permits</u>&#8221; means all licenses, permits, registrations, accreditations, certifications, qualifications, agreements, authorizations, easements, orders, certificates, franchises, qualifications, rulings, waivers, variances, Consents, enrollments (including national provider identifier and Medicare numbers), and exemptions pending with or issued by Governmental Bodies or accreditation organizations, or the administrative agents thereof, in each case, that is material to the Companies, taken as a whole.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(rr)&nbsp;&nbsp;&nbsp; &#8220;<u>Permitted Encumbrance</u>&#8221; means Encumbrances for utilities and Taxes or other governmental charges not yet due and payable, being contested in good faith, or the nonpayment of which is permitted or required by the Bankruptcy Code, easements, rights of way, restrictive covenants, encroachments and similar non-monetary encumbrances or non-monetary impediments which do not, individually or in the aggregate, materially and adversely affect the use or occupancy of the Leased Real Property in the operation of the Business conducted thereon, applicable zoning Laws, building codes, land use restrictions and other similar restrictions imposed by Law which are not violated by the current use or occupancy of the Leased Real Property in any manner that would have a material adverse effect on the Business, matters that would be disclosed by an accurate survey or inspection of the real property, as applicable, &nbsp;materialmans&#8217;, mechanics&#8217;, artisans&#8217;, shippers&#8217;, warehousemans&#8217; or other similar common law or statutory liens incurred in the Ordinary Course for amounts not yet due and payable, licenses of Intellectual Property, any Encumbrances arising under equipment leases for equipment owned by Seller or any of its Subsidiaries, such other Encumbrances or title exceptions which do not, individually or in the aggregate, materially and adversely affect the Business, any Encumbrances set forth on <u>Schedule 10.1(rr)</u>, and solely prior to Closing, any Encumbrances that will be removed or released by operation of the Confirmation Order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="46" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">46</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ss)&nbsp;&nbsp;&nbsp; &#8220;<u>Person</u>&#8221; means an individual, corporation, partnership, limited liability company, joint venture, association, trust, unincorporated organization, labor union, organization, estate, Governmental Body or other entity or group.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(tt)&nbsp;&nbsp;&nbsp; &#8220;<u>Purchaser Group</u>&#8221; means, with respect to Purchaser, (i) Purchaser, (ii) any Affiliate of Purchaser (including, following the Closing, the Companies) and (iii) each of its and their respective former, current or future Affiliates, Subsidiaries, officers, directors, employees, partners, members, managers, agents, Advisors, successors or permitted assigns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(uu)&nbsp;&nbsp;&nbsp; &#8220;<u>Retained Business</u>&#8221; means all businesses, activities and operations of Seller and its Affiliates, other than the Business and the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(vv)&nbsp;&nbsp;&nbsp; &#8220;<u>Retained Entities</u>&#8221; means Genesis Care Pty Ltd and its Subsidiaries (other than the Companies).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ww)&nbsp;&nbsp;&nbsp; &#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933 and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(xx)&nbsp;&nbsp;&nbsp; &#8220;<u>Seller Party</u>&#8221; or &#8220;<u>Seller Parties</u>&#8221; means (i) Seller, (ii) if before the Closing, the Companies, (iii) if after the Closing, the Retained Entities, and (iv) each of their respective former, current, or future Affiliates, officers, directors, employees, partners, members, equityholders, controlling or controlled Persons, managers, agents, Advisors, successors or permitted assigns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(yy)&nbsp;&nbsp;&nbsp; &#8220;<u>Straddle Period</u>&#8221; means a taxable period that begins on or before the Closing Date and ends after the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(zz)&nbsp;&nbsp;&nbsp; &#8220;<u>Subsidiary</u>&#8221; or &#8220;<u>Subsidiaries</u>&#8221; means, with respect to any Person, any corporation, limited liability company or other entity of which a majority of the total voting power of shares of stock or other equity interests entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees or other governing body or Person thereof is at the time owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person or a combination thereof or any partnership, association or other business entity of which a majority of the partnership or other similar ownership interest is at the time owned or controlled, directly or indirectly, by such Person or one or more Subsidiaries of such Person or a combination thereof. The defined term &#8220;Subsidiary&#8221; shall not include any Managed Entities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="47" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">47</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(aaa)&nbsp;&nbsp;&nbsp; &#8220;<u>Tax</u>&#8221; or &#8220;<u>Taxes</u>&#8221; means all U.S. federal, state, local or non-U.S. taxes including any net income, gross receipts, capital stock, franchise, profits, ad valorem, value added, import, export, withholding, social security, unemployment, disability, workers compensation, real property, personal property, stamp, excise, occupation, sales, use, transfer, conveyance, service, registration, premium, windfall or excess profits, customs, duties, licensing, surplus, alternative minimum, estimated or other similar tax, including any interest, penalty or addition thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(bbb)&nbsp;&nbsp;&nbsp; &#8220;<u>Tax Return</u>&#8221; means any return, report or similar filing (including the attached schedules and any amendments thereof) filed or required to be filed with any Taxing Authority with respect to Taxes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ccc)&nbsp;&nbsp;&nbsp; &#8220;<u>Taxing Authority</u>&#8221; means any U.S. federal, state, local or non-U.S. government, any subdivision, agency, commission or authority thereof that is responsible for the administration, imposition or collection of Tax or enforcement of any law in relation to Tax.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 23pt; text-indent: 72pt; text-align: justify;">(ddd)&nbsp;&nbsp;&nbsp; &#8220;<u>Willful Breach</u>&#8221; shall mean a deliberate act or a deliberate failure to act regardless of whether breaching was the conscious object of the act or failure to act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">10.2&nbsp;&nbsp;&nbsp;&nbsp;<u>Index of Defined Terms</u>.&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Acquired Contracts...................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Acquisition.................................................. 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Agreement................................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Agreement Dispute.................................... 36</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Assumed Liabilities..................................... 2</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Auction Outside Date................................ 17</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Back-Up Bidder......................................... 16</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Bankruptcy Cases........................................ 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Bankruptcy Code......................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Bankruptcy Court........................................ 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Chosen Courts........................................... 36</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Closing........................................................ 2</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Closing Date................................................ 3</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Closing Date Payment................................. 2</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Code............................................................ 9</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Company..................................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Company Benefit Plan................................ 8</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Confirmation Order..................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Current Representation.............................. 40</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">D&amp;O Indemnified Party............................ 22</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Dataroom................................................... 20</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Deposit........................................................ 3</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Designated Person..................................... 40</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Effect......................................................... 45</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Enforceability Exceptions......................... 10</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="48" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">48</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Entities....................................................... 25</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Equity Interests............................................ 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">ERISA......................................................... 8</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Escrow Agent.............................................. 3</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Express Representations............................ 20</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Financial Statements................................... 6</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Fundamental Representations................... 27</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Information Presentation........................... 20</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Intercompany Balances............................. 25</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">MoS........................................................... 25</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Outside Date.............................................. 29</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Parties.......................................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Party............................................................ 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Petition Date................................................ 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Phase-Out Period....................................... 23</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">PJT............................................................... 5</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Plan.............................................................. 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Post-Closing Representation..................... 40</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Privileged Communications...................... 40</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Projections................................................. 20</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Purchase Price............................................. 2</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Purchaser..................................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Restructuring............................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Schedule...................................................... 4</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Seller............................................................ 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Topco........................................................... 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Transfer Taxes........................................... 38</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Trial Balance............................................... 6</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Winning Bidder......................................... 16</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;">10.3&nbsp;&nbsp;&nbsp;&nbsp;<u>Rules of Interpretation</u>. Unless otherwise expressly provided in this Agreement, the following will apply to this Agreement, the Schedules and any other certificate, instrument, agreement or other document contemplated hereby or delivered hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The terms &#8220;hereof,&#8221;&nbsp;&#8220;herein&#8221;&nbsp;and &#8220;hereunder&#8221;&nbsp;and terms of similar import are references to this Agreement as a whole and not to any particular provision of this Agreement. Section, clause, schedule and exhibit references contained in this Agreement are references to sections, clauses, schedules and exhibits in or to this Agreement, unless otherwise specified. All Exhibits and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Schedule or Exhibit but not otherwise defined therein shall be defined as set forth in this Agreement.&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;References to the &#8220;transactions contemplated hereby&#8221;, &#8220;transactions contemplated herein&#8221;, &#8220;transactions contemplated by this Agreement&#8221;&nbsp;or words or phrases of similar import, shall, unless stated otherwise, include references to the Acquisition and any other transactions contemplated thereby, including under the Plan. References to &#8220;in connection with the Bankruptcy Cases&#8221;&nbsp;shall, unless stated otherwise, include references to the Plan, as Applicable.</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="49" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">49</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 32pt; text-align: justify; text-indent: 72pt;">(i) &nbsp;&nbsp; References to &#8220;as of the Closing&#8221;, &#8220;as of the Closing Date&#8221;&nbsp;or words or phrases of similar import shall mean the Closing after giving effect to the Closing Date in the Plan, unless stated otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 32pt; text-align: justify; text-indent: 72pt;">(ii) &nbsp;&nbsp; Whenever the words &#8220;include,&#8221;&nbsp;&#8220;includes&#8221;&nbsp;or &#8220;including&#8221;&nbsp;are used in this Agreement, they will be deemed to be followed by the words &#8220;without limitation.&#8221;&nbsp;Where the context permits, the use of the term &#8220;or&#8221;&nbsp;will be equivalent to the use of the term &#8220;and/or.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 32pt; text-align: justify; text-indent: 72pt;">(iii) &nbsp;&nbsp; The words &#8220;to the extent&#8221;&nbsp;shall mean &#8220;the degree by which&#8221;&nbsp;and not simply &#8220;if.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 32pt; text-align: justify; text-indent: 72pt;">(iv) &nbsp;&nbsp; When calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period will be excluded. If the last day of such period is a day other than a Business Day, the period in question will end on the next succeeding Business Day.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 32pt; text-align: justify; text-indent: 72pt;">(v) &nbsp;&nbsp; Words denoting any gender will include all genders, including the neutral gender. Where a word is defined herein, references to the singular will include references to the plural and vice versa.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(c) &nbsp;&nbsp; The word &#8220;will&#8221;&nbsp;will be construed to have the same meaning and effect as the word &#8220;shall&#8221;. The words &#8220;shall,&#8221;&nbsp;&#8220;will,&#8221;&nbsp;or &#8220;agree(s)&#8221;&nbsp;are mandatory, and &#8220;may&#8221;&nbsp;is permissive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(d) &nbsp;&nbsp; All references to &#8220;$&#8221;&nbsp;and dollars will be deemed to refer to United States currency unless otherwise specifically provided.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(e) &nbsp;&nbsp; All references to a day or days will be deemed to refer to a calendar day or calendar days, as applicable, unless otherwise specifically provided.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(f) &nbsp;&nbsp; Any document or item will be deemed &#8220;delivered,&#8221;&nbsp;&#8220;provided&#8221;&nbsp;or &#8220;made available&#8221;&nbsp;by Seller or any Company, within the meaning of this Agreement if such document or item is (i)&nbsp;included in the Dataroom, (ii) actually delivered or provided to Purchaser or any of Purchaser&#8217;s Advisors or (iii) made available upon request, including at Seller&#8217;s or Topco&#8217;s offices (or such other office as Seller or Topco may designate).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(g) &nbsp;&nbsp; Any reference to any agreement or Contract will be a reference to such agreement or Contract, as amended, modified, supplemented or waived.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(h) &nbsp;&nbsp; Any reference to any particular Bankruptcy Code section or other Law will be interpreted to include any amendment to, revision of or successor to that section or Law regardless of how it is numbered or classified; <u>provided</u>&nbsp;that, for the purposes of the representations and warranties set forth herein, with respect to any violation of or non-compliance with, or alleged violation of or non-compliance, with any Bankruptcy Code section or Law, the reference to such Bankruptcy Code section or other Law means such Bankruptcy Code section or other Law as in effect at the time of such violation or non&#8209;compliance or alleged violation or non-compliance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="50" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">50</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(i) &nbsp;&nbsp; A reference to any Party to this Agreement or any other agreement or document shall include such Party&#8217;s successors and assigns, but only if such successors and assigns are not prohibited by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 23pt; text-align: justify; text-indent: 72pt;">(j) &nbsp;&nbsp; A reference to a Person in a particular capacity excludes such Person in any other capacity or individually.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[<i>Signature pages follow</i>.]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="51" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">51</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><b>IN WITNESS WHEREOF</b>, the Parties have caused this Agreement to be executed by their respective duly authorized officers as of the date first above written.</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" style="width: 5%;" valign="top" width="38%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><b>PURCHASER:</b><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 35%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 5%;" valign="top" width="3%">AMERICAN SHARED HOSPITAL SERVICES</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 35%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 35%; border-bottom: 1px solid rgb(0, 0, 0);" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Ray Stachowiak<font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"> </font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">Name: </font></p>
			</td>
			<td style="width: 35%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Ray Stachowiak</p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">Title: </font></p>
			</td>
			<td style="width: 35%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Executive Chairman</p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><i>Signature Page to Investment Agreement</i></p>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" style="width: 5%;" valign="top" width="38%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><b>SELLER:</b></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="width: 5%;" valign="top" width="38%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="width: 5%;" valign="top" width="38%">GENESISCARE USA, INC.</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 35%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" style="width: 35%;" valign="bottom" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left; width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left; width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="border-bottom: 1px solid rgb(0, 0, 0); width: 35%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/ Shaden Marzouk, MD</font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Name:<font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 35%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">Shaden Marzouk, MD&nbsp;</font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="width: 5%;" valign="top" width="3%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Title:</p>
			</td>
			<td style="width: 35%;" valign="top" width="35%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">Director and Authorized Signatory </font></p>
			</td>
			<td style="width: 10%;" valign="top" width="12%">
			<p style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 35%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 35%;" valign="top" width="35%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" style="width: 5%;" valign="top" width="3%"><b>TOPCO:</b></td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="width: 5%;" valign="top" width="3%">GENESISCARE USA HOLDINGS, INC.</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="width: 5%;" valign="top" width="3%">&nbsp;</td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">By:</td>
			<td style="width: 35%; border-bottom: 1px solid rgb(0, 0, 0);" valign="top" width="35%">/s/ <font style="font-family:'Times New Roman', Times, serif; font-size:10pt">Shaden Marzouk, MD&nbsp;</font></td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">Name:</td>
			<td style="width: 35%;" valign="top" width="35%"><font style="font-family:'Times New Roman', Times, serif; font-size:10pt">Shaden Marzouk, MD&nbsp;</font></td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;" valign="top" width="50%">&nbsp;</td>
			<td style="width: 5%;" valign="top" width="3%">Title:</td>
			<td style="width: 35%;" valign="top" width="35%"><font style="font-family:'Times New Roman', Times, serif; font-size:10pt">Director and Authorized Signatory </font></td>
			<td style="width: 10%;" valign="top" width="12%">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM"><i>Signature Page to Investment Agreement</i></div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Exhibit A</u></b></p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="A-" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM OF ASSIGNMENT OF EQUITY INTERESTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">THIS ASSIGNMENT OF EQUITY INTERESTS (this &#8220;<u>Assignment</u>&#8221;) is made as of [&#9679;], 2023, by and between GenesisCare USA, Inc., a Florida corporation (&#8220;<u>GC USA</u>&#8221;), New England Radiation Therapy Management Services, Inc., a Massachusetts corporation (&#8220;NERT&#8221;, and together with GC USA, each a &#8220;Seller&#8221; and collectively the &#8220;Sellers&#8221;), and American Shared Hospital Services, a California corporation (the &#8220;<u>Purchaser</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS</b>, GC USA is the direct owner of sixty percent (60.00%) of Southern New England Regional Cancer Center, LLC (&#8220;<u>SNERCC</u>&#8221;), a Rhode Island limited liability company, and NERT is the direct owner of sixty percent (60.00%) of Roger Williams Radiation Therapy, LLC, a Rhode Island limited liability company (&#8220;<u>RWRT</u>&#8221;, and together with SNERRC, each a &#8220;<u>Company</u>&#8221; and collectively the &#8220;<u>Companies</u>&#8221;; such equity interests, collectively, the &#8220;<u>Interest</u>&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS</b>, each Seller desires to assign, transfer and convey all of its respective right, title and interest in the Interest to the Purchaser.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>NOW, THEREFORE</b>, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Assignment</u>. Each Seller hereby sells, assigns, transfers and conveys the Interest to the Purchaser, and the Purchaser hereby accepts such sale, assignment, transfer and conveyance of the Interest from such applicable Seller, in each case, as of the Closing (as defined in that certain Investment Agreement, dated as of November 10, 2023, by and among GC USA, the Purchaser and the other parties thereto (the &#8220;<u>Investment Agreement</u>&#8221;).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Parties Bound</u>. This Assignment shall be binding upon and inure to the benefit of the respective legal representatives, successors, assigns, heirs, and devisees of the parties.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Governing Law</u>. This Assignment shall, in all respects, be governed, construed, applied, and enforced in accordance with the law of the State of Delaware without giving effect to the conflict of law principles thereof.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Effective Time</u>. This Assignment shall be effective as of the Closing under the Investment Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Execution in Counterparts</u>. This Assignment may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of such counterparts shall constitute one Assignment.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[<i>Signature page follows</i>.]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="A-" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><b>IN WITNESS WHEREOF</b>, the parties hereto have caused this Assignment to be signed as of the date first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;"><b>GenesisCare USA, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">Name: ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">Title: ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;"><b>New England Radiation Therapy Management Services, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">Name: ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">Title: ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;"><b>American Shared Hospital Services </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ___________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">Name: Ray Stachowiak</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 198pt;">Title: Executive Chairman</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="2" data-prefix="A-" data-suffix="" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">A-2</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>Exhibit B</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM OF BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT</b></p>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="B-" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT (this &#8220;<u>Agreement</u>&#8221;) is made and entered into as of [&#9679;], 2023, by and between GenesisCare USA, Inc., a Florida corporation (&#8220;<u>Seller</u>&#8221;), and American Shared Hospital Services, a California corporation (&#8220;<u>Purchaser</u>&#8221;). Seller and Purchaser are referred to herein individually as a &#8220;<u>Party</u>&#8221; and collectively as the &#8220;<u>Parties</u>&#8221;.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, Seller and Purchaser have entered into that certain Investment Agreement, dated as of November 10, 2023 (as amended, restated, supplemented or otherwise modified from time to time, the &#8220;<u>Purchase Agreement</u>&#8221;), providing for, among other things, the sale and assignment by Seller to Purchaser of the Equity Interests and the Acquired Contracts identified on <u>Schedule A</u> to this Agreement, and the assumption by Purchaser of the Equity Interests, the Acquired Contracts, and the Assumed Liabilities;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, Seller desires to sell, transfer, assign, convey and deliver to Purchaser all of Seller&#8217;s right, title, and interest in, to and under the Acquired Contracts, pursuant to the terms of, and in contemplation of the consummation of the transactions contemplated by, the Purchase Agreement; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, the execution and delivery of this Agreement is required by Section 7.2(e) of the Purchase Agreement and a condition to the consummation of the transactions contemplated by the Purchase Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties, covenants and agreements set forth herein, and intending to be legally bound hereby, Seller and Purchaser hereby agree as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Definitions</u>. Capitalized terms used but not defined herein shall have the respective meanings given to such terms in the Purchase Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer of Acquired Contracts.</u> Subject to the terms and conditions of the Purchase Agreement, effective as of the Closing, Seller does hereby sell, transfer, assign, convey and deliver to Purchaser, and Purchaser does hereby purchase, acquire and accept from Seller, all of Seller&#8217;s direct or indirect right, title and interest in, to and under all of the Acquired Contracts, free and clear of all Encumbrances (other than Permitted Encumbrances).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Assignment and Assumption</u>. Subject to the terms and conditions of the Purchase Agreement, effective as of the Closing, Seller does hereby sell, transfer, assign, convey and deliver to Purchaser, and Purchaser does hereby take assignment of, all of Seller&#8217;s direct or indirect right, title and interest in, to and under the Assigned Contracts as of the Closing, free and clear of all Encumbrances (other than Permitted Encumbrances). Subject to the terms and conditions of the Purchase Agreement, effective as of the Closing, Purchaser does hereby assume and agree to pay, satisfy, discharge and perform any and all of the Assumed Liabilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="B-" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Excluded Liabilities</u>. Notwithstanding anything to the contrary in this Agreement or in the Purchase Agreement, Purchaser shall not assume or otherwise be liable in respect of any Liability other than the Assumed Liabilities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Terms of the Purchase Agreement</u>. This Agreement is executed and delivered pursuant to the Purchase Agreement. In the event of a conflict between the terms and conditions of this Agreement and the terms and conditions of the Purchase Agreement, the terms and conditions of the Purchase Agreement shall govern, supersede and prevail in all respects to the extent of such conflict. Notwithstanding anything to the contrary in this Agreement, nothing herein is intended to, nor shall this Agreement be construed to, amend, affect, enlarge, diminish, supersede, modify, replace, rescind, waive or otherwise impair any of the representations, warranties, covenants, indemnities, terms or provisions of the Purchase Agreement or any of the rights, remedies or obligations of Seller or Purchaser provided for therein or arising therefrom in any way, all of which shall remain in full force and effect in accordance with their terms.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Jurisdiction and Exclusive Venue</u>. Each of the Parties irrevocably agrees that any Action of any kind whatsoever, including a counterclaim, cross-claim, or defense, regardless of the legal theory under which any Liability or obligation may be sought to be imposed, whether sounding in contract or in tort or under statute, or whether at law or in equity, or otherwise under any legal or equitable theory, that may be based upon, arising out of, or related to this Agreement or the negotiation, execution, or performance of this Agreement or the transactions contemplated hereby and any questions concerning the construction, interpretation, validity and enforceability of this Agreement (each, an &#8220;<u>Agreement Dispute</u>&#8221;) brought by any other Party or its successors or assigns will be brought and determined only in (a) the Bankruptcy Court and any federal court to which an appeal from the Bankruptcy Court may be validly taken or (b) if the Bankruptcy Court is unwilling or unable to hear such Action, in the Court of Chancery of the State of Delaware (or if such court lacks jurisdiction, any other state or federal court sitting in the State of Delaware) (the &#8220;<u>Chosen Courts</u>&#8221;), and each of the Parties hereby irrevocably submits to the exclusive jurisdiction of the Chosen Courts for itself and with respect to its property, generally and unconditionally, with regard to any Agreement Dispute. Each of the parties hereto agrees not to commence any Agreement Dispute except in the Chosen Courts, other than Actions in any court of competent jurisdiction to enforce any Order, decree or award rendered by any Chosen Courts, and no Party will file a motion to dismiss any Agreement Dispute filed in a Chosen Court on any jurisdictional or venue-related grounds, including the doctrine of <i>forum non-conveniens</i>. The Parties irrevocably agree that venue would be proper in any of the Chosen Court, and hereby irrevocably waive any objection that any such court is an improper or inconvenient forum for the resolution of any Agreement Dispute. Each of the Parties further irrevocably and unconditionally consents to service of process in the manner provided for notices in Section 9.3 of the Purchase Agreement. Nothing in this Agreement will affect the right of any party hereto to serve process in any other manner permitted by Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. Except to the extent the mandatory provisions of the Bankruptcy Code apply, this Agreement and any Agreement Dispute will be governed by and construed in accordance with the internal Laws of the State of Delaware applicable to agreements executed and performed entirely within such State without regards to conflicts of law principles of the State of Delaware or any other jurisdiction that would cause the Laws of any jurisdiction other than the State of Delaware to apply.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="B-" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.&nbsp;&nbsp;&nbsp;&nbsp;<u>Waiver of Jury Trial</u>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY AGREEMENT DISPUTE IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND THEREFORE HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY AGREEMENT DISPUTE. EACH OF THE PARTIES AGREES AND CONSENTS THAT ANY SUCH AGREEMENT DISPUTE WILL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE AN ORIGINAL COUNTERPART OF A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE IRREVOCABLE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. EACH PARTY (I) CERTIFIES THAT NO ADVISOR OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY AGREEMENT DISPUTE, SEEK TO ENFORCE THE FOREGOING WAIVER AND (II) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.&nbsp;&nbsp;&nbsp;&nbsp;<u>Binding Effect</u>. This Agreement shall be binding upon Purchaser and, subject to the terms of the Bidding Procedures Order (with respect to the matters covered thereby) and the entry and terms of the Confirmation Order, Seller, and shall inure to the benefit of and be so binding on the Parties and their respective successors and permitted assigns, including any trustee or estate representative appointed in the Bankruptcy Cases or any successor Chapter 11 cases.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">10.&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Assurances</u>. In addition to the actions specifically provided for in the Purchase Agreement, from time to time, as and when requested by any Party and at such requesting Party&#8217;s expense, any other Party will execute and deliver, or cause to be executed and delivered, all such documents and instruments and will take, or cause to be taken, all such further or other actions as such requesting Party may reasonably deem necessary or desirable to evidence and effectuate the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">11.&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment; Waiver</u>. Any provision of this Agreement may be (a) amended only in a writing signed by each Party or (b) waived only in a writing executed by the Party against which enforcement of such waiver is sought. No waiver of any provision hereunder or any breach or default thereof will extend to or affect in any way any other provision or prior or subsequent breach or default.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law in any jurisdiction, such provision will be ineffective only to the extent of such prohibition or invalidity in such jurisdiction, without invalidating the remainder of such provision or the remaining provisions of this Agreement or in any other jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">13.&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Agreement and any other agreements referred to herein or therein, and any amendments hereto or thereto, may be executed in multiple counterparts, any one of which need not contain the signature of more than one party hereto or thereto, but all such counterparts taken together will constitute one and the same instrument. Any counterpart, to the extent signed and delivered by means of a .PDF or other electronic transmission, will be treated in all manner and respects as an original Contract and will be considered to have the same binding legal effects as if it were the original signed version thereof delivered in person. Minor variations in the form of the signature page to this Agreement or any agreement or instrument contemplated hereby, including footers from earlier versions of this Agreement or any such other document, will be disregarded in determining the effectiveness of such signature. At the request of any party or pursuant to any such Contract, each other party hereto or thereto will re-execute original forms thereof and deliver them to all other parties. No party hereto or to any such Contract will raise the use of a .PDF or other electronic transmission to deliver a signature or the fact that any signature or Contract was transmitted or communicated through the use of PDF or other electronic transmission as a defense to the formation of a Contract and each such party forever waives any such defense.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[<i>The remainder of this page is intentionally left blank.</i>]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="3" data-prefix="B-" data-suffix="" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">B-3</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>IN WITNESS WHEREOF</b>, the parties hereto have caused this Agreement to be executed by their respective duly authorized officers as of the date first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:216pt;"><b><u>SELLER:</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 252pt;"><b>GenesisCare USA, Inc. </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 252pt;">By: ______________________________<br>
Name: ______________________________<br>
Title: ______________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:216pt;"><b><u>PURCHASER:</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 252pt;"><b>American Shared Hospital Services </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;">By: ______________________________<br>
Name: Ray Stachowiak<br>
Title: Executive Chairman</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="4" data-prefix="B-" data-suffix="" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">B-4</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Schedule A</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Acquired Contracts (Local RI Commercial Payor Contracts)</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Vendor</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Agreement</b></p>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Original </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Contract </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Contracting </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Entity</b></p>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>State</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Aetna Health</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Management,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">LLC</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Payer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Agreement</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2185.4910C</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">GenesisCare</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">USA, Inc. (f/k/a</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">21<sup style="vertical-align:top;line-height:120%;">st</sup>&nbsp;Century</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Oncology, Inc.)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Rhode Island</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Blue Cross Blue</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Shield of Rhode</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Island</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Payer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Agreement</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2185.5136C</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">GenesisCare</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">USA, Inc. (f/k/a</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">21<sup style="vertical-align:top;line-height:120%;">st</sup>&nbsp;Century</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Oncology, Inc.)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Rhode Island</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Integra</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Community</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Care Network,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">LLC</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Managed Care</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Agreement</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2185.5377C</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">GenesisCare</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">USA, Inc. (f/k/a</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">21<sup style="vertical-align:top;line-height:120%;">st</sup>&nbsp;Century</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Oncology, Inc.)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Rhode Island</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Pace</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Organization of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Rhode Island</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Payer</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Agreement</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2185.4914C</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">GenesisCare</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">USA, Inc. (f/k/a</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">21<sup style="vertical-align:top;line-height:120%;">st</sup>&nbsp;Century</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Oncology, Inc.)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 20.2%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Rhode Island</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="B-" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">B-5</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ams-20231110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/16/2023 10:04:45 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:ams="http://www.ams.com/20231110" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ams.com/20231110">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20231110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20231110_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ams-20231110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.ams.com/20231110/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="ams_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>ams-20231110_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/16/2023 10:04:45 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.ams.com/20231110/role/statement-document-and-entity-information" xlink:href="ams-20231110.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.ams.com/20231110/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ams-20231110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/16/2023 10:04:45 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ams-20231110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/16/2023 10:04:45 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.ams.com/20231110/role/statement-document-and-entity-information" xlink:href="ams-20231110.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.ams.com/20231110/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139818541341376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">AMERICAN SHARED HOSPITAL SERVICES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Nov. 10,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">1-08789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">94-2918118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">601 Montgomery Street, Suite 1112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">94111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">788-5300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000744825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>asha20231116_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ams-20231110.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000744825</identifier>
        </entity>
        <period>
            <startDate>2023-11-10</startDate>
            <endDate>2023-11-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0000744825</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-11-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">AMERICAN SHARED HOSPITAL SERVICES</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">CA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">1-08789</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">94-2918118</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">601 Montgomery Street, Suite 1112</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20238K">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">94111</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">788-5300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20238K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K">AMS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ )(MP5Y>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M4$L! A0#%     @ )(MP5[MW9<7N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ )(MP5YE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  DBW!7=/Z< U4$  "R$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ )(MP5Y^@&_"Q @  X@P
M  T              ( !F P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  D
MBW!7EXJ[',     3 @  "P              @ %T#P  7W)E;',O+G)E;'-0
M2P$"% ,4    "  DBW!7.JJBYT !   \ @  #P              @ %=$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ )(MP5R0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ )(MP5V60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="asha20231116_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ams.com/20231110/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ams-20231110.xsd</File>
    <File>ams-20231110_def.xml</File>
    <File>ams-20231110_lab.xml</File>
    <File>ams-20231110_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="asha20231116_8k.htm">asha20231116_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "asha20231116_8k.htm": {
   "nsprefix": "ams",
   "nsuri": "http://www.ams.com/20231110",
   "dts": {
    "schema": {
     "local": [
      "ams-20231110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ams-20231110_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ams-20231110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ams-20231110_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "asha20231116_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.ams.com/20231110/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20238K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asha20231116_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20238K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asha20231116_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ams.com/20231110/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001437749-23-032371-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-032371-xbrl.zip
M4$L#!!0    ( "2+<%?Z1@.*8@,  &@-   0    86US+3(P,C,Q,3$P+GAS
M9,U7R6[;,!"]%^@_L+K3E.PD@(TX0="T@8&D#;( O06T-+:)2J1*4EG^OD-J
ML97(B>Q#T9-)S7NS<3A#'Y\^9REY!&V$DM,@&H0! 1FK1,CE-+B_I6>W7V>S
M@!C+9<)3)6$:2!6<GGS^=/R%T@N0H+F%A,Q?R-VJD GH<Y4!N5;:\I10$D4L
M.F+#<#@B43@)#R8'A^3ZBE*GX-DD$Q.O(.,$O9!F\CS7J9@&*VOS"6-/3T\#
M]V6@]!(UA",FI/,CAJ#&FZ2%?AK5V(C]NKJ\];H;<"KD[RYX-!Z/F9?64&-S
MW2"]"P;BP5(],B?QT=30-TK;'COQG)O&X\1J:E]R,-T<%#,G=B9"&D9T& 4;
MN4ELVZO*S"$KA8T1$-W>HZ#E?*P*:?5+-[@2M@A&Q%OR(N*VYD)KK*-MJBMI
MBP+/\:H;[B0M*,_:^</](%:9QT11A#7,K=5B7ECXKG1V#@M>I)B[0OXI>"H6
M A(L\Q0RD+8%V!!;KI=@?_ ,3,YC>-]>7<TBR['PB>QD;:OE\@I<JIA;?PFW
M4MR.UCSJ/M%H2$?1 $T';&<?QDRK%)B$I;O!_?Q(M6ZQG!=CYT5TU-.+;=>I
MR[K9BO<KZE;[!-]YS;8Y\!'3[\TNT;^YMCTKH":XI!_ND^[U_>^5[1KN%KOD
M^ITVTLON)J7>[&U_W9GZ55@%=XO]8V[WMWY!;W*:W=XN;/3,7N8;O%^US5:&
MN93*>AVU*SS/A5PHMW6#;E)/NQM8$#]0)US'KEV\/W99KE4.V@HPFP/3*UAI
M6$P#;+BT;K8/*9\/< [4B#?ZVTW3=RND0'JY]J[FNJL[#0RF-(4RP_\PC@06
MN\:!%"&%.X+_+9A<PZ[!(,7@ .:[A>.H=R@B M]^. JMG^(T47'A%_A.I?@K
M[ MUM:DSKS\@CG=_,WMWCI=^]5?:.+4^E_*%TN=%>!*&(3Z0SRL;F\LSF9!O
MWAR9K<T=LU>V&O.%@>2G//'KF*=QD39)K4@5HHO0KJF/\:^/[0V#M<[)?WG5
M+%AW.ZE>9(3/C=4\QO>8U046G3MI/*J'.C^8GC([L\T#=@UQ&GR $2FV E>:
MI693H"EA"R>]T*K(IX'_#S(16 'X!O0E6'Y!E_ _T0R_NZBP2/U7O"%")7<>
MEQ2Z-,.:&,O6B]N_4$L#!!0    ( "2+<%?L*M8YUP0  .0L   4    86US
M+3(P,C,Q,3$P7V1E9BYX;6S-6EV/XC84?:_4_Y"FSR$$9K8=M.P*,>P*=68'
M#:Q:]:4RR06L=6SDF '^?>WP,<P2.X;!*"\0XI/K<ZZ_;H[X^'F5$N\%>(89
M;?M1K>Y[0&.68#IM^]^'06?8[?=]+Q.()H@P"FV?,O_SIU]_^?A;$'P%"AP)
M2+SQVAO-%C0!?L]2\ :,"T2\P(NB,/H0-NJ-IA?56_6;ULVM-W@, A6 8/JC
MI3[&* -/$J%9_K/MSX28M\)PN5S65F-.:HQ/98QZ,]RA_2U<M29B_\ A^#;<
M-.ZA1Z&7S1P;W=W=A7GK'IKA(J ,&H7_/#X,XQFD*,!492567#+<RO*;#RQ&
M(D]EJ01/BU"_@ATL4+>"J!$TH]HJ2_Q]XA"/.2/P#!-O>_G]N7^<"4Q%F. T
MW&)"1(@DG$>8<9AHB>[2I_J_53W_?O"D6,_E1,AP.B?@A^^EE+ 481JDD(Z!
MGTFN,,:%:>(4J%HGP::S<YEJPER6[$Q&X_%B#,&^OS/Y&B(YRR],T(*(]R?X
M;1P-W1W7GXFJGE":U6*6YAM8%$7U,&<JU[T V8F00Q@O\@NY/0;R&XNUW!<F
MC*?Y-O!6@0P6[ +E3$^.HU$@=6**%?!!_MQB%5,76C8<8"5 [O8'^Q%A\=%X
M9;OQSB"N3=E+F #.^U<7>2XV(P;XOU[>X?V;)4'0&$C;US5OF!"UY3)^D([K
M,2F>81=G=+\=F?[K:(S0F$ !NS+H]1C*J0A].;4R.Y9'<$=,'V"*R&8,.RM<
M1$Z#<)RYD0QOR-1ALV,F ^"8)3V:W,N=P4"I$.=T33[#%&>"(RJ^H;2(F@GF
ME%E?ULQ\SG@^E8=J2^VR!15\W66)GJC54TYY?\$$OBT.:Z8CDL<0IXQ&:-5/
MU.DSP9M2NH1>"=XIUTZ2<,BR[9?:P2(M3P/V&AR[\O*)C]A2?Z1ID=?@E\_^
M)S[@[ 5OWJF,)#7P:S =,%DRD7_QW+BT36!'+-7 =3@@#:^B9E=GK Q(!C-&
M]7N+#N*(T=\<"UFP=EF:+NAVHR@Z^XTX1]R&C.!85N]T^B@G-<>(%!#3@QRQ
M&G!060"YNO+Z0U7[_&DR*1S-<O!U6/:S; '\)*[:1UR--L0+.<G646,\PJ*P
MAM=!'#$:<:3LON$Z';.BJ5?8[C@[O54\0W0*FCK/!'-Z!O12X%.9C*^<+<5,
MSJ,YHFOM(6!$.^+9D9,Z41/["T'3 F:%[4YSUI6=<43Z<H6M_@)]MC0X';=7
MTZ/#8X]QN7[;?ET^E=M!K9BP#)*V+_AB/S6V3M/Y5M^$L]3\DLC*[ K919F(
MZ.(BWKH49ZDHMCIV:JXQ* 8C\E51J?_!+%[R7U6=IVM[DU$!*]$C^3G3]C.8
MJHN3=1_X[D:=QPX*.\43NN+$+/+JWR?MV!ZQD-.HK!R#M6*AJUDY7>6^C(6L
MFXK*.L'%L5!Y6U&5.AO(0M*'BDJRLHXL]/U147VEEI.%MC^KK4UG5EDHNZNV
M,J/#97-67ZH4=J3/X(S9J*M>*:+WUVST5*\6,3MT-IJJ5X=8V'LVPJI7B939
M@S:JJE=YV-J*-NJJ5X2<9D3::*Q>(6*V,FTT5:\ ,?BA-H*J5W>4NZDV+]-5
MK3<L3%@;>=4K. Q.KHV@ZE4<%C;P@=\8_J1-AOWQ:7]??:B_S\H[_P-02P,$
M%     @ )(MP5Q[9:X[Z!0  13P  !0   !A;7,M,C R,S$Q,3!?;&%B+GAM
M;,U;76_B.!1]7VG_@Y=]V96:IFEG1FK5=E1U.B,T_4"%:E<[6JU"8L#:Q!<Y
MIH5_O[8#E( =$L#.OI1 ;LZY.??$UT[2R\_3-$&OF&4$Z%4K.#YI(4PCB D=
M7K5>NMY-][;=;J&,AS0.$Z#XJD6A]?GZYY\N?_&\;YAB%G(<H_X,]483&F/V
M!5*,.L!XF" /!8$??/)/3T[/4'!R<?+AXL-'U'GP/ F0$/KOA?S3#S.,1"(T
M4U^O6B/.QQ>^__;V=CSML^08V%!@G)SYB^C6/%SNC?GR@-7@CWZ^<QFZ ?UV
MIF*#\_-S7^U=AF9$%RA  __/A_MN-,)IZ!$J58ED+AFYR-2/]Q"%7$FY]120
M,4)^\Q9AGOS)"TZ]L^!XFL6MI7 ,$OR,!TA^OCRWC8SGOHSP*1[*0MV'?9R(
MC!7$B.&!_KB$L<)A,HMSF47P26;QJPZ-S\;"'1E)QPEN^7OFV<&,0'Q'#YRP
M'M9"YET>,FXC]TW@@V;? W'='C;O3<C#9BP&+WS@C#<@#YKQ(SZP,]8!#Y7M
M#FGRS10KY9;(F'NQ-0^3<"6#J&*;#]DKL'C*L>A!*Z-D M%&^MFB4V0X.A["
MJQ]CHEJ4W/#DALI<?/GGCG+"9Z*EA80NJ%2J5RW3[CR31#8"8.MG6 [A):M*
M59)@4UJ&,YBP*&^1@DDV<DR]EV[K.N="/W*VOR_]]V2*:=ZPA6HAB[;D,8_P
M(Q"]<,R+YS!@D)9(!=LTR$])4"@A#U34>W'5)#GGS91DFKH:(FJ6=@W%=G45
M'5K46#*ZK;!)-*B@AI4Z?X%HDF+*VW0 +%7S,C'"X#;'J:[H5<)K.J ,TK8=
M%MQHA1S]D/1(\;LU1R5QH:YJKFS3"_L)KF:90NC^=E%PS5A%43?NDJ*>9H=H
MA++JCIX +W'$ZNX=72 A7%7^"$FV1FI=4 JV26"UILO5X1<QJRXIKC9NQRH7
ML-R5.Z<5LX482>)&*J^7$2KK8\4+^0SE&0])QEE(^6.8ZJQ0%K;3"J (Y68E
M<(3>69&D;6!%8) 0JFICT01M&@$; U/]I<N%_VYA0CF;W4)L]D2EHW:R2"FR
M*\<4DCA"*@T$#,U303*7!FQ4377844Z+)OM*$OPX2?N8&1VU&;*3?=YA7'E%
M,J*<L@%+:&2#*GI8+'8OG+9CT=3(@.3/";94?DO\3C8P8+KRA*!'1?[F'+)-
M7JBMFT7OW,2QD#>;?\@%<6#T34GL3I[1X+GRRYQSN8'4'8PGVD23*9,5:NEE
MWR>W8O.)]>#-?-_:&+F/1][1G#M$4LNIB"1OSAT:.77>,.EDWQEJJO/$.@Q>
M2?[XNK2@AO!]/+(&Z=PHRTGK(H/FW&)25V>94MGL^Z8#&0^3O\BX=/E3%KR/
M9PJ SAV3LR-!W]0"IU17G5M*!+/B%3F@W3 <&MRAVUW3#ZL0MAV@>HDD<U]O
MK5*P30([3TI%:9+."*AYB6H*J?NL= W&^L-2R8<481/K#Z-J4$4.*[7^@Q'.
M,;V%-)W0^1)']YBT-*YFU;58MDL_)T5%5J?E+]<0*HMCQ0A=2$A$.*'#!S'?
M8"1,-"XP!]6TP":0[?J_,Z(%I=/BET@'U32Q4O8.P])J6.2N'KW)%ZG8TV"@
M'?6W!]>T@1G0MAT$LQ>M4*.<&RERI\:H("K44\N%4=I9-L&LEEV,A^QGF@U8
MY];),_C?.,BLL]Y'6P2TTVUP-!&-;A:<]GN$:]^R,874[31K,+;=H4@0#%!P
M^EO_=[2@=]MK3-)!%4VL%+S'0OG?)=U9V@?=S$*[OV:I"QC6ZYR3H9S-:7GU
M6L%6$:Q>R7?3:"3TP88W)\K"=KRB5Z&LSQ[GG&A!ZO[%B5(%H:HT%F\8WJ68
M#87UOC%XXR/18<8AG1GO&)9&[W3+4(OHZI[A@ASE[&A.W\ MPW)AH:9B5OQR
M(Z8=L9QZ?$W"H<8AVOTU/5' L.V")1F2;$Z+KM<*MHI@<2"X%80L3-IB0CG]
MCLU#@"%NIXM_#<O593^G18H7">(&+GB3C%!9GPTOK)S$O=BZ?O^)Y/^?*G[Y
M#U!+ P04    "  DBW!7K/QKJ',$  !\+0  %    &%M<RTR,#(S,3$Q,%]P
M<F4N>&ULW5I=C^(V%'VOU/^0IL\A!&:V';3L"C&SJZC,#AI8M>I+91(#UCHQ
MLLT _[[7YJ.,B!./*B.-7\B'3^SCX^OXYIB/G[<%#5XP%X25_3!IM<, EQG+
M2;GHA]\GT6 R3-,P$!*5.:*LQ/VP9.'G3S__]/&7*/J*2\R1Q'DPVP73Y;K,
M,;]G!0[&C$M$@RA(DCCY$'?:G6Z0M'OMF][-;3!^C")5 27ECY[ZF2&! R!2
M"GW9#Y=2KGIQO-EL6ML9IRW&%U!'NQL?T>$!KDIS>7K@''P;[PM/T(NJ-UV-
M3>[N[F)=>H(*4@6$2I/XK\?1)%OB D6D5*IDBHL@/:%OCEB&I):RL0N!$:&N
MHB,L4K>BI!-UD]96Y.%).,XH?L;S0!V_/Z>O6D2%:&6LT+HG2=*.%2@&NA(7
MN)11SK*U/H%1C>!(Y ZZ,V>\T.RA1[J))<?S?@B51<>*%(5?WUR/W*T@;@0I
M5A2'\:D'*XX%/*2A([AQ0"NN+GJS9X&W$D.8G@E)6?:JOZIE<0PF@;/6@KW$
M.2:Z?76BU=!*P,4_#[I!B'I$3DU1-,.T'YJ*]TRHBA7&SP3YGTQ&>('HOKW!
MEH@*,@:$(S[WAW%)_QN+*9I17$&L"7H]AA"(.(7 JI+/!NZ8Z12JKV%V7NR8
MR1ASPO*',K^'>5A#J1+GB-L^M)_Q@@C)42F_H:**6AW,*;,4EE:^8ER'SD2]
MP(9L74J^&[+<3-3J*:>\OQ"*OZV+&>9&DI<0IXRF:)OFZET_)_L5MX%> ]XI
MUT&>PTHG#@?UQDB,/&NPU^ XA-,G/F4;\U)F1%Z#GX[^)S[F[(7L4Z]:D@;X
M-9B.&20H]&^RJIW:=6!'+-7 #3A&!EY5Q:[R%:B0CI?P46&<O":((T9_<B(A
M/1RRHEB7AQ=%52)0BW/$;<(HR8B$#[-'"&I.$*T@9@8Y8C7F6*D WXPZ%Y^J
MW)H_S>>5H]D,O@[+5(@UYF_B:GS$U6CC; U!MDLZLRF1E3FS">*(T90CY0I,
M=L6,585>9;EC=1ZVV1*5"VS(\^I@3M> AP+S!8CQE;.-7$(<K5"Y,RX"M6A'
M/ <0U+D*["\4+2J8598[U6P(C7%$4YAAVS^P62T#SL3MW&08\"Q@'&9P/VR'
M 93 /.8X'^V;,/HQVF[0/* Q[2GU,LH$SONAY.M31"&>75@7KRLZ(.(5XLJN
MR):$YL>GYYP5]1_IK,E0@.IUQ]]OUQMM &;A8UC*D+Q_&>S]B*,F'@7&94^9
M[=>]E1KO*SZ,:IB=(2L5.GZI4&-&6<G1]4..-_M*5N+<^"2.R<^R4N+6)R6L
MK#,K63[X)$NC4V<ER6\>2F*R!JT$^=U#06IM2"M5[CQ4I<;TM$O0/,E7S8ZK
MG0R>)*KU5J^=%)YDJQ;VLIT>GJ2K3:ZVG1B>I*>V)KJ=*)YDJF]SZ^VD\21;
MK=\FL)/"DRRU9HO"3@=/DM/F?1$[.;S*2BUV8>P<,T_2TIH=(#L=/,E++7:=
MSG8<X@M)H.(?GTXEZD?]K1?N_ M02P,$%     @ )(MP5]BC: QW$@  QW(
M !,   !A<VAA,C R,S$Q,39?.&LN:'1M[3UK<]I*LI\W5?<_S.7L.>M4(4 8
MVQ@[KB(8)VQL[ *RY]S[96N0!IB-T&AG1C;LK]_N&0DDC&.;^!4?IRI%I'GU
M]+M[6I/#B9X&9#8-0O6A,-$Z:I3+5U=7I:OMDI#CLKN_OU^>89^"[=20;)3K
M.!O*P'2M5BJ[96A-.V*#SQ=]\_UL8]HUI-Q3^9Z*>:6QN"R;)AA3W<[.RV\$
M8;O,0Z5IZ+%%?^6OVQGT=<M_G)WVO0F;TK0SGVD'ELX-2$'A8<!#]L?'WFE9
M2QJJD9!3JKD(82YWQZG4G6UWL2AT_78S0K$UL^3ZW=RV7M6I[BXP*,(PGJZ?
MQ]>RK.<1*T,G!WHQR;UT7*P<;%HB?T35T(Q*6W*XC[5DXQMQOU^&]N6V;NKG
M;F>VE@%$BN &0$P+ E)Q*FX&RTI'<CW;8$L.\FOTR#,--@^I6C -5Z)6=?>^
MQV:V1SH D+R"R?4T2#=1=7-RHM?*R8Z5$[UD97X[*SNK J G<>@SZ8LIRXWN
M'7\ZX;#QL2IY8IHA\=T(/%NK,&Z!Q6=\/<&@(<]IRAE3&JUE!VS(=?9$'&HY
M7S]STI@;(&]@&XE,X]97N(Q[-S 9]_)@Q%*RT+L)CJ0U-X3-O,GZ[MB2ZZJD
MOHX->)GK1*=YJL S$M?T<5VW4C@ZG##J'[W[RZ'F.F!'5$UHTKC[S_JW$JCZ
MP[)M>O<7Z/6_CD,^L9!)JIE/AG,RL-QT#-Q$+H34-" .<=VRNVL6(6ZE4:DU
M:A5R<48<Y^C=X91I2A DA_T[YI<?"BT1:A9J9P#R4"">??I0T&RFR];2E(\.
MRQ;,PZ'PYT3I>0"\.X*NCN+_80U8)=('Q+P8T2D/Y@WRV[]CH0\&?,H4Z;(K
MTA-3&MJ7!R2BO@^<WB 5'I)*R>7A 0&"*"$;A,9:' !B?'Z9KN1S%044)@65
MR0I'__/ND,\:"!&3Z0/W?18F#]"K:_6JW<Y,]]!*^HB0^I<""2F*'K!XHSEE
MH0]_]4E QX6C$0T4.RSGIKCWG.T0Z#5OP:22!AT@SNP+FQ>.*O!GKU:K5W>N
M+P!+E%<W ::;(8,RA2]0(3:4$6)8EQB+U9@8XP\\Y:3\5 +K6DA:4;]]*"@^
MC0*&-$P6R<]K7B@1R^396/-&LD/"_>4.EZW,;'#YS'U\,^),$@,A6VNN6YTO
M>22L#C8 KE\A CP)?_D,2DSJ8Q"!(P3.<5W'K:1CEVT9@/T;.J<MRZ672Y5S
MN#!46E JA[-RCAG+P+?P^R[+OUG!6)&(@Z44&2$RCY=4<AIJ8!)P,8(#7-^A
M 1^'#0]0P^3!E,HQ#QLX "1E>/2UVQFTCTE_T!RT^X?EX9$%XXFAZ+=;7WN=
M0:?=)\WN,6G_T?K<['YJD];YV5FGW^^<=\FSP?9[L_^YT_TT..\6R7&I52+5
MRDYM_T[P_&T%H+_=!:+<^K_],J.5@Q_8=WWC?9^<]\[(_138L?!BU(G&(. <
M=>>+Q5->;^&[N^WL!6!P<\X!GNZUNP/2:U^<]P;/Q\$78!]C&$&T('WF8>1!
MW&URWB/NSI;_GH@1. ,,FV+)-0< VN"ST'#,2-/3V.SN;]=^%H[?$$^HS7&K
MDD7@#)&M])E1T.5,:<(N8532S/SWC3O)A@WU/A0@-FSX,.,4.DU\.I_#M"Q<
M)SL7QHRTK7DI''7%)9L.P4"ZE2+!6:_+THNGR*8Z: /GJ<?&7&&0K;O08KB_
M>=;N=5K-+NE_;O; U'T^[U]T!LU3TF_W_M%II5;O?EA]>/[;:L\H"!N"C6RW
MW BABO0CYJ&KXQ/P>CM:D=8$?!4FWS\Y]34=!HP,A02GY4.A FX_"X+$*5\\
MJXAZZ?/]D7?%?3V!?U9^32!Q C;2#>/=)R\D'T^2-P43WD 4A '&T:&6\(R/
M?KKR)9.:>S1(<*]%E*RPO5W:^]6,A_Y/IX_OIS4PB86>J6:1%)?([GFU8=F^
M$WI"@F(R6:4^]F[98+DE?"L%+8 (I@TY_0Z[(R+*VK\%@T.AM9BF9+(X3+GD
MUL$9]+LO%?VKV#WA 8,!H(4-*EVG4M^K[[_A\;YX'-!9)PG:/,.I&:3NUYSJ
MOEMWW?K=\ J_1M)?OL!O&7DD0I)S/0%#_G=PLI3/C1N6JM4G!0BL2TY?O/_S
M<.U62TRG7*GG0CUJ$F*Y_L^$]4ZO3]K3*!!S)I\%[WFU0[JBM ;]ZU2*)]"9
M"3\4M@MWH<SN7LF]@32+F:IWF@ET5>WZ3)N!N*1_"M_+MQ5-WY=,J>3GE(?,
M-79BM^*2,YA@+&"R.>EKR9@NDG[,0<>ZKEO]GC?_M+L>_LC&6_#/<SD05Z%-
MD-&0G$ TX''EB75;+-XW'+V;8YE 8TS8N;R GAP/@>[B40Z?T!O*B\Y/XQ E
MV+T00(?@_WFT\-;W:\#*FSM"+U\E;"5;QU#W0@)/\8@&I#UC7JSY)2/G(U#6
M3/V9C"30GR #W&R9WL&OC7++)@Q_V5F?#?&P3'S\]DN]ZNX=**)9P**)"!D)
MC>M4), P08PI!T(EH\#O/FN0K?N)(&K8)HRV0E=SKYVNO;]G]OM4 #==()QI
M7+-7KSL[VY7*ZLRO/??=%9HTHR@ \0(V?89<V@ET@U#+)M,D21X3G0/L,\($
M6CAF/NFC/2.G5&G2,ZG=IT^I/1Q:<JNT)LS[1B#D)#0"$Q]!3XV9NQD9LD!<
M(1*P$7%#ZLX7,C(E)(0KD"[-0A^0HP51?!H'FH9,Q"J8$P4.M!K-S<AD@!@"
M':Q?+>R4<IF[-"4&A(;SM&TD E@<QZ';P3$24XVW+.8/9#%MG/ ]8_7CZ-O$
MMQP*$0PI4!OV-,OJR=\EU\!@&(K'81*2*231_EZM=O!#*;4E6O;W2M5',.(Y
MK"0; 71D=T*BS'%;+P8^JU5W$D'0^6,V/%W;<O=(ZZ1'JMN5$G1\F=;_5<G+
MSD\F+WT!AA08)AR?@0:'18.'%Y;'%I7E'L@TV<1U.7%KU'&K&5')'4,O!*56
M*=F>[W-<^B8Q;Q8FD9@+R="Z8*V:*4=!;T9"2(D^^<]G9F WCI?9SJWVQJWY
M3G5K^/YNDF3[OLG2FRS=198Z2L5,_NDD:ILYM2WO;A*5]'W)$O585G[IVMH8
MD$F((J-UY6=&/R4Q(6#P+02\MU+)Y[QKI?K3YRP'^'D!4K%-O0EI!52IS1.V
MU=+^]Q.VEE:.'=10X%'ZQ(UFY)>*^7-PHTJI[I9VGP$YDIH,97\^'8K@N<Y"
M:L^Q];2(S;#%0E&"V/\^X?"FM] -#U37\2S,WS1FCH:D/Z&HYCX+%7'\BJ;/
MY"4>7MPS?9PHS[E;'1JY*ARAW06D];7POET_[^L*<D$E^0<-8O:(4O?"I.I^
M.$UDT(H@D.RL_R(JMIY%*#?Q"O';M>M'PRFGII)M2VV[_]=OKV*7I,6W?R8O
MJ!/ZZ$DR_,C.,TEX:/Y&KB;,U'^M9,BY(J!#P W%&<9D+,65GJ!#&F'6G"KB
MLQ$/;>6OS296=E+':265: OUM\G6;[^XNWL')J.8=H9E@%@1U@SCB8CU:JM#
MI[IFKK75_^FDZ.$NQV6F_8G/33*28QRRS+(D_;MC0&C?0*<'#;EL<4"ZU">S
M4LLN=%NT]9-C_U^QTGPT7Y&GT7<D!,^"UXH;OW86-0%A8@$$("!,H3#A2*R8
MZ040)"=>^'T^-R&*_9X/J6;6"N:X^!6'I9'@(>P06B2[Y K&@8AB<0Y8?^J9
M[Y2Q,WXQ[5/I*WO6Y=\4"VUOT44LE)6]$ED0^\F1OH;:'OKW'PH7GSY^641#
MUJ 1$^.0;)"#,K-X8Z,<? 5&+S_7R:"WF"P#$TDL&,DLL#)V,G* $ZZ_Q+B-
M7'SJ?CU;V47^Y]WA1*8+7S0_M9V/O7;SB],\&;1[#4*#*SI7!TE\:#\?S@%S
M0";,[JH:S0ZPX@:_0$Y#$3*DWC=@U#CTG7P3?D^[@H+/Q^M1@'C<& &#\]8I
MWDWQ/13<QE;DFM(H$O.F2!0(QRCY;CO[(7?"0Y;ZJYMY1AUR.#SJ:#8E;JGB
MED@;/XW 8VY!*$D/5<@Q&EINRH^:8\E,9JCT>CYZ6XN7<RR&7?G"K$AN#VVV
M4%=A@4ZU<I"8)O/D'KPG1G*-PX+X#4DGO&1*FSS;12Q!O:D,@G,S=2Z:BUF,
MIL4+"Q17+8""?.TWBUBX7LH-Z0.S,[D8!0IW=1! 'V 0H-+1R<B!B#R1#BSF
M-/.5"5/MU(0BJ+86 @4+?G'Y9-.$:X4;YK 6WHJ@#5O!]I5&AXUA  R:O2]B
M]/U"0[QV. X03@R#10A8;>'%&I*T#.**Y/2T9?;1$V-X^SL/ DZGBO0@E+%E
M%@.8BD9ST[-(MD#!H%4#O@W@708W Z TTPFHX-@ML*1A9N.+&B2;$A&E@$<,
M00!<@$93 #^B<V/]0DT]V">:0HJ(LC2,@$=,F/_7:K&^4RF"=BM91C:?DZZ@
M0R'FAK"2!^^EO8(BB\AE9A6X  >#6)HQE.Q6?KV.U=SFYB6SY.J&B8C,?1<P
M+="0C.+06%Q N5P@4UMD$L\2P=H=9;SMB? !&H7$*KVFDJWU7A;6,81AXI,L
M&(/9DLQE<0]2)TNW*04D4>"!^@YR 'XO&R*=@'<,._DL$N!1)9X3A@P2W" J
M@368\L" @8!!OR+.;^4NCI#L.T#T*9TCRP#?C1C7UWF&+T'B6"8HI^"&83_+
M3"D;!WQJ1GM<>O'4WF,#VF 8 [,C^:]XX@8N805!'YK"J8!;V<?F%<ZG&HPN
M],<:*)F923(=RW Y+&715\P\*'S&=::6?3 L%,8)1A:((WB%59KAB"<W7Q'C
M5Z4\]34T]#%5YHI\I.$W&4?:FP/J8JF-WC$A:JI%C]&EYS8X'; 9S=NCU?%+
MXQ 9/QRK1M.HE;@NB4# [9??0HY!;_R'+D4 5$X$(F'==30'X &AW3 *.N4O
MNPLNT][H0= 1EL>9_6!7! _YTQ0\FW(XHW\-%E2*AE7 BQC^7Z'1@5_L8*OO
M$AS#(#M)RH2 7]^$+BI;(&MC>VO)$D!2\3&JSM3\64\()E!(+[HPS@LUD-6%
MX"BA_*;&XC.C@0F*_ 3!H%YQDP!V8@(F8(!QF]@%& [DW>[Y1CV> @@<R+$R
MW%B""<@;@ ("MMSH0E*GS%@&!#7$^V=V*\0'![YHUC3K6)4S23!I(A(CH*G2
M6&H22XSK6(7!0%B,'(>,A69)T$=G%)1"ZCO57KN0(X*,/\ !'SA>Q"#JT!L6
M 9=:L@AD !B#)GQX127&WCP1 P]\30B4]8+E6VD4GV%1*V"KXD=S"B89#H2+
M);/I%@C1:<9& *19,5BNO&)#8&K)J *O8!B %R!2E\'P,WA%8,H2V,00MYW*
MU#HM8ZK5F0DN4 +6:3PK ]KX&))9B!,[(5%<%'[')-DXAB8!\Z0BI19:,(.&
MU\YML&4V%B:5$D\-@V6<$%_ DBB-8);-E1W6OS2Y&I80$.R0BH?_LBQDE0$X
MEL'B*H6E]PZZ89AXSZ,8W7S4(LO5BHEO@ME:#=[P!,:#[F7(F)@PG? A^ UN
MI>3:=1??UUJ&7%R=90;Q5TVX--3>-Z'VR2(Q9JP[&@VK"A*<J9\]PEZ3*M[>
MA;X&33S$#T\;CGE3.,++=C+[?JMXV+2,RJV5MA^[2.@0/Z'+Y>5\YB6?S#=L
MA(%WG^*A0"+^70%$Q5&;UC[5=Q_E('O#;1UC?,8C>T_!#=O:Y+@^)=X&)Z<I
M@F[_*OHE<%#6+&S*$;5'^3HSSQ&4V/L@V>R?._OU:J6&EX<NQ!_/JAS@$PD^
M1X/9+9E\P2*KMTSF#>?6;YH*L-EKDW?%6])SUDC?GH#TC6FEQI%<<T<6?6!>
M?4S\NY7:"^:.%B!70O0T!C\(XT5JX]MCJBDQUUEL(>Y]/-Q"EST)PCKF7FB"
M%T.#HV9O-GN03UL>OB[B[:3K[:3KYSSINNDRU<ZG;G/PM=?N_^Q7-N:+MC,'
M-(MP6281Q=V*6(KK2@+\&.-^&N,QOBEH26Z M.$D'HM @["QXI!-:#!*4PC&
M64HZ8%P78QK-3 ?N[41(V)O_BMW\_?W'KVNNU>Y9G[A2HK?[ Z6SS[:R>T__
M^.%6KFW;CR\V]:_?:/?\M'M,9_ .=ZEN[G6_,<_+9AZRRCW7G:(< Y&$@[*N
MTK*<LF8S8LOK7NYX(]N/\<X];V';L1^+/S1![GFK7&UWW:UR/XB<QU03>'6U
MW\C$Y;MI7+YYL?V;0+\X:W#W5&)9E4F/SJ<B]$FKA$<!WD1<<?KM 1*+;V;C
M=7/91[ \-_#.&].\,<UZIC%?T#4R%PJV)A1/XL.'R$$^5<;D1]?)'D'NWY+K
M/&WV!\XR.[@V>_F@6<D4"/A'@G;\+\.._@M02P,$%     @ )(MP5_'4N0.1
M]0  W[H&  T   !E>%\U.3@R,#0N:'1M[+UI<]M(EC;Z>?I7X/7,]"M&P&I+
MWLO5CJ!ENDH]*EDCJ:IFXL:-&R"9%%$& 386R>Q??\^6&Q9JLUR0Q(F8+HL$
M@43FR9-G><YS?IR7B^3]CW,53=__Y=]^+.,R4>_5U__OY=LWN\]>;,.W/_Z-
M/_S+O\'W_^?IT^ GE:H\*M4T&*^"TWF53E7^,5NHX"C+RR@)G@8[.W_;>?6W
MW6>[SX.W/[Q\\</SG>#HE^#IT_<_+E09!9-YE!>J_/N3JIP]??-$/DVCA?K[
MDUF6+Z+RZ525:E+&6?HDF&1IJ5*XNE2)6LZS5/T]S9Z\_\N/?^-!_SC.IJN@
M*%<)_3PMGQ;QO]0/P<ZS9?DNH ]FT2).5C\$?_UGE97O3N.%*H)#=1$<9XLH
MY0_?!<MH.HW3LQ^"9W$:/-O>B=-WP:3*BRS_(8BJ,GN'SUSJ!RVB_"Q.X>+E
MUX >5*JOY=,HB<_@PSP^F^MGWV@P,"=XK?=6^G?_M_:3_QL&]$D8%"J/9XW'
MPKW&[T=?Y_$X+N&#[9T?_S9^_^/?\"KXS_+]7Z[Z5HF:]>BE_IJ.B^4[_SWF
MN;[Y7.$2P+7+K["*68*+^._/Z/_>!>-H\N4LST!PG]:_NHBGY1P?\>P_X;HL
M!]'^(4A!YMX%>FZ>+\O@F2<+[IO4WN.='3?-%OUY'N5QE)8_I"CKR3MGCB<@
MZ"I_)X_"']@7]5?J;I\)$K-_^-OHY/27T>%I,/SI>#3"?['D= ^DL8I7&4H?
M7O;C\'3T,1B>!)\_!8>??QO]\F%T#$(0!JC#P@?[VJ"_HW0:1(LL/7NP+_G3
MZ'!TLG^R-SP>!;^>#,-@_W!OF]>TJ,PPSE5>QI,HD7N5V?)=$J?JJ2B2G5U0
M"$_>!S_^#7[S*.8I^/GSP<?]PY].W E[B.\-.^#!OMOPE]'Q_M[P,#CY&9;U
M(ZSIR='^Z? @.!D=_[:_-SKYSF_^G0]H_^'3^#R8)%%1_/W)T4\?_NN)'HIW
M2[[)4[1U?F 32#[)>;QD>]3N]>GTV-S,-9AD4=PQUWX[GSW-LXOFAQ.5),'1
M3X>__F(G$*Y H]?]CSNA1\.?1D\_'(^&__5T^.ET= Q&:W(1K8KZ+'EOJU=A
M]UJKT)B GS^V3P!;C#=\_=//>P=Q^F7M!)AY:!7>:UN55H9:C=^K;..@OH\[
M#&:]90+9,]U/%BFB_?QC]?YT^.%@A';*WN?#4[#)8 M7[[_S-BZC<:)$KO[^
MY!GX:+!@XC^9OXME--%_7U_?L="0E+I;DAPQ;T=JUPR\4W!?<_@'_G>*T@PC
M2/_^9/=)QQD?X"&OI?/E?SHO64[-;:[VTQ;O[PDN%BS9472F>'EPF?C.\%\:
M:+_&Z]_-&:.^:5,AY&?CK=UG+\!.?OX&_N?ERP$M1?.-8)OSOW>N_G9TGV]U
M5C9.QN/3_3W82/O!T:_'>S\/3T;!\/!C<#+DS37Z[U_W3_\7+!_0I. &G="7
MPSWX%(]1W'K'P[U3>WS^&TW8MQ&;\?M=ON]U%^+E2UJ#QD+\^1.^@U&'FTW3
MVV=W.[2C*I_,HT*1)W02@5[+9L'HGU5<KH)]U+RJ* OZ<CB!3W,U#?;@GGDT
M*8M;+/VZ5_KV9XB6K=WZB&^_R_L@7(W7ZHMP@:04\12CI7$&RW@4K19PFC\F
ML>FS3GK>6[%)LB+&D,SCD9,^JY<7?963CVH)@G+_]$ECXST,??*RKW+R>US.
MYUDRO8\ZY1:R<EN=<C/WBA?SQJ[9S?VPKJUQ/_RP?7[MX]$1.%RCP]/AZ?[G
M0_:[?A\>'P\/3_='E)\Y&1T<C(Z#X]$!7'+X4W#Z.3C]>00^V2]'P\/]T5WY
M9"]NYI/U]US;[:]/]CD_B]+X7V0UD^OUWQ6,8@;#,9_L1<NXA _E(O#9]K(%
M2':L[I]7UK O'L)QN-M?KVR_**HHG:C')"A]UD/]]<.R=);$D[)XAS&? ESW
MC7+IB<STUB?[D&=?5'[_Y*3AO#P,W=);G^Q G45),"20XZ.2ECYKE5=]E18T
M;I,8C19X8CD/#J(+.)2.5+Z([^&9]$!US>N^2L^G. 71B4'?G)11J1;WTI!I
M[,V'H7+>]%5H,/F9)&I2@N\='.79$L:RNG=2T]B3#T/5O.VKU)QBK0@\T4C,
MN^! 1<4]C,K<0G+ZK&]VGO55=$;I>9QG*9Y.H'%^B<KR/OI1#U3A[/0V6'P0
MC;.<8L(CL)&S^XFP:%@!#T39]#8&S+*B5/!!I6H6E\%1$MU#/_P6<M-K;=/;
MD# <2RI'3^K^@@ ;MN,#T36]#0GO98N%RLG_/HI6V3TT:II&XP/1,[T-#_\2
MI=&9 ILF+1&)/#S+U3V-V]Q&=GJM;WH;+#[-P92).+/ X>)CE1!APU$$H[J'
MOOB#U3^]#1F?1E_OK0O^8#5.;V/%PW&A,#>%,"P81A2GP=X\2L_@IN";?U3G
M*LF6]_3X:@0^'HCJZ6T(^:2:S>))# *U0H$:%H5Z9')S6R5TSX#+][N ]+K(
MY3O")^_L/+2BT>?W!* ,.NH$,Z7Y_=-1#[)@ZWE_D<?#JIQGN8ML_PU&,44/
M'T\Z[>0_*D'JLP+J;1C:I-GKE>J/2G3ZK(-Z'(V^_Z#VAZIO>AN.OJ^H]H>J
M77H;>[[?L/:[T"OWPXO]+;C<?]5,27?FPCY_:#6V+^Z)"]NHL;U_._=!<DJ\
MN"^N[/WV7O]$CHF[E)W>>J\/P@5YH JGMWZK%#'=0PJ;)C+M8>B7WGJK)VI2
MY3$B7;!0\O[B&!YD[?Z+_CJO]S;*\2 +:E_TMZ#VGD<YNL3E+_!?I/;NZ ET
MR^X_#X&,/][P\/>7A_\R"OW;]:ZZ'OO^W>R:^T"\WVN0TC<@ZN_U^WU[$%8?
M[(#>XEXUV'68YXAVO:<(UP=)YO.BOQP))UERCNC61R4I?=8O_>5$^'UX?(A^
M!F5H?@&[+#B(5MELMM$RO9&=WF;X#K/@4Y:#9Y$B45AQ'Y-Z#U7?]#:K!S*#
M5'.JC,OX7-W;VHL_4=<\$+/_7J!6?@L^# __Z_C7H].]_P6/_-?CT^"7X>GI
MZ/BN2."QYO=A%5F\["]"Y4.4?LFK93E9W=](ZRU("_M[@+WL,2IEN<RS\RBY
M?Y+R)]+-;8ZL[WAD[<-!]=OH<'BHFTK^=#P:_<*AY+LYLUX_M#/K57_/K.%D
MHL!)+[-@/YWA]_<33/D@20Q?]??8.E9G51*560ZFCIQ@]]#8>9#$8J_Z"Z,\
M5E&1I902',U VS">$FEW[Z?:V7V0+#^O>@RIK/)RKG(,\U0Y-A>X?TKG-C+3
M9Z736VSE</(ES2X2-3W#;&<P7@6Z@W;^#HR>J5HJ^!_X9C\]5T49GTGOX\,L
M^%R5V T9V<CB>]E_:_=!<@&]ZB\@\V.<JPF81<5?__W-[L[K=^PR8B[L,W($
MJ=H7*'Z+]/X6,>T^R++F5_W%<1)38HRR$B7!KP41F/T2Y5_ D/I@ICDX $E+
M[V,+@]T'6=CTJK]XH/U4#*G[)RH/LM;@57]!0 >QMHV"DVJY!._M4<E,G]5+
M?^% 1UE1/MU+LB).SY!+_'X"#G<?)!3H58^A0$0/-:$&V9A,G<"T/C*YN:V^
MN6<YLGM-1O+;/B;)#C_N,Q')Z>=@[^#SR?[A3W>4(=N](:JCOV?8Z_YFR/:R
M=!HS-?T1./>*8D5E%I1S%7P>)V(3%>B)F< 2H5_O*<?F[H/L6_FZO[FTFPC8
MHY*J/JNMWN;:KB%5]U51/<@>=*_[FWW[/8KA\=0SP0C7HY*:C4U^KVSR_>!T
M=/S+_B'Q ]Z5*?[FH9GB;_IKBI^J?!&G#X# [6$>76_Z:V./9C,U*5%H'!FZ
M=V+S_$_$&VW.KN](;OL_P2_[)WNC@X/AX>CSKW<%M$9Q>EAGU]O^GEV'6?KT
MI,K/X_,H03UTK):Y0B9)\<,P8O1[A+0,1 .'?YK.9-FY2N%S1$O*1VR*WS_K
M^S8:K+\'W]L>'WQ?E_<3"O+\04+7WO8W8'28P:,?F:#T6:7T-@ST(4Z1OBM@
MF_H=@K%A#/?2#WO^(/%F;WL,Q@8QF1(.F^T=M&(>E=3T6>/T%E5].H]S[@6^
M"CZH5&&W5;C\/AY6#U3A]!8PC6[7L9ID55ZH=UC(H:+B_H%=GS](L.O;_N*B
M3Q0\/1K'25S>/]:[VTA+GY5,;Z'1V!.DS*O)_0PJ/U#=TE]0],EDKJ95<A_-
MEP>J6?H+A$9RNT25ZAXG.Y]OV/MOS-X?;^C[^TO??U5AO/G318HV9/X/F<R?
MEI;)_/5J-L[6^_%^#Y',_VV/R6]/EFJ"Y %(ETSD7?>QD+?3/+CO_D=O,WW_
MJ/*XF,83TTEW]'625 7R)_^FTNH>BM"#+"X $>IM#O"G#)Z>8A;P(+IX%UAD
M.,C6*CB%']X_1M/;2%&O%5%OLX&'67",D\]%*.73S[/9_9.:!TD]"5+3VVS@
M'A:#JWP9Y27CY(X^?GI48M-K9=/;3.!1-4[BR;W,YSQ4%=/;]-^'*OD2G$2)
MHG[,]S!._R#K2T!B>IL"_!1/*P2EK-SBVD<E-WW6-$W2U;[(S6GT]=ZV>W^H
M6J;)FMH7:?$JL&=@SH %?*S.HIP N7Y)"3+8IE%1X'"E7K(LLSQ5JZ=[28P0
MS*,\/H\3=7;_ CXO'B3Q-DA>;T/-I]ERDMT_.?D3:P,>2 ;F7A1,_D\P_,CL
M6\.#X./HT_ZA4'%APYK]P]/1\='QZ'3_M]$=MUM#>7M8K6MVGO6WI%(70WY4
MLSB]IW0DM]%0_3W)0&IZ>Y(AY_I7-(=(;-24& 'NH> \2.,;!*>W:=-CA&RB
MX! Y*9C:Y?UDD7BQKNW1O3=S'LX+W-;R GMD__#CZ'\0,#;ZGY_W/^SKEGV;
M^;Z+^1Y]G<?CN R& ?7XV'F'W<P7Y'B;"EG\:_3/*BY7K$54@;3&O7Z=#XW7
M^1 G1&&! 7)*P#GO)W]6BR5%'1S4\K=ZR5;4L*LY&^C/:VOZAP$=WF"'[PEV
M^ :&B?,8$9>Z:[Q_^-OHY!3[M-J.K6U0X3O<.7?PLG]411G/5NY#Z=N86GC]
M\/S54NJ%"VGG14K):*%@J\2O4*'M/GOW8_7>T4_5>_IXY]T@#*91"8Y!1-;>
M87:N%F.5PVJ#P?QL]WD8P"T6T51A+S'4=]$B2\^"K6@0#!<@(Y,H#4[F40YW
M^#DKEG$9)<&)RL^172,,HF /7F66Y6D<P?;)EQDW/PRV[*@<FE]W5%OC0?"3
M2E41%WMP^^#7DV$(KSG9QKM^@MT63VNWA#< _UA]C8M2I1,5P&?(_XJO!_LX
M5]DLQ+>,@JD:EUD.T_ATF16% GTNT, H@*ORLRB%%9K*9?R;Y3*!5P5%'#KS
MJ:EDW6'C;;8F Q:-VOAAAA*,71?V13ZJ)+K K__<-Y& IWV1;<N^' IE+K\;
M71G@B',U4SFN>YG1H&#$R)5Q'D^K*$E6/$!GF;&@W7D$W0W49J(F97RN^ ?X
MEOY/J.Z]>K^M?[47D8S1:Y7HRP95 ?^4 11S>'0PC\X5W6JA(H3M%:#-R@!;
M<,[UA5F.,XQ[ D]E.-G_AY[R&/3%[S^/X! \"5&J_E&E*MCAG8[JPIM]55*8
M*?@(8N<+.0N$E8<09.!,4;/*BQ@F>2*Q*E H\&&<@ZP42U[G8#B;Q4D,MX1=
M,,D6"Q3P:7">)55:8D9Y C('BPI#S@,0P&6)RFB';A67L%#R;QCJKVF,BNND
MQ)L%>]D41'IGAR?YU^V3[;UM_O=?_WWGU6O]O_3)SK,=,?-V7C[?K;_XARC]
MDE?+<D+B"A_H=:,_\#G^;,1IRW#L36!D54[B1Y>=9!5.%$PK[&[0G\+3^!6D
M'\>AA]P<#-_'?_3%/)[,9<IP3_Z1Q6F)6VFZB%/4'K@_\<G+/(-IKG+0SLL*
M-(V=XSWX,:C][6#W^=.WSU[MO BV/A[_8Q!LT9.W@Y/MC]LXOFWXR-VN8= U
M:W3+PATHJH@82_O8:@YF<1JEDQ@&@R(D>BJ21F_H)F!Y<95CF@\F-YJ <IPB
MW)^E"Y_+6Y]5B*'^MKN\E&U>6]EC]];> /7JD,[%YZ+*# /%W@N-DL0[\\G$
MBPJFWTHTW +,P;,Y#FH6YPM#WAII41;YVPF6243?&#5-U_*D_AB__P<N9+!G
MY?](KC_VKL=/Y) )Z)3Y1#.K@B,8]4$YW::A[Y<%'#1X!+AC_?%O\?O_YV,V
M^0*SANO_^MG+_Y>.GD6T"L;@ZR![C9J"*5@M9>D4+A;/Q$4,8K/(IO$L1A'+
MLP7LSX4BTG7X;UTZ</CNA*_5@@].T[)M%8.RF^+<PP9=YC%*'#/42\LHHU>S
M"Q3F^"NLX5+E$S+E7CW;!O=@H'6?"&:LW6KR4+5FP;<:I6<)KOVQ.N-MM8=R
M =N=#.@P.#C80_OC> [J+-@OZ-HD7I * P%A,HA -R5RS+63P]'QWE[3Z%D_
MWF,X'_+@=_"EXP@V[G&$$X$"? HCCI:K:PXH=$=T_/OQJ3,>'HY_(.&@C^'^
M*H+]ZEHE>WR_=79)793Y)[&GX7@&4!G4%Z;^ZV8\Y+%N"ML_9@KZ*T?M"8;E
M!.8']-A6#*(#MLD<#BD\PXQ<@9/L"59]/MD C^'GM+/0P,CII#F*5K#C]N 5
M\@B1) D>CU,T@E"HA:0@&.)Z\+Z,2F/'W"0&5#][AOQF4SL$[P"*RC+"09"!
MBA-1X+A,6 JO)4N#)!@/?-02<#EX9615B.9(NT]'_!/._J**;&^,$CNL1I/Z
M\=E^>M(;<#_6QRNU137^ \FU90+A$K!9\81'GP+M*5F0AOTG)@':%O@]G>=;
M=<WB6 V?\6Z>6L.+"_BRF/&*!5OV"($1H\PMD>^[+%DN#J(+L!!S_#L-+AA,
M):,3SPKW6$#68?,T(K,_Q%<CD9/MYL@37*XO]5VIW_;W:1?13\ P,5L"-'/I
M'WA6!US@%EO*G]T[&[]H[B2V/UPW5?8#W;6 ?Z.OD9ZK%9[%N'7ED$#Q!R\6
MW\4.Y9H/#[ML5%IB_3OK=Z,M?AX7VH1L",M4C*=/"@0 %)?)Q#E7'8DYKT+S
M@"2;H/%,%VMKMBZ$<#4JLKJ2J,ETJT5-3HZ_F/H=[1B: OPH/.K#S[^'P2EJ
MB$^?CT<D#S"'18SKIZUTG!Z82766X899YFH1%\J*U:(J*_)]/)YLV+Z&)!LE
M6)BQ><(CO1)-S<T7H W"Y*6PL&#0)^J, C-C:IN-5X[%N!%U()_QG?$$FH$9
ME%T4WW,1[VD"8DT(?I.#Z%T.XMO##5SN$HW3VZ<,Q#B'&1B_/_KU>._GX<F(
M0'HG0V8V&?WWK_NG_\N8O=')*2/XAGOPZ?'H(_&>' _W3D_N:2;#F2SW_]LT
MZ,ZVQ.V:_^MD"/AD1QN\);',AGBKD;WMZI8,M2)82#'E5>$EHZ103S"V'CW%
M0WI59G]_LM0?5&7V='F65HN_/RE*T)+R^30NEDFTHL]WY3.<@C1:P"UK<^5\
MCQ/V]R<X8_(AW$$F.Y)/X "8Q5___D3^I*=ZSRFJF7L!SB8)X=^?L!#6]N(=
M;@'S_[O/S7Z0=0U>[]:WB#Y+G[S?B@9=J_WY&]DFW8:F>\:1$8M'=;588&[%
M&'CLY?  **6@+5/7NF1_["M\GIXICK)RSV\R *+"&,U&?H_R> *W: S!/J?-
M5NTV5<-K&\I;<3I)JJGV0LAQA0L.),!"/L&,3G]T'A,5Y>S<2.X/1CA*)]5B
MG*.I"[?CJ"@XRRG';6/Q)='&U",&"2(O@>/-CB%<J$F5TT.I\! ]$8R4F?"B
MM\(X!HG64.S^];L"3$PO<OPQ@Z&A0318:[&L98&Z]4E@Q?S[G$,WWH3C;[L)
M)6; AF>'-Q &BFCT,0\4&>_';%+\^93O;!Z%VTAOJ];MU.9]46Z6?>0=Q.9B
M[,1J -YI<9ZK\PP%$3./N UH[(V]"0\/Q>V&?X#BA[OD9WSQDIF(V*OBP3D[
MR78;)4^=1B:),+SQ:?05C9QXYN5D^0=&PIW=8D+WF'*"K7Q2C<'%8&IP/OR<
M/(07%<A50BE^^#2SVS&KS(RV* J8TKRBR^PO0*GB7[-2G&3M_J_-"[6H&"_1
M_'AV:FUSDNG3,2"0VC7VT)[K7+[#R*8&=3RBV;P#X^,4XS1GL///T!CP77AV
MH9=13*$UJTQTJ,6$KM;%I3OVFAN5]537#L716%]A1JZA#O]C-WSS\EGXC(+B
MC02^IR<?Z::[@^-Q6/K:#TZRJ517\"$X:)XV4Y5@_#5$!3J)JD*)0,GGF&:%
M#YS3@I));%T=J;R@F!WH7[D"4[28-3E+45+A!,0PKT1ZL/\U'K!T!Y&50=O!
M"2*2J*+@C =\_5$MX8U*[X4XLFLE\@4?IB;=)?=OY,B<&+*KGRR\Z+06:=97
ML9T)MIZ6\ES)?N$)(RB:NV'P6IXG$U<5C)3=./0C;93#]KW %).Q3VNIV>@\
MBA,Z<6=@L=)92J\ZCM(O9&E4.,K"WMTLQ-1="3\Q@TM:.]KY9TIA[B? 3@WP
M.A<9B]C6[B#X4,'DP/K ]*P*/T1/0#!X3X9_U(/V9BKCPIFT1[3GKW70/E]W
MT/*LTLE*$CN1:7;M)O$5Y:.E&ZLH)%9Q[8P"+3*KAE7-3/:6F*^,;/I1#ZQI
M=)GG&7_7N5[<.#<;2(&2Q9(M1Q)FU\,V=VO-8]EI,_E-RL24T1>%R)<)H4EA
MMZGE'+.\F!N#64'['>^KT)C,LS2>6/<:!CK5[AUNF)UG/\")%RV"480PIY3D
M1J<VP+',, V\FT[]?201;9S&687NMIM.@_TUK93.E&TYJ;(5YOD0?3;5.W!,
MC7E*@P$R+I%)3&M1Z8I8M"3,7&_:3;2AXN?1Q+EX93!6T#@5J#%$_? NYY=!
M.$X]^C$&4[_FP]7?_,*0+93SK/!\//]N SK#HM(]H7A)221P%03(J;,*>%AQ
M2L&J1]Y.W7H,!L8HTFPR 66/JJP%;]I C+I[Q(6-]D[WW<\TAXE9CI$3>[<C
M8FGBDVN&T3ZM76? D_>[F]1*?U(K/3S%7ZPYQ<6NW?C'M_6/G2!Z5(1MV!&O
M0H&L[@@A2SF<OV6P@/V';@M[&10.(]LG6X#:AXM <<\S=(T.#O;J)L6HF,!.
M ?NCYDCH6&.T(+,<?(4HP<'\Q^Z;EQUNL2,.%L%X7:< W7[])G&*;@ALJ664
M$V:F4!)# *\.E,Y3#0:$0YK>,E#\-MJ96$1P110[<"[W=;O@)1]BZD5@L2"%
M0"[H:-7.''LI:5:2A6!M '2;D!@I%.296),YR(%2#!<O"C[JC8/U1S6-"4LG
M7^O4P"3'=%IF4@5L,MFDQEC@+VB9G,%[PDRL#^F*&>>>YNMW[I^X7[ZG2KR#
M8,9^':1%7B/"R%)M^7/)3WN0JJU"XLWVSM9TP!"PW&AA_'0V$#LW]X-HU[OW
M6-\[D \F@Q9X)+K[<3[!_"KGJBY0+\G+7&15,D6Y].QZ_=;U&?EVKSX@ARTU
M<,V<(ODZ$K!5#&3'(-T"O ":#'J+F.B,CVRF5(8M_C.JABH@L* @ICVY"?E=
M89=,;K-+K.);FY#JD!H68,?_BYH>^/J;@ TD.T-D[!L*C]7C()A5GO)^<<&;
M,#MI,,.PX];+>NB*$T;D+NHI@W?8".3E CE=FZK0_C7[UK7H(KF(VBR3Y:="
ME'H0XHHB!?*.1D04+%4:)>6*@PI@[Z PQ0BG!TN.*XFGT2(Z4U3"BF6H49&E
M9#F)C4;A# H'83&'2@O4N*(09Z(1U0R'R#$KD,@,) UNJ+XNJ23)!)^RY1(N
MJU(.<#&\,E483H#'I?!'B54FA'5H!*]B1"PD<63J:QM7B!6"3YV47KBL+836
M'3R3E#(GBAATR0$/F1 ^C"SL ;99O,!ZWAAG#1$J43*I\%Z\:\'?GE"<FRT]
M+0:S*J?%8'%PL@56)C SL"SK2L&:B!K"$>( HCCWJ[VH&L<Q!W.%]C$*H#&.
M;0Z#P1ZU6?70)QAE,K?HD,J &Q+!P2E!IR2ZD-I=+K39:)'+M8A:?ZQ9.YMC
M;>&W/3&T1R61NV[+I\7HQW7V Y4\X'&4\+YMQU?54D8FQ]:=:-T5/?>(Q.E:
MX967:\(KOX-<S)G8@!,E]=RG.)^NJ0U*O)JPEKV0GW,-!R'-2"T6Z"-RO817
MM.0JE'>XBI3V@QM*'A.41'T 5W@X/I< .77AF2OXEI69$9<7+UZ:I Q6*\8&
MYS,#15CP,TCF!#)C8B1:N%7,JCH-]H]/F&KH]Z=OX:A1DTJL/;M1&EH<*9"Q
M=.TBE2,3J]V#F=2+@([-%@K?QI9ZH_*D:C9LH(8;JRCUP2C1?5M)JKTH =M1
M@@&74"(H?ID['.\4#EBJW*UZU&616V(94HD#DS$P*HIG\LW;U^Y$<BT](ZH8
M=<:^&YHM9EG0(46C ELO':LS/!?IR)5[%@B;@ 5ZN@OF/-UF9QL> W_.!W6:
M GPNO!E&',10PM6XZI.<&V_M]M"_>@@IAN??,<7P?)-BZ$^*H0?5&U[YQO'H
MZ'AT,CH\'5JJY=^'Q\?#P]/]T0G6<IR,#@Y&Q\'QZ  N.?P)YA9+PH*]S[\<
M#0_AFA^+RKQ-C0L.J> 2<)B?BJSL[!+_W\Z/?X/?M+:\_=.52Q_,DM'7B5H2
M%,?D+!">"T<L(W'P\,+#!&413RO&#FB7QH$3S&*T#&Q@O5ZZF^7$1E4K.(!#
M5+>V=TQ,>W*##PCF=*Z(D 7-8WK %IZMH<=!H(O/KT-"H']3*R+WL=KKO7MP
MK9ZQ;R\#-L6'['=+Z6'AAWHL;-O)]01(+A4+%,*O871OM<)  ;C3\'4!<\+Y
M(<XB!--X1A"0DNZK*3/HABU?7:4P\='NB]VUQ51NS00MSG]72-&&9J'^Q'!L
MF0"'QWGQB&;]CD#&9CI!"9%M38QEJ*]<4/]FGF^3V!JY/DR,7'3=]#:@25>!
MH<L+@W-XT!0^TFQ0NIXZ.,LR)'2-N*Q:Q[@4AJ68X@?4Y1]NPV'2C;4--T=F
M/$KR,'I0K1G9,KL0HK6H*N=9CM^E"I.OR)4&FIDL%TY!MX0P=8$*CLNEKD*U
M3:/?#NKS1'.1@$^4%DSW]$_6#^([@U.L@_LT)T5S6K8XTZ9Q<71($WYKDITQ
M'V&C$@SF;] RG>2'>O,9NV Q0<#IH) >%T+7P,'GPSC&]/H7C##B</B]I*SE
MGY[B,[,:(N@0Q\RO087[X-97%F>7F?D)G=GAL*0_%1S:A1T>^MR(?&WIUAN$
M-E1.]%L<=N99AP.S2A@(@/VS%'8<#H93L#@*%8RHI&JC+&Z3WPL^>YFWAJ77
M56BH$0][FI:*XJ 2,L$**R,)V=)G=" 'R90_@CR0PRU@3_Q]E@L1&T5SU%>D
M,2IHL\ W&A;+B!2TOJAD%+P*_ "U0<CY!HP_F0#^62RGC%04X#]-GDB8ET*,
MF>5<O#9A.P#6,9M\L8:S4%RYP_=F(>!8EZY#$*A' <ZN&.87\XQ? _Z-C6V#
M:BG!7U"\E=G0-WS\MKN8ERU>Z9[&85M1XA932>6*<U9C6EE;NT.U=5)Y07&T
M F.5&(4^PV4.!0.>>\@B'&WC-<(V&7&7U9<7GHSN17!YL+H&7_L)+9JM= 9W
M!HX2/P>D^;EHF3N [5(1U<2U/R(==2US?5VMW[[($X?63ZQSQ\Q376Q31K3K
M);@F=VJK>TU-;BJ8+HWK#VUB<Z:QX2WK[?F'QK(0%IQ4@J7&NZ[7U]<IR:B@
MP.'Q'2N5LE&"5VO+3*RA?W$R&!.J*NTHL\C=#% =?T:;8\:%YSJ18$AT])YI
M/!TW.1[^6$.PXJ) _!JQ?A'1,',M+W[64DQ?*Z+W8!]W641_G0KZS59MWZIK
MJX5TE\IWN.\HD,*[EJIQ3+;%^(9K-B@5E$N273L)C3T.0@ 2&R4LX]F8(:1"
M03YV'L(Y#CS>9-=H=BESAY"?#?]E!CE6#/HM'!GRZ1+;PDJ[V-.H>D]CP@A/
M2&8'087U$*G"T(KP( 3C.Y8]H"0)IM6#J8)R4F(-,%8J1XZ'RZC]X'*$1DCW
M$9>)\\LY.6*"$K$WY%2X/0)-38Y#[:91T*1$T(B8B'CPK^'B\S@C4 ?Y>:9V
M46YY98L3SWA> &7BH3=8K] ,AUX:=&1<5CBX8)QK D#"/,\B=$6V]$O@?Y%)
M0/)H\$D2+:4,FGB $>L)HJS=._B3S- \YAK82"Q0O-Z"PT*A%I[(7U0U"VN0
M6$9EG'WCT086@@YVFYDDJ=(*+ULKN=RX5MIB(64Z@<=B%;BJDS^[II.HY;:;
MT!+!^KO+?< P%MGP5ID+,-LQI+?B<UE>ZP22J,.JN'/AG"A>'5F$QKYP0CK7
M$-Q"! ]SMV)4XNF%,J:I13U) V%A$3-H6[;2>;7AVTE"E<THD7P)?$;O[N!U
M\7VDAKCX5NXQ1\_NCV=L,XK-3)Y.%^Y<*UWH9 #_LYZ-U*-[CKJA@NG"?U""
M\>Z.U"?O;YSN"CI]=+_CLY>DB F*@'44;OXC2YEM,5?G,;R.I6.AR!4><E/0
M %G.4$6*R!$[2X?UTYE+7BM#_K1<P:398 5NAA5X\1VQ B\V6(%'AQ6XFH.P
MKA#Q0YY]@8.)G0+)7J/O>?2/4T+QIO!E<+!]Y'5'^H?+;8^F<@86&=XG=(&8
M2$Z!'SF=-5BWV5"1!/TP!>N X<A,HOMIGY!N,JW][=_4N(\V#A7#=(-_.U/:
M:E[$U(THU.$@<*D78_#UE:[[(C1WP3AQ)U!0ZE1YV!5!N!1IS8%&"BK2\7 F
MJ7_=QBHCHO2QFD?)S#D5I-9-AQ%[IZ3[(>#KH* 'R# <#"?2G=H1\S5.20#W
M9(_1=%EARQ76XB++<<?82@$4!%!,\:+P8^WL]4ZY9PP)R446((O*2D5Y09!Y
M95@/7>0"W\1&FO!6\@)8ZL"Q^SS4WL5_I=D%[!PFI- TD.4<C7&5^@0PUL_/
M--[?,>WC@ED7,#&YI+(A=F'LE1I5&>K4 %G%3K\/Z]0LG-N)_5,SUTG/;&E/
MD=O6Z/T6E0S;9JLYP1)==L4PF&!,]"NEI[:^RA,2EP:OT38'1VZ3=^ZT6'X.
M%PO./)L2G?R/E\^(\0JK"3P/!$L)D ,=Q'N)CA?ZH[*4 YW =6ZS^[+]-C;V
MHG],.FQKI=ULC#"2MV:J%[BDA6:J>Y:(AT<\%(KQB)<BDF5JIAHII>B+2KF;
M&B5.PO9)"DW$GX?I7^0U\PIE"U&.1VIW'5V^E((2F9=Z8R<-A^(.&1BH5:!A
M;;X)LU:F QO'EO%!L 7/\>#!D4[!D5_1OQ;1%UK@A,C)_5P#"?M,T9;F \%U
MXZ_!5<.33Z8>;5'\>[71^M?1^J_6QCU-B(S.: Q#OY.PPP8P=&O T)5.T%=P
M QUE<0,K'?KH*O&6J^$.0K]8("XX'[/^N%1PMS0ZHY!4*<G/*%<W/</-Z2TF
MHQ''FEMO34C!^-N(*ESULXJ2<C[!<5 B!0?#__#B<W$I)S4&$&ST+)0,D&FX
M(D%WQ[20A#AJ*'.U*&)[D::JTU:$3EC1D6WC@NMGV-&3+1.-NI9N+2%))XI(
M3Z&7=DKU:A/3PU*'_FWG;ES:Z9IUNSR"3UM]/ AIKWL[3QK JAMO0+D![051
MWAU2(-\.+%C%+9H2^!4^Q>_\J0%:.$0XLPTVVN"US 3,- &F/"FLH[!HOQ29
MD_2B?4,)"IWJ_3[!Y>!W6^%T17T5,@CCZEO96RO0'?.HL,K$US=Z(S.WM4Z-
MN,D40])"4VNRC>YTTY)B)192Y,%::%H^K?!=>)Q OKN>%C[6&/]#B*B^_(X1
MU9>;B.KCB:C> 8+36LG?W?9=SE<%\F*!LDLQP!EP] '5'VIP^BRT5UEN_Z*(
M$1]:AM;WAB'%%,C$PQ;-RQDW=8=GVP,37=ULQ9!C\+WI;&@):WKAIM0/,MS0
M1L!^"(R2DB&2/0"R=DZV;OTI=3AYJ&N0>>P8>\"00)00;,5O3N]Q/%L+O&:,
M]D_Q]V_3=+/('%[/#FEKYY[!63 AY- 4#, )1I)"QBZ#[%"I.PLKM;J@V!%:
M+^3J7%S;<OJ!@#1@?X!-RIVI"V&$(<MO'!'+!!$)4!!K$B\C73: +_!3!MN7
MVK9&VM]#^KRS/%HPD,9CR LFH"42HBVDSO3"?!,PQ$\U: %V=M\,M=MUDE&^
MY(3!>2L,)2(4.*5+M0Z:2$-M!/G*']0J/-? F24F:5(XFJ1MU50Q,)PHR7'B
M8PQOS4P7RGJV!-_9QAPIQJ9-P(;KU[G'./I)$!;;,Q??$1N/Y_22LOV'TG5>
M6B8LJS'\8$YU+07' "6RJ%>0ETH3%R"K8)4+Y1JO2F%PE6U?;C;_;<A?O,*?
M&YT'VD^8U * /^\?#8>N-_O]CN3MX!HZK?6=4#U=7S-9?XS25C6?+.<X3X"^
MG^"O;94(9W%M>B1G>DUZC,U!U;L'T:+ACH9'2K:8@7JZ@EB0X3>9 SJ+=0<(
M5G)_YI(^GEU^K9#\ZS4A^4\F8W]B*M\%BZS[C$M]N(TKO3:P7=K/JA3<>I;C
MN0[_77*5R0^8V:2EK-*HFE+AHEM?CWOA7*65M!PP:7Y=SV=3?0P,V-E]"D<L
M6KNP^AG\@ [T?U2I"IX_"X/=9[O/0TDX?:M'\O/@VW^@=<I/H.S9I/Z4D@12
M^*::-XRDR=<2A@(NLSM@OU[_E.[S0>[C%>W3E?"P1:WNC-&4A<PVN*EG<QQ@
MN)87H&OA_<8K;5<Y,6C0<G!2HU-A@10TR)20T9R$SS1EL>GV)E54XM^ 5YY]
MT0Q^R(8I'>@9PH?!O#Q9Z0B],5),J)ZC]+RHH5G14!"JO%QNDME.7<E49$XM
M5TD[DZHQ=+<F$C6_IT"IRSZ<(.36:A!PI5TAJHI:1Y#5$A>8;,9SX:FB="YN
M3II*6/U_#<C5B8AE\.IOX71J@RE;9GDDNY"*\J;6TZKU<?P,"A,<,BY#.>%K
MM5DVT#\>J_)"29G,L9+5<]/.9+AR5M1P2TJU4/TRIV;.CH2)/L] ZZ/=SYE?
MTS)0>E<'M=;5NMQ(GE<3*S>-V[]SX"'$^%Y]QQC?JTV,[_'$^*YER[Q95P$)
MPD8''E+['PDHR@67^<3?X56LT\LS"C_T3MOTS[=<3W*B\X"BX6WHL37WA_Z*
M9UI-,\64PV!U(") D1T2!HNXH+*U91Y+M9)%#.D2&WQ>J]@8*)W)@14;)NK;
MY;.=_&<B/>RNE@2]Q"LE5&:A09EDDIN2WXJV^81;5$A:&/Z%#O"7:7:1DE4"
MVQIA:Y2$1">F6NH$)1H9,9ADAF)R&N53O_#/M7)6P<FJ(/N<\MTX*FKA./7C
M:].X,,^8&;"F_BAV:]3T7MA(WFU2/K_70B+NS*X7+T_1T'I2!$L7S\:NAFK&
MMPA"@T#*R,9WCQU D1>#PKL3A<1:V ?Z(]C^CD4*+.IX*IU?& ^,M:.QY$I0
MC@IDL:'XN^.3A::J?8+RC'8<1Y%)RU$8AN\QBR.F";'N'"&'RRSA0MUXP< F
M+'NG7<9Q:HJ0KPET%198*H6SV-BFL,R^4H+@Q[)PJR-?B=>]HQ[N>J2[YEI&
MU-LU1M0I%GP04X.<A.^" X5HW@T^\[:V#G+J4;WLL6H8J*=M9&]P0/F\R9OY
MOXT!0G4G%*AJ+,#UBU"WI0C5#XV^U3V'J#K:A)F":#K-)2A"JJMM'$Z )#35
M\D3X)DJ;(UTNC7;"MT&,^N'H>&^/PT2(L.+>GCL[+Q&*7P1#BBR%P>]9EA;9
MY(L"7^AX/WBV^^;MRVT=RL$3B*DVW38-EK$%"]#T'P:;,-25L65>Z3BP!(5-
M()A&3J]LXFIM$W#%&B SQUL<PM4_B72.P/3>6"SPJ'3;A]5+% 9AXP#1' 9F
ME,7:07.FF>&P](;8X@1+%(0<$(S-..4U52E!Y+C%"5>9M +G7'0GWM?\CAG_
MF.S+4 %2&9M^*Y2A(DM@M?'?8#X[Y!!(E9!')5C&U<(IH=(%>0="I7<FR5J=
MYN6'NNQ5B!QG)B#L6BME(7X_F4+?1OAP),<D]]2FKWX4>&A@R"P3B9L3,<\[
M-B(< .16]U*W+&MZ)9R"*6-9Z6MI$4.A*]2,%I;.@I-<=KDM/MMI(<9TD 6;
M9*$%D[N-FMD0XDV]A"T:G1DJ#,V$H2&1#LD&/3AJCDN;;PC4U-P5K0P9'E&%
M+ ,QYC9?3+7&3 SBEL? 53XRBN*J$16WPLEGLGBGBY/\M;]AKG5KAX :K"9#
MCZS2Q@*H164K6[%0LXD)*S8I:6'-A8<L%GBSR:1:KCIUA"X=PAY$IG*573]\
M"TS3X&SP;BFHT0F-T7VZQ^)F&RA0XQ.K?)S*/YVF>$0VP_6HCY^ML1-&Z7F<
M9QH ]$L$ODM^G3I5)LRNU]A<)=5-K=/,OKDFMV=(.<!:G4WH);2N$WHQ<95Z
MN8SI\.-@@?PIP].$D[%=M0=.\8 I"NB \C5O;5[G>K'#,#!1 E>[Q$6]X:E+
MR#E5<,;AD9#^4:6F#3IE&83?31/@>*BQ#]ETU21A:YVEJ>9>%*!'O:Q8E_:X
M.$UN[D+?8GJ9HY=9;J >'FP+R98,8S"/J6T@I'I5RP1Q'8%8F_C!S]&_X.E9
M55A)E/8PK?H/I.>?N*ZFS)?8?E/!?TFXS*Z7R(,/> FEBM:I'DC1\, I\ F(
M.M^0W:Q\/3M,C=(59,-I &5V=B2$OT4FQAPAU0HBK%I__X:]Z0XSU(!>/&6C
MF2)SCY2/FSYM.@<L!![S7\OK]^XD> AYT=??,2_Z>I,7W>1%VZV9=9T<#J)Q
MQEQ6(\)8HTZXCC%#36<W><Y;U6;7,+2DL(>@(A).3M; ,@*&%_YYKJ3P,/*:
M22+_TE)+L=[QO=R4(PM+0_?AJ0G*3R@/-RT#G#\UBX9W2NG&G0:H=$'-7JFQ
M04;M(RT^#;1,CD8.Q4GBQ2(^R^70=YXRCW)0#6W/QVX^>:P]7N=;A0;O*IO-
MBDO)^FO3<BTVDPTD]4X"MAY"N[EC3!VZON@.-TUDHT3XI%;)M6@U$Q6RCS:]
M<;K?Y1N\!I=8B_UI'1/:P& 7QHV<6B:%.LYF,@4AM?%*UQ(S;#2GU\P8I>+9
M5*<8I+P/>%.FNR3M59Q%6R1 MBL8+$P28]B2VD#MWMQZM/ZGM,6E$;5,1K*R
M[I2;C.>I02[M+]C2(,DNGB(P@ )J-,5%F2V7&)UK\<(H@7N)+/A)XK'"+W7'
MZ09WZB/2%]<S;]8QWX^TJO_ ++[$#+_)5WZ+?*5K!>YJYA@GMQ6UEP#H,BZ*
M_9BM9HYD85L.ELC@;Z$+O$EPXR'<0.7^#O?!Q7ES^SN Y-4Z%2F >*?P3X5N
M<+FE_>SSK><#T]5 O\6Q*@7($>QS)UVWB \OWWG[^@67JRZX5L&A:QP=[Y\,
M?<)&CNF73NN23/_KZ9@CV%,-0W=Y[D+P[=)*:-_0M415Y%^ _Y08"@Y::0HT
M+,8L=&"(HD0SM(2**N?6)!3L!\-021AA2<T>EKH2$O%1S%QMU1V>%I9+4=[*
M'B_H=(&%Q+<OL'Q ALCH^:<9^'UXUXRYSYPYT5(CD!'#\G>#,7D($N[;$I&B
M1F)@3112+#%7FA/61^H5B2Y$<&%Y/*ZD+-/K!.V'HF:^I+:+=NVPE5MTV@?^
M/3LE79=C#AJG9Y-DL..(YPYD:._8O<F8N#/\R\84/>:^MM:5^D&NBO;*33::
M^ML8RI3-$DOV2ZM=YG10L/YFVF:42A9=+C&M!Z\G#(;-WTTAXVU$.$0UT38V
MW<"=LD*0:JN&=TD-D^ZTF];GL\3;ZQ^\V-FUKC73_IA[/=LUM_)P>'9O8\.:
MT&P!YY68NTBN"J2%UE6WBIF/-IM6YF2!]4.RQ?.KS<SSU\[4]&\W/81([YOO
M&.E]LXGT/IY([YVRW*P+[.["'?Z41/5C#"8['NZ5%C>^6C#9M:AL(81KR,XJ
M<CZ82M@Q9%L"P6C]V7YO91L!IL\ 0K0?-N8[Y@8_!IP&TD GDKD=M5M#DJ)C
M+G:5<QE]I3>O?%_)KU?&Z_SZY$.B&)K'8ZF_-C2_EWES+YZ],D>E:Q*\>/OZ
MI6LN\-F/V!YRN=K.Z]9%8-(2LG1<[F$&]]51#E2>7I59SD:X0XQR3AVN%E*8
M(@%%VV-I!KMS$B/=S+0"LX(- TW'K7/ ;"C=Z#6\,)K#<.Z&Y809O&[9M<X*
M6IAQH8$.*9'OQPSD,(%<OE__K)<>*H=N[7!X>8NT*S9&\ZCC->/^U>FTP??G
MD40)6")<U72FZ!.),4NPXYPNYOYGPX%[?B!D2$I5G$)V)X)0I4[DVH]Y@&2=
M.;TJ<5K',$X=/S( P &WSB6H3Z6<!EUM8DP-)&G4< O4="2W>HQQX=C\8;#U
M88"Z,2=H'HD\WZEHQ# L&A%N18IU_3#(M=]SIXI.YQJP4U,:,*.2A%\(4L,[
M&0\&T8WK1K?9CU?9CS<YKF/FZJ)SDON#KVI<82^>[2"DSW5B/5+7*)A%YUE.
M(J/5/Z]_HA WQ"55K2>OT#ZT ^"]O)HWYJC0G-:VHSF=8873EYV/3SFS9M(@
MC_:Y?Q@Q\(O,3MM5(A)""+A/XQ%M:3__U*H7^ZFNV>?J/./(<Z/+*1Z^]D^O
M%XWA)5D@@MYTJS;<QJ@]:OS<FC3W]D_1YZ3EOJ&=2YI@C(UI6</H1AAF4*BC
M5N "M R.H>!YI::-0L1FP$.S.0J*LWSJZ%U,4^)'KOA=J&0FW<GU/\O54EDE
M([8"HZI=PB@33:WMA+=OGGUP-\)V,.JJSM3GRU1P_'4SM\VP[7[.XU%_U\O)
MK6MQVVAN*>CITS550KA1FK]K;*D;%">)J#3;=K)XM%?AB/CX53Q\@5O((UEA
MI[P%/[XR79Z3X!"$06N9*QI#$R1':O'5PDL*AO  N7K1T"R/*HP/H'\B/:6_
M3241FZ&F<*@6$29KE<>M"[9,QQE-%-5:6H08<Q_ O:ZLR)AO:.C&4^T'1PZ5
M'B*9$VZ[BDO /]M:QZ4U\N>;8R^ZLY5U6)V>[%=KUHR'!W:$7NHVQ1U")LK*
M^T8+>%-NZMZ[4T6'DG+#2CH&^[<[ES(60XJ '7[BK"HX;A3K->B6;]K]^G3!
MD 86N/"_2(S  YG('\C,]KT:QKK\_#>K.&/2_G:MU-I.>4W[8&)P=)JB%/'7
M8.O5P.?,@SUAV26F)L_CNVVX1MR+N]DSH%D21PI+3+^L^9*LSOIWB#Z$C,3;
M[YB1>+O)2#R>C,3U#,%UK4SW\.S(B4+R*%IENHJNEHAXT006:0P1(74Q&+KU
M<@#G<GZ&M8V-NS8(-Q>@TZN<31T0H:( "RY)B"E7UXXYQ(QM7*+D%&E'TWL:
M*4A['#&+.6MC,4H<9S:18#N\FNYK(X8/& CS>&E!GJT]6O!W%";0CIAY[N6/
M[7YHV$!Y]D]!]T2XU[4Q]?OMV".T7<BY>:D05Q9U[%R$,1%<5E?P#7:N\TEN
M#0?"X,'_9W.J_O  GWZ#/-_-C:,"T6@U0Z.=4I8,J=HK,GM6BHJ8MYBSX;8<
MYE6YQI0%ND$(B19U3IZ7BBGK'0O(^!RLV;GU/=1H32&J G<S!;&\:YW>;3).
MWN<XEBEHGA[:3#W9DNMZ3)ZZ^0E:H&.I0!'FV$93;<]'4;7>GV63Z;:CV733
M(6JYT _ZZUXN0N/%"M^)JSDICT:7BE8P+4@K[W"OB+6F"5[A#/A-D9UHB^;^
MQ?N YW#FRZSP'V Z9TZAC=92)K]AJN2@; L0VP'$Q?$V?VB?>@7'BC?F.9V*
MQ3*K"K]$9.VC[7O1<N";;?9>Q]Y;1R9_&GV]"5?"ZPT$I:?XHN[:@"&Z1[#<
MQZJL\K19U>ZC2SV -!K>>*1[H0B=M\"NTUKOVM^W,,X3H 2F!A:>;V<4L4OZ
M"D/$NPZ9$934]U8'^3BJ"HKU@B"5C$DM#"./*5* "Q?1%R'B094'#D4/X9;]
M$Z5N\+*($HQ,Y[X;Z[]>NKH%R<J-B,HRBJ>,LP&)A"N(; *Y\E&B))+?$HK\
M:3@\,E%V':S^RL;:' _05", -+5/7 @=4[U$0-[-"_L^JAS3'8 =P4]W2B\O
M(@2Y6.MJFDVJEBH07D -:@))T7%3VXG>7E&:5A!L,A*+C;ZI3@V(P^$TTEID
M%4?,6;[7B[%C[=5 =@P1(X/&4GX,+-B/+2P6M)HRW#\^,<4=-!LUC;BJ%ZQL
M"<P'C"#/.VI1BO I/LT[!W2?77U:?T:.&@2I87*C4(,ZG1AKU3J/KLW%,3:
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MYNY+P[/".VRQN3<O6NTJ$>/2]:6-$\#Y$Y%<W_0_RS+GB Y*/8JV9V 5M1(
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MPV]>AP\7JIGTK"7RR1X9N0$<UJ[5)5"\W:#;)M%2RX;V! O-1%*B<46+.:>
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ML'2G<]R:ND.DMF5;"O_H_J8"U+B#U-NY2DJ:&%L9SN7 R&[EM*#5$1G^M\.
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M_%2,:(!STN* ?!]+EM_#DU(/XWPO0IY[0V$=-<)[CJVU35H'F(\BAX70W9[
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MIWXM[?]>Y P?+9 TYES-&\RFCM=>#<?K;QP$'+6]&SQD?^,8Y,3MC>3$S>C
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M@+<>5;J06'V-.PBQ82KMYEW@7W-*#?@P/?Q3G"T&$\9T^G/ 4AQPR\K@,CX
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M!\%UNQ9FH:WBM,+^W67=!1N*4\T,GS<* -Z92$3/07MC!8T)SQV1Q.'+Q"?
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MF(H]STR62V4=)DOA13;D=U!U1P[O%K6U7RN0D=CDS8%65UGLUQ>]G(^%R3W
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MW;O_1)_B3<)-RTF70N^WEY_\PC0VM\DB;IM@@OALIE3;;._!QE=-:<4I!=!
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M&3>VEOPT/UDJ5.QH!C$;X\)CY/7CB#(0=44D X\@KU/;\8'GW933#+MK1YD
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MEKH$NX- VN'B_@Y5]XRW,OT[I3]=V"I&D#=0SS5&U6M3?],^8%AH0''<O6
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M/><93)YL1/A_4H4N"%U(JHBJ([A<M*B,UF"Z:6,9J'6),*@/=QW$DF,^D;'
MZE1U,I4F)=.FK)I(#T;7=1)3HS0I7.:& ")7^*?4'S-A\\B@S>FC%K5H<9[P
MB<NP"V,<S0R8C]Q /6/I>[>_G<$9/<+V%\ZBP*O_;!".@;1A>%="+=2Y"0=R
M# *;2TC!=A_RI;IEUJ6P#H'1B89KBEKA*:X2,CQH]0SX$?S-WU>NB<*KVM38
M:I!_W@N824?$*W#WU*9F(R[LL2I0PI-?Q7ME][II1CT-D5=0RRIL2Q!]J1NW
MK@$^FL..K>S,LEXYAV7B==F(EP:;AM3::QHYM'95$[U+:LO=)Q,WET?O=<4
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M:36.(JG<VID[J!QAZY2[CYS*MW -SY%Y#)71L.*M92_]>HL6H99DQ]'?BZH
M6YJ,/'.>0C,F-H3+F241;03><)R/FLFPQ*SH*MA1-1Y,V3-8?DSQB+U+%I<W
M?[.T_V01[3O9->0L,/8'\[(OG^SKZ$/BFGFD)'\& A=CBW.3K"W8,^][HO7/
MNC?]:TG6:6)U$WSU- (5HP)EIAK#'W%:P7WE%5\T34I06B:45^NDP\ZQ2S>9
MKO4UYG>^_*SYG2^W^9W?8'[G*O+E^T7RY?CC*&MB_Z"S:'E3U%C#5-41FS#
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M"67VAE3.3?1PES*>8<HW[<#%SKQG@@UHV*PD*<4,Z' +;R]W=40(<$K8[BU
M:8%YB:=/R=R3.WR=;H6%NXF,9;51^7B02&--91P5]I 2>IB8^8.&,TY:QG*K
MI0NG&OYC,$G!2$\S=CGPF8VY\JMH@L9AE*EBQ\4M W [50:QAHQ^L(<,SX8<
M4A'E*K)@SR\]6*4%9])!@*%G3OYA37!A.S4NIGXKYS+*0'B+I?FF3T5?P(JX
MN>7PC<^B\S@)(DI1![G(/5#L:Z(-8<:[*]F$U E_U*E5P;\/''Z8]QO3IE%N
MX,RH+CG5Y<XI+I3I*X1^.?9%L,?QS8SW@YRGA7O._#O!0:_O0L?D"C;Z4>X8
M781?\=1/[422;SD)_#2.R'>#%0%%%* "8 @UED=)U,8UP+&("M&X&>K:&EGZ
MYL17*9)5D59F:C<PXLP'6-CF9CUJ1(8[Q!(HD;$##$_(4VTZ9.%3J3$4!9GX
M!^-$'G0=%<$  _D;;2]IH5:',%BC[GP47QG=D*[A>S.2_\@[!L"2 W#HL%,/
ME2M.$X0K%(?*Y.P\2MC)3U%!?S;->!7#"#)K(X;S452Q?1XNYFBSH<$&S_!+
M&!,$6&M3U! ,^<\#JH36*K0KD],]#/7**![+ZQ7,QOA0/,2PD(_P%!GQ>94,
M*^><#AGR(D[2)%VQ?JJFVCPQE*\>"742=^Z":_N/-3K2$,[+F_5\TR28JB*I
MT)*J!K#8TY*T'(:2O&)4C-#.(>;$Y:B3LMGS8!0"4G(E>+Y2B%L4H2EOH6SH
M9RJXP4D68WDG4Q$G'17 )OC"O,/5DM!F]R562F-5FI59[<NJ_RZXL>42GSN3
M+<?6\U2<FG[/5TN)CB2J5IC:9"DM? _3'WJ3YZH*$PX<'N/I/@J",84C<?GW
MI;66ZI*XT.X^3@+V%>.+A9"+B0/JIC9J"K6'.?AMW-RU6(E8[692H-.PI7BM
M-#JKS:F8*LU92,\#+<>C3.SZ%ON]T[/<N KP?'\21^$-&S\8H)1*QSJ=P1JB
MJC/#$S571>,\VXV,5%UX6>?>YW;?*+\W20ZL.FU%]*D]%6>1\!1"O89X[95X
M#!)NK"%(*H&ZE'W]O'KF% .RF+D&NBLN0LR((Z'706%Y/O!>;0[SX7V0U\<N
M3@\D=,7Y0HV*+97$W-O=QC'M6<F^#_QD&@:)0G[)9*0#H3Q*RK;.AV4<IAP\
M86I5-H>:&?4\',E$([ZE1]$)<B2CAVQ+%^.':$T8&9T:%S6PJA9WIB[ L<@_
M(YH$>VIOH0</&:]O02B>*)F X8X ,9U.=XX)OFA>+0"R8":A^J$,^. N8WVA
MIQB]Q,4W=9Z7DEN?0JXJ3&W^G,/'19R[S&25!<QIF $H3FV:4 J.B=Q:F%&Q
M#IE#IE2>\IUTO+NH=C1 O"(2V_ T+))%-FJ:,TYVN8V%>K]3-P@KF0_F;012
M--)QE3:KH_L8N!"CJ1]]V\>$B)65SK<ET+<8CSMZ43SN117$FGM'VQN.LU<0
MVU)U6?L*Q1=5#=?+V9S_B+?:14_I>(8Y-S,P\Q,ZM1WC+8IT4=VKK#&^_EC4
M#_5@X%;4:;=!15Y'L;=%RG4)R?I)75%M+<:UK:53GT=]\^E[E7,_CY(O[]8I
M+4P-URK&^]JXND*;>L-^Z[SAO3&%>DMUB7](D^9J\AJ:\[Q2MC^7A$T9C,>;
M-!B/*X/QEYA9EM1E72BLMZ4SQUJ46LH,[K3C&Y@X^RX\NX=I]2:$;SW_R7 (
MI+L;X,N/WIKW##8:%^R9\PP6S/U4F&;H27ZQG@*UJ'/)W6BG?H05+.6?7765
M77[='9.TIQ0-E5D^H@9_BC2>AF/]4/8\PG,]\B]"@>[QW^XG,7=]GL#[\Y0:
MUP_VZ[_][*O]OB]IET$TCA,M,$ON_9,$CN(LB^^)$TSZL^E3K()?S&Z(6>43
M;YP_7XO^URP(7>4OS2>/<A'0_L1-(= A$V0CT,WI=#-@WY;B*UG#\,6FQ,V)
M,HKPO_F9ATZ_V/@@[T"U79#[T^62MRWS@JE^E5N8S<IM(\@B7YP'_C2;E"ZP
M^35CM=)AM]NM]><H'A\<*;7A6GJ9\B;D'<QU7&-*YJ!AZ)0XUV^!3M4/_SC9
M/_YX>/!Z),SP8)<N9[G'?.?V_;?W?ND(U \_IS,-RS(NTS *]J1[YK!^@(.3
M@E; 2](::D&OL^2I=,R[$:[==T_,O]VW8 MNP?S0G^#):#>=J@+XE7FRC%7-
MZ2P0+2Q#)/!CZ0+L34+,.8UO!0U:Z?#M0K*URTAEJ/Q2VD6&RLGAT>^5H5(9
M*I6A4ADJE:'RPPLU/+I+RE?Y%B?F9N6K+&4S=8+L,4Z^5>Z;E[O!QF(CBU9E
M'*TTCHX^?'@]@E891Y5Q5!E'E7%4-JMZ_DWY$TXWN?.C\#]UN*AT^*OD8VM7
MD,J!\TLIEHHT'5<V2F6C5#9*9:,\WT9Y!_]CJNT&SHFV&]Y@+T^%MY9X?6'I
MUI.22[>>K*Q<"A]&\?CIR^?WD^Q^^N5_4$L! A0#%     @ )(MP5_I& XIB
M P  : T  !               ( !     &%M<RTR,#(S,3$Q,"YX<V102P$"
M% ,4    "  DBW!7["K6.=<$  #D+   %               @ &0 P  86US
M+3(P,C,Q,3$P7V1E9BYX;6Q02P$"% ,4    "  DBW!7'MEKCOH%  !%/
M%               @ &9"   86US+3(P,C,Q,3$P7VQA8BYX;6Q02P$"% ,4
M    "  DBW!7K/QKJ',$  !\+0  %               @ '%#@  86US+3(P
M,C,Q,3$P7W!R92YX;6Q02P$"% ,4    "  DBW!7V*-H#'<2  #'<@  $P
M            @ %J$P  87-H83(P,C,Q,3$V7SAK+FAT;5!+ 0(4 Q0    (
M "2+<%?QU+D#D?4  -^Z!@ -              "  1(F  !E>%\U.3@R,#0N
9:'1M4$L%!@     &  8 @ $  ,X; 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
